Unnamed: 0,report_number,date_received,manufacturer_g1_name,brand_name,device_name,product_problems,patient_problems,text,manufacturer_std,brand_std
15,1222074-2021-00053,2021-07-14,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,EVA TDC VITRECTOMY PACK VGPC INPUT 23G,"Unit, Phacofragmentation","['Material Disintegration', 'Material Integrity Problem']","['No Clinical Signs, Symptoms or Conditions']","IT WAS REPORTED THAT DURING VITRECTOMY SURGERY, THE SURGEON NOTICED A PARTICLE IN THE EYE WHICH HE WAS ABLE TO REMOVE. THERE WAS NO SIGN OF DAMAGE TO THE RETINA AND SURGERY WAS FINISHED WITHOUT COMPLICATIONS. THERE IS NO REPORT OF PROLONGED SURGERY. THE PRODUCT HAS BEEN RETURNED FOR INVESTIGATION. NO CORRECTIVE OR PREVENTIVE ACTIONS CAN BE IMPLEMENTED UNTIL THE INVESTIGATION HAS BEEN COMPLETED. IN REGARD TO THIS EVENT ONE CANNULA WAS RECEIVED FOR INVESTIGATION. VISUAL INSPECTION UNDER A MICROSCOPE SHOWED THE PRESENCE OF PARTICLES. PLEASE NOTE THAT THE INVESTIGATION IS BEING CONTINUED IN ORDER TO (IF POSSIBLE) DETERMINE A ROOT CAUSE FOR THIS EVENT.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
16,1222074-2021-00104,2021-12-21,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE NCBF","Unit, Phacofragmentation","['Fluid/Blood Leak', 'Improper Flow or Infusion']","['No Clinical Signs, Symptoms or Conditions']","THE COMPLAINT IS UNDER INVESTIGATION. IT WAS REPORTED THAT AT THE END OF SURGERY, AFTER CARTRIDGE EXCHANGE, LEAKAGE WAS NOTICED FROM THE BOTTOM OF THE CARTRIDGE. NO REPORT THAT ACTUAL PATIENT AND/OR USER HARM OCCURRED OR SURGERY WAS PROLONGED/DELAYED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
17,1222074-2021-00095,2021-12-22,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,EVA TDC VITRECTOMY PACK VGPC INPUT 25G,"Unit, Phacofragmentation",['Contamination /Decontamination Problem'],"['No Clinical Signs, Symptoms or Conditions']","IN REGARD TO THIS CASE, THREE CANNULA'S FROM A DISPOSABLE ONE STEP CANNULA SYSTEM WERE RECEIVED FOR INVESTIGATION. VISUAL INSPECTION CONFIRMED THE PRESENCE OF A WHITE SUBSTANCE ON THREE CANNULA'S AND ONE INSERTER. SINCE THE ORIGIN OF THE SUBSTANCE COULD NOT BE DETERMINED WITHIN DORC, THE PRODUCT WAS SENT TO SGS LABORATORY IN BELGIUM FOR FORENSIC ANALYSIS. FTIR REFLECTION ANALYSES REVEALED THAT THE WHITE SUBSTANCE WAS IN FACT PRECIPITATED VAPOR FROM THE GLUE THAT IS USED DURING PRODUCT ASSEMBLY. A DATABASE SEARCH SHOWED THAT NO SIMILAR COMPLAINTS HAVE BEEN REPORTED ON THIS SPECIFIC LOT PREVIOUSLY. BASED ON THE INVESTIGATION PERFORMED, IT WAS DETERMINED THAT THE REPORTED EVENT IS ATTRIBUTABLE TO AN HUMAN ERROR DURING QUALITY CONTROL. PLEASE NOTE THAT ACTIONS HAVE BEEN TAKEN TO PREVENT RE-OCCURRENCE OF THE REPORTED EVENT IN THE FUTURE. THE RISKS AND MITIGATIONS ASSOCIATED WITH THE REPORTED ISSUE ARE IDENTIFIED IN EXISTING RISK DOCUMENTS AND NO NEW RISKS WERE IDENTIFIED AS PART OF THIS INVESTIGATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. WE WERE INFORMED THAT PARTICLES/STAINS WERE NOTICED ON THE VALVE AND THE INSERTER OF THE TROCAR SET INCLUDED IN THE PROCEDURE PACK. NO PATIENT HARM OR PROLONGATION OF THE SURGERY OCCURRED DUE TO THIS EVENT.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
18,1222074-2021-00096,2021-12-22,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,EVA TDC VITRECTOMY PACK VGPC INPUT 25G,"Unit, Phacofragmentation",['Contamination /Decontamination Problem'],"['No Clinical Signs, Symptoms or Conditions']","WE WERE INFORMED THAT PARTICLES/STAINS WERE NOTICED ON THE VALVE AND THE INSERTER OF THE TROCAR SET INCLUDED IN THE PROCEDURE PACK. NO PATIENT HARM OR PROLONGATION OF THE SURGERY OCCURRED DUE TO THIS EVENT. THE COMPLAINT ARTICLE WAS RECEIVED FOR INVESTIGATION. VISUAL INSPECTION CONFIRMED THE FOREIGN MATERIAL AS DESCRIBED IN THE REPORTED EVENT. AS THE ORIGIN OF THE MATERIAL COULD NOT BE CLEARLY DETERMINED WITHIN D.O.R.C., THE PRODUCT WILL BE ANALYZED IN A EXTERNAL LABORATORY. AS SOON AS RESULTS ARE AVAILABLE, THE ROOT CAUSE INVESTIGATION WILL BE CONTINUED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
19,1222074-2021-00097,2021-12-22,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,EVA TDC VITRECTOMY PACK VGPC INPUT 25G,"Unit, Phacofragmentation",['Contamination /Decontamination Problem'],"['No Clinical Signs, Symptoms or Conditions']",WE WERE INFORMED THAT PARTICLES/STAINS WERE NOTICED ON THE VALVE AND THE INSERTER OF THE TROCAR SET INCLUDED IN THE PROCEDURE PACK. NO PATIENT HARM OR PROLONGATION OF THE SURGERY OCCURRED DUE TO THIS EVENT. THE COMPLAINT IS UNDER INVESTIGATION.,DUTCH OPHTHALMIC RESEARCH CENTER,EVA
20,1222074-2022-00006,2022-01-25,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,EVA TDC VITRECTOMY PACK VGPC INPUT 27G,"Unit, Phacofragmentation",['Unsealed Device Packaging'],"['No Clinical Signs, Symptoms or Conditions']","WE WERE INFORMED THAT THE TYVEK LID ON THE BLISTER IS NOT PROPERLY SEALED. THE PRODUCT HAS NOT BEEN USED. NO PATIENT HARM OCCURED. THOUGH THE COMPLAINT FORM INDICATED THAT THE TYVEK LIDS ON THE BLISTERS WERE NOT SEALED PROPERLY, A SUBSEQUENT EMAIL FROM CUSTOMER SERVICE STATED THAT ""THE PACKS WERE NOT UNSEALED, BUT BROKEN"". IN REGARD TO THIS COMPLAINT, TWO 27 GAUGE EVA TDC VITRECTOMY PACKS WERE RETURNED FOR INVESTIGATION. VISUAL INSPECTION OF THE RETURNED PRODUCT CONFIRMED THE PRESENCE OF CRACKS IN THE BLISTERS. SINCE ALL BLISTER PACKS ARE VISUALLY INSPECTED PRIOR TO BEING RELEASED FOR DISTRIBUTION, THE OBSERVED DAMAGE MUST HAVE OCCURRED AFTER THE PRODUCT LEFT THE CONTROLS OF DORC. THE OBSERVED CRACKS SUGGEST TRANSPORT DAMAGE; HOWEVER, SINCE NO INFORMATION WAS RECEIVED ON THE STATE OF THE SECONDARY PACKAGING, IMPROPER HANDLING OF THE BLISTERS AFTER THEY WERE REMOVED FROM THE CARDBOARD BOX CANNOT BE RULED OUT. THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. THEREFORE, NO REMEDIAL OR CORRECTIVE/PREVENTIVE ACTIONS WILL BE UNDERTAKEN AT THIS MOMENT. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
21,1222074-2022-00026,2022-03-23,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,EVA,"Unit, Phacofragmentation","['Free or Unrestricted Flow', 'Improper Flow or Infusion']","['No Clinical Signs, Symptoms or Conditions']","WITH REGARD TO THIS EVENT THE EVA SYSTEM WAS NOT RETURNED FOR INVESTIGATION. HOWEVER, LOGFILES WERE PROVIDED FOR REVIEW. REVIEW OF THE LOGFILES CONFIRMED THE OCCURRENCE OF THE ERROR MESSAGE INDICATING THAT THE PUMP MODULE OF THE EVA SURGICAL SYSTEM WAS OFFLINE. INVESTIGATION OF THE SYSTEM BY THE FIELD SERVICE TECHNICIAN DID NOT REVEAL ANY ANOMALIES. IN ADDITION, NO REPEAT ISSUES HAVE BEEN REPORTED ON THE EVA SYSTEM INVOLVED SINCE THE REPORTED EVENT. BASED UPON THE INVESTIGATION PERFORMED THE ROOT CAUSE OF THE REPORTED EVENT REMAINS UNCLEAR. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. THEREFORE, NO REMEDIAL OR CORRECTIVE/PREVENTIVE ACTIONS WILL BE UNDERTAKEN AT THIS MOMENT. THE USER IS ADVISED TO MONITOR THE SITUATION AND CONTACT DORC IF THE ISSUE REOCCURS. IN ADDITION, COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS. SINCE 2019 MORE THAN 850.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT NOT ALL OCCURRENCES OF THE REPORTED ERROR MESSAGE WILL LEAD TO A PROLONGED SURGERY. IT HAS BEEN REPORTED THAT DURING PROCEDURE, THE MACHINE STOPPED WORKING AND THE DISPLAY GAVE AN WARNING MESSAGE INDICATING THAT THE ASPIRATION SENSORS AND FLUIDICS MODULE WERE OFFLINE. THE SURGEON WAS ABLE COMPLETE THE SURGERY WITH A BACK-UP UNIT. DUE TO THE REPORTED EVENT SURGERY WAS PROLONGED >30 MINUTES. NO ACTUAL PATIENT HARM OCCURRED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
22,1222074-2022-00027,2022-03-23,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,EVA,"Unit, Phacofragmentation","['Adverse Event Without Identified Device or Use Problem', 'Insufficient Information']","['Endophthalmitis', 'Insufficient Information']","WE HAVE BEEN INFORMED OF A CASE IN WHICH THE PATIENT INVOLVED DEVELOPED ENDOPHTHALMITIS AFTER USING THE EVA SURGICAL SYSTEM. THE PATIENT WAS OPERATED ON (B)(6) 2022 AND WAS PRESENTED WITH ACUTE ENDOPHTHALMITIS ON (B)(6) 2022. A SAMPLE WAS TAKEN FROM THE VITREOUS CAVITY INDICATING THE PRESENCE OF STAPHYLOCOCCUS HOMINIS WITH THE TIME BETWEEN THE INTERVENTION AND THE APPEARANCE OF THE INFECTION, AROUND 3 DAYS, QUITE TYPICAL OF THIS GERM. ADDITIONAL INFORMATION OBTAINED REGARDING THE PATIENT INVOLVED INDICATE THAT THE PATIENT RESPONDED WELL TO THE TREATMENT PROVIDED. NO OTHER PATIENT RELATED DETAILS WERE OBTAINED. INFORMATION REGARDING ACCESSORIES USED DURING THE SURGERY PERFORMED WAS PROVIDED UPON REQUEST. WITH REGARD TO THIS COMPLAINT WE WERE INFORMED OF A CASE IN WHICH THE PATIENT INVOLVED DEVELOPED ENDOPHTHALMITIS AFTER USING THE EVA SURGICAL SYSTEM. THE GERM HIGHLIGHTED (AND IN ABUNDANCE) IDENTIFIED WAS STAPHYLOCOCCUS HOMINIS WHERE THE TIME BETWEEN THE INTERVENTION AND THE APPEARANCE OF THE INFECTION, AROUND 3 DAYS, IS QUITE TYPICAL FOR THIS GERM. REVIEW OF THE DATABASE REVEALED THAT ONLY ONE SEEMINGLY SIMILAR CASE WHICH OCCURRED AT THE SAME SITE WITHIN A TIMEFRAME OF 4 DAYS WAS REPORTED. INFORMATION REGARDING ACCESSORIES USED DURING THE SURGERY PERFORMED WAS PROVIDED UPON REQUEST. HOWEVER, NO PRODUCT WAS RETURNED FOR INVESTIGATION. DEVICE HISTORY RECORD REVIEWS OF THE DORC ACCESSORIES INVOLVED DID NOT REVEAL ANY ANOMALIES. IN ADDITION, NO CASES OF ENDOPHTHALMITIS HAVE BEEN REPORTED ON THE CONSUMABLES USED DURING THIS REPORTED EVENT. FURTHERMORE, NO OTHER SIMILAR CASES HAVE BEEN RECEIVED ON THE EVA SURGICAL SYSTEM. BASED ON THE INVESTIGATION PERFORMED, THE ROOT CAUSE OF THE REPORTED EVENT COULD NOT BE DETERMINED. THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. A MANUFACTURER RELATED ISSUE BETWEEN THE REPORTED ISSUE AND THE EVA SURGICAL SYSTEM INCL. THE DORC ACCESSORIES USED COULD NOT BE IDENTIFIED. THEREFORE, NO REMEDIAL OR CORRECTIVE/PREVENTIVE ACTIONS WILL BE UNDERTAKEN AT THIS MOMENT. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS. SINCE 2019 MORE THAN 850.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
23,1222074-2022-00028,2022-03-23,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,EVA,"Unit, Phacofragmentation","['Adverse Event Without Identified Device or Use Problem', 'Insufficient Information']","['Endophthalmitis', 'Insufficient Information']","WITH REGARD TO THIS COMPLAINT WE WERE INFORMED OF A CASE IN WHICH THE PATIENT INVOLVED DEVELOPED ENDOPHTHALMITIS AFTER USING THE EVA SURGICAL SYSTEM. REVIEW OF THE DATABASE REVEALED THAT ONLY ONE SEEMINGLY SIMILAR CASE WHICH OCCURRED AT THE SAME SITE WITHIN A TIMEFRAME OF 4 DAYS WAS REPORTED. INFORMATION REGARDING ACCESSORIES USED DURING THE SURGERY PERFORMED WAS PROVIDED UPON REQUEST. HOWEVER, NO PRODUCT WAS RETURNED FOR INVESTIGATION. DEVICE HISTORY RECORD REVIEWS OF THE DORC ACCESSORIES INVOLVED DID NOT REVEAL ANY ANOMALIES. IN ADDITION, NO CASES OF ENDOPHTHALMITIS HAVE BEEN REPORTED ON THE CONSUMABLES USED DURING THIS REPORTED EVENT. FURTHERMORE, NO OTHER SIMILAR CASES HAVE BEEN RECEIVED ON THE EVA SURGICAL SYSTEM. BASED ON THE INVESTIGATION PERFORMED, THE ROOT CAUSE OF THE REPORTED EVENT COULD NOT BE DETERMINED. THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. A MANUFACTURER RELATED ISSUE BETWEEN THE REPORTED ISSUE AND THE EVA SURGICAL SYSTEM INCL. THE DORC ACCESSORIES USED COULD NOT BE IDENTIFIED. THEREFORE, NO REMEDIAL OR CORRECTIVE/PREVENTIVE ACTIONS WILL BE UNDERTAKEN AT THIS MOMENT. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS. SINCE 2019 MORE THAN 850.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. WE HAVE BEEN INFORMED OF A CASE IN WHICH THE PATIENT INVOLVED DEVELOPED ENDOPHTHALMITIS AFTER USING THE EVA SURGICAL SYSTEM. THE PATIENT WAS OPERATED ON MARCH 11, 2022 AND WAS PRESENTED WITH ACUTE ENDOPHTHALMITIS ON (B)(6) 2022 . A SAMPLE WAS TAKEN FROM THE VITREOUS CAVITY IMMEDIATELY BUT CULTURE RESULTS WERE NEGATIVE FOR BACTERIA AND FUNGI. ADDITIONAL INFORMATION OBTAINED REGARDING THE PATIENT INVOLVED INDICATE THAT THE PATIENT RESPONDED WELL TO THE TREATMENT PROVIDED. NO OTHER PATIENT RELATED DETAILS WERE OBTAINED. INFORMATION REGARDING ACCESSORIES USED DURING THE SURGERY PERFORMED WAS PROVIDED UPON REQUEST.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
24,1222074-2022-00030,2022-04-13,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,EVA TDC VITRECTOMY PACK VGPC INPUT 25G,"Unit, Phacofragmentation",['Material Fragmentation'],"['No Clinical Signs, Symptoms or Conditions']","IT WAS REPORTED THAT DURING VITRECTOMY PROCEDURE IT WAS NOTICED THAT PARTICULATE MATTER WAS RELEASED FROM VITRECTOME AND ENTERED THE EYE. THE PARTICALS WERE IMMEDIATELY AND SUCCESSFULLY REMOVED.  NO PATIENT HARM OR PROLONGATION OF THE SURGERY OCCURRED DUE TO THIS EVENT. IN REGARD TO THIS COMPLAINT, ONE 25 GAUGE DISPOSABLE HIGH SPEED TDC CUTTER WAS RETURNED FOR INVESTIGATION. THE PARTICLE THAT WAS DETECTED IN THE EYE OF THE PATIENT WAS NOT RECEIVED. SINCE THE PARTICLE WAS NOT RECEIVED, INSPECTION AND TESTING TO DETERMINE ITS ORIGIN WERE NOT POSSIBLE. THOROUGH EXAMINATION OF THE CUTTER REVEALED NO ANOMALIES; THE CAP AT THE DISTAL END OF THE OUTER KNIFE AS WELL AS THE BRIDGE AND WELDS OF THE INNER KNIFE APPEARED TO BE COMPLETELY INTACT. DEVICE HISTORY RECORD REVIEW REVEALED NO DEVIATIONS AND A DATABASE SEARCH SHOWED THAT NO SIMILAR COMPLAINTS HAVE BEEN REPORTED ON THIS SPECIFIC LOT PREVIOUSLY. BASED ON THE INVESTIGATION PERFORMED, THE ORIGIN OF THE PARTICLE COULD NOT BE DETERMINED. THE PARTICLE MAY HAVE ORIGINATED FROM ANY (METAL) INSTRUMENT THAT WAS USED DURING THE OPERATION, BUT WE CANNOT EXCLUDE THE POSSIBILITY THAT IT DID IN FACT ORIGINATE FROM THE CUTTER. HENCE, THE INVESTIGATION FINDINGS DID NOT LEAD TO A CLEAR CONCLUSION CONCERNING THE CAUSE OF THE REPORTED ADVERSE EVENT. THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. SINCE THE REPORTED ADVERSE EVENT CANNOT BE ATTRIBUTED TO THE DORC CUTTER, FURTHER REMEDIAL/CORRECTIVE/FSC ACTIONS ARE DEEMED NOT REQUIRED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
25,1222074-2022-00033,2022-05-03,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,EVA TDC VITRECTOMY PACK VGPC INPUT 23G,"Unit, Phacofragmentation",['Fluid/Blood Leak'],"['No Clinical Signs, Symptoms or Conditions']","THE COMPLAINT IS UNDER INVESTIGATION. IT WAS REPORTED THAT DURING PROCEDURE, IT WAS NOTICED THAT THE CLOSURE VALVE WAS LEAKING. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED OR SURGERY WAS PROLONGED > 30 MIN.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
26,1222074-2022-00039,2022-05-11,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,EVA CARTRIDGE WITH 0.5 L COLLECTION BAG,"Unit, Phacofragmentation",['Contamination /Decontamination Problem'],"['No Clinical Signs, Symptoms or Conditions']","THE COMPLAINT ARTICLE WAS RECEIVED FOR INVESTIGATION. VISUAL INSPECTION CONFIRMED THE FOREIGN MATERIAL AS DESCRIBED IN THE REPORTED EVENT. AS THE ORIGIN OF THE MATERIAL COULD NOT BE CLEARLY DETERMINED WITHIN D.O.R.C., THE PRODUCT WILL BE ANALYZED IN A EXTERNAL LABORATORY. AS SOON AS RESULTS ARE AVAILABLE, THE ROOT CAUSE INVESTIGATION WILL BE CONTINUED. WE WERE INFORMED THAT FOREIGN MATERIAL WAS NOTICED IN THE PACKAGING. THE PRODUCT HAS NOT BEEN USED. NO PATIENT HARM OCCURRED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA CARTRIDGE WITH 0 5 L COLLECTION BAG
27,1222074-2022-00054,2022-08-03,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,EVA,"Unit, Phacofragmentation",['No Display/Image'],"['No Clinical Signs, Symptoms or Conditions']","THE DEVICE HAS NOT BEEN RETURNED/ ACCESSIBLE FOR INVESTIGATION YET. THE INVESTIGATION WILL BE CONTINUED, WHEN THE DEVICE IS AVAILABLE FOR EXAMINATION. WE HAVE BEEN INFORMED, THAT DURING PROCEDURE. THE EVA SCREEN FROZE, WHEN SWITCHING STEPS. THE USER WAS ABLE TO RESOLVE THE ISSUE, BY REBOOTING THE EVA. DUE TO THE REPORTED EVENT, SURGERY WAS PROLONGED, 30 MINUTES. NO HARM TO THE PATIENT OCCURRED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
28,1222074-2022-00056,2022-08-04,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,EVA,"Unit, Phacofragmentation",['Insufficient Flow or Under Infusion'],"['No Clinical Signs, Symptoms or Conditions']","IT WAS REPORTED THAT DURING VITRECTOMY PROCEDURE, THE CONSTANT IRRIGATION WAS TURNED OFF UNEXPECTEDLY. THE SURGEON WAS ABLE TO RESOLVE THE ISSUE. THERE IS NO REPORT OF PATIENT/USER HARM. NO REPORT OF PROLONGED OR DELAYED SURGERY. WITH REGARD TO THIS EVENT LOGFILES WERE PROVIDED FOR REVIEW. REVIEW OF THE LOG FILES OF THE EVA SYSTEM REVEALED THAT AT THE STEP CHANGE THERE WAS DETECTED A TOO HIGH PRESSURE DIFFERENCE. THIS SITUATION IS CAUSED WHEN THE INFUSION MODE IS SET TO GRAVITY, IN COMBINATION WITH SPECIFIC OTHER USER SETTINGS. THIS MAYBE AN UNINTENDED USE ERROR AS IN SPAIN IT IS COMMON TO USE THE VGPC MODE, NOT THE GRAVITY MODE. THIS COULD BE THE ROOT-CAUSE OF WHY THE CONSTANT IRRIGATION WAS TURNED OFF UNEXPECTEDLY, HOWEVER THIS CANNOT BE DEFINED CONCLUSIVELY. AS A PREVENTIVE MEASURE, THE SOFTWARE WAS REINSTALLED. THE DISTRIBUTOR WAS INFORMED ABOUT THE POSSIBLE ROOT-CAUSE AND WAS ADVISED TO MONITOR THE SITUATION AND CONTACT DORC IF THE ISSUE REOCCURS. REVIEW OF THE COMPLAINT DATABASE INDICATED THAT NO SIMILAR ISSUES HAVE BEEN LOGGED ON THIS EVA SURGICAL SYSTEM SINCE THE EVENT OCCURRED. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. THEREFORE, NO REMEDIAL OR CORRECTIVE/PREVENTIVE ACTIONS WILL BE UNDERTAKEN AT THIS MOMENT. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS. SINCE 2019 MORE THAN 850.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
29,1222074-2022-00070,2022-09-22,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,EVA TDC VITRECTOMY PACK VGPC INPUT 25G,"Unit, Phacofragmentation",['Fluid/Blood Leak'],"['No Clinical Signs, Symptoms or Conditions']","THE SURGEON STARTED THE CASE WITHOUT A PROBLEM. ALL TROCARS WERE INSERTED AT THE START OF THE CASE WITHOUT A PROBLEM, AND WITHOUT LEAKAGE NOTED/DETECTED. HOWEVER, TOWARDS THE END OF SURGERY, THE SURGEON FOUND THAT ONE AVETA 25G TROCAR VALVE (WHICH WAS PRIMARILY USED FOR ACCESSING VITY-CUTTER, DORC BACKFLUSH, AND DORC ECKARDT FORCEPS) WAS LEAKING A SIGNIFICANT AMOUNT OF FLUID. SURGEON DID MANAGE TO STOP THE LEAKING BY MANIPULATING THE VALVE WITH MICRO FORCEPS. ADDITIONALLY: NO REPORT THAT ACTUAL PATIENT HARM OCCURRED OR SURGERY WAS PROLONGED > 30 MINUTES.UNFORTUNATELY, THE INVOLVED TROCAR WAS NOT RETURNED. HENCE, NO PHYSICAL EXAMINATION COULD BE PERFORMED. DEVICE HISTORY RECORD REVIEW REVEALED NO DEVIATIONS. PLEASE NOTE THAT, DUE TO A RECENT INCREASE OF CLOSURE VALVE RELATED COMPLAINTS ON THE AVETA TROCAR, A BROADER INVESTIGATION WAS INITIATED. A DETAILED INVESTIGATION OF THE MANUFACTURING PROCESS REVEALED THAT WHEN IN THE MANUFACTURING PROCESS THE DRYING TIME OF THE APPLIED GLUE ON THE CAP OF THE PRODUCT IS TOO SHORT FOR THE VOLUME OF GLUE DISPENSED, VALVES MAY IN SOME CASES BECOME STICKY. AS A RESULT OF THE INVESTIGATION THE DRYING TIME OF GLUE WAS INCREASED TO PREVENT RE-OCCURRENCE OF THIS MALFUNCTION GOING FORWARD. IN 2022 AN INCREASE IN COMPLAINT RATE WAS OBSERVED, WHICH TRIGGERED A DETAILED INVESTIGATION OF THE MANUFACTURING PROCESS. AS A RESULT THE DRY TIME WILL BE INCREASED, AS THIS WAS CONSIDERED THE CAUSE OF THE INCREASE IN COMPLAINTS OBSERVED.PER ECF 2022-390, A CHANGE WAS INITIATED TO INCREASE THE DRYING TIME BETWEEN GLUE APPLICATION AND NEXT STEPS OF ASSEMBLY. THE CHANGE WAS IMPLEMENTED WITH AN UPDATE OF ALL RELEVANT WORK INSTRUCTIONS. AS OF 07OCT22 ALL AVETA TROCARS ARE ASSEMBLED IN ACCORDANCE WITH THE UPDATED WORK INSTRUCTIONS.THE ANALYSIS INCLUDES ALL COMPLAINTS WITH FAILURE MODES CI-CLOSUREVALVE-LEAKAGE AND CI-CLOSUREVALVE-DEFECT-REMOVAL RELATED TO COMPARABLE TROCAR SYSTEMS. THE SURGEON STARTED THE CASE WITHOUT A PROBLEM. ALL TROCARS WERE INSERTED AT THE START OF THE CASE WITHOUT A PROBLEM, AND WITHOUT LEAKAGE NOTED/DETECTED. HOWEVER, TOWARDS THE END OF SURGERY, THE SURGEON FOUND THAT ONE AVETA 25G TROCAR VALVE (WHICH WAS PRIMARILY USED FOR ACCESSING VITY-CUTTER, DORC BACKFLUSH, AND DORC ECKARDT FORCEPS) WAS LEAKING A SIGNIFICANT AMOUNT OF FLUID. SURGEON DID MANAGE TO STOP THE LEAKING BY MANIPULATING THE VALVE WITH MICRO FORCEPS. ADDITIONALLY: NO REPORT THAT ACTUAL PATIENT HARM OCCURRED OR SURGERY WAS PROLONGED > 30 MINUTES.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
30,1222074-2022-00073,2022-10-17,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,DISPOSABLE EVA VGPC INPUT SET,"Unit, Phacofragmentation",['Missing Information'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED BY A CUSTOMER IN JAPAN THAT PRIOR TO USE, IT WAS NOTED THAT THE LABEL WITH LOT NUMBER WAS NOT ATTACHED TO ALL SIX POUCHES IN A BOX. THE PRODUCTS HAVE NOT BEEN USED. NO PATIENT HARM OCCURRED. THE COMPLAINT IS UNDER INVESTIGATION. INITIAL RESULTS INDICATE THAT THIS IS MOST LIKELY AN ISOLATED EVENT THAT IMPACTS ONE BOX ONLY;  THIS IS SUPPORTED BY VERIFICATIONS ON OTHER BOXES OF THE SAME LOT THAT SHOWED THAT ON THOSE BOXES THE POUCH LABEL WAS PRESENT. IN ADDITION THE BATCH RECORD SHOWS A REQUEST FOR REWORK ON LABELING THAT COULD EXPLAIN WHY ONE BOX MAY NOT HAVE BEEN PROPERLY REWORKED. ALL POTENTIALLY IMPACTED BOXES SHIPPED TO USA HAVE BEEN QUARANTINED AT THE LOCAL DISTRIBUTOR.IN REGARD TO THIS COMPLAINT, ONE BOX INCLUDING SIX DISPOSABLE EVA VGPC INPUT SETS WAS RECEIVED FOR INVESTIGATION. THOUGH THE MANUFACTURING RECORDS SHOWED THAT ALL POUCH LABELS WERE PRINTED, VISUAL INSPECTION CONFIRMED THAT THE LABELS ON THE SIX INDIVIDUAL POUCHES IN THIS PARTICULAR BOX WERE MISSING. A NON-CONFORMITY RECORD (B)(4) WAS INITIATED TO DOCUMENT FURTHER INVESTIGATION RESULTS. BASED ON THE INVESTIGATION PERFORMED AS PART OF THE NC RECORD IT WAS CONCLUDED THAT THE FAILURE SHOULD BE ATTRIBUTED TO A HUMAN ERROR. FOR UNKNOWN REASONS, THE SEASONED DORC EMPLOYEES THAT WERE INVOLVED IN THE PACKAGING AND CONTROL PROCESSES OF THIS SPECIFIC LOT BOTH OVERLOOKED THE MISSING LABELS.THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES.  COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS.ALL PRODUCTS ON US MARKET WERE STILL IN POSSESSION OF THE IMPORTER AND HAVE BEEN VERIFIED. NO MISSING LABELS WERE DETECTED. THE INVOLVED INSPECTORS HAVE BEEN CONFRONTED WITH THE OUTCOME OF THE INVESTIGATION AND THE CRITICALITY OF THEIR INSPECTION WAS REINFORCED/  AS THE INVOLVED PERSONNEL WAS HELD ACCOUNTABLE, AND THIS IS CONSIDERED AN ISOLATED EVENT, NO FURTHER CORRECTIVE ACTION IS PLANNED.THE ANALYSIS INCLUDES ALL COMPLAINTS WITH FAILURE MODE AS REPORTED VGPC-LABEL-MISSING. THE DISTRIBUTION FIGURES DOES NOT INCLUDE VGPC SETS THAT WERE IN PACKS AS THOSE ARE NOT INDIVIDUALLY LABELED.",DUTCH OPHTHALMIC RESEARCH CENTER,DISPOSABLE EVA VGPC INPUT SET
32,1222074-2022-00093,2022-12-27,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Excess Flow or Over-Infusion'],['Insufficient Information'],"IN REGARD TO THIS COMPLAINT, LOGFILES AND PICTURES WERE PROVIDED FOR REVIEW. BASED ON REVIEW OF THE AVAILABLE INFORMATION, IT WAS NOT POSSIBLE TO DETERMINE THE ROOT CAUSE OF THE REPORTED COMPLAINT. THE ISSUE COULD BE ATTRIBUTABLE EITHER TO A USE ERROR WITH THE PEDAL, TO A FAULTY FLASH CARD OR TO A PROBLEM WHEN COPYING SETTINGS FROM THE USB KEY. IT CANNOT BE CONFIRMED CONCLUSIVELY FROM THE INFORMATION AVAILABLE. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. THEREFORE, NO REMEDIAL OR CORRECTIVE/PREVENTIVE ACTIONS WILL BE UNDERTAKEN AT THIS MOMENT. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. AFTER LASERING, THE EVA WENT INTO ERROR MODE WITHOUT A MESSAGE ON THE SCREEN. THE SYSTEM INCREASED THE IRRIGATION/ASPIRATION UP TO 150 AND KEPT REPEATING THIS CONTINUOUSLY. BOTH THE SCREEN AND THE FOOT PEDAL COULD NO LONGER BE USED. THEY DIDN'T FUNCTION ANYMORE. AFTER TURNING THE SYSTEM OFF COMPLETELY IT KEPT REPEATING '150'. WHEN PULLING OUT THE PLUG THIS STOPPED. THEN RESTARTED THE SYSTEM AND IT WAS GOOD AGAIN. (ISSUE DATE 16/12). NO INFORMATION IS AVAILABLE ON WHETHER THERE WAS IMPACT ON PATIENT OR DELAY OF SURGERY FOR >30 MINUTES. DORC HAS MADE SEVERAL ATTEMPTS TO OBTAIN FURTHER INFORMATION, HOWEVER NO ADDITIONAL INFORMATION WAS PROVIDED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
33,1222074-2023-00001,2023-01-20,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Communication or Transmission Problem'],"['No Clinical Signs, Symptoms or Conditions']","THE COMPLAINT IS UNDER INVESTIGATION. NO CORRECTIVE OR PREVENTIVE ACTIONS CAN BE IMPLEMENTED UNTIL THE INVESTIGATION HAS BEEN COMPLETED. IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT. WE HAVE BEEN INFORMED THAT DURING PROCEDURE, THE EVA WAS PRIMED WITH 25G TDC PACK AND SURGERY WAS STARTED. SURGERY WAS GOING GOOD FOR 5-10 MINUTES AND SUDDENLY DURING CORE VITRECTOMY STEP , GOT THE ERROR FOP65545 (COMMUNICATION BETWEEN THE MACHINE AND THE FOOT PEDAL HAS BEEN DISCONNECTED) THE MACHINE STOPPED WORKING , SCREEN WAS RED VITRECTOMY , IRRIGATION, AND ASPIRATION. DUE TO THE REPORTED EVENT SURGERY WAS PROLONGED > 30 MINUTES. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
34,1222074-2023-00005,2023-02-09,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,EVA VITRECTOMY TDC KIT 2-STEP 23G,Vitrectomy Kit,['Ejection Problem'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT WHEN PULLING OUT THE TROCAR INSERTERS, THE TROCAR CAME OUT OF THE EYE ALONGSIDE THE INSERTER. THE SURGEON REPORTED SEEING SOME PARTICLES STUCK TO THE VALVE. NO REPORT THAT ACTUAL HARM OCCURRED OR SURGERY WAS PROLONGED > 30 MINUTES. IN REGARD TO THIS COMPLAINT, TWO INSERTERS WITH PROTECTION CAPS WERE RECEIVED AT DORC. UNFORTUNATELY, SINCE THE INVOLVED CANNULAS WERE NOT RETURNED, A PHYSICAL EXAMINATION AS TO THE POSSIBLE CAUSE OF THE REPORTED FAILURE COULD NOT BE PERFORMED. DEVICE HISTORY RECORD REVIEW REVEALED NO DEVIATIONS AND A DATABASE SEARCH SHOWED THAT NO SIMILAR COMPLAINTS HAVE BEEN REPORTED ON THIS SPECIFIC LOT PREVIOUSLY. THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. SINCE THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES AND BECAUSE NO ASSIGNABLE CAUSE OF FAILURE COULD BE DETERMINED, FURTHER ACTIONS ARE DEEMED NOT REQUIRED AT THIS POINT. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. THE ANALYSIS INCLUDES ALL COMPLAINTS WITH FAILURE MODE CI-CANN-EJECTED RELATED TO COMPARABLE TROCAR SYSTEMS. PLEASE NOTE: THIS CASE WAS SUBMITTED TO THE FDA BY ERROR. CONCERNED PRODUCT 8500.23G2T IS NOT AVAILABLE ON THE US MARKET.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA VITRECTOMY TDC KIT 23G
35,1222074-2023-00006,2023-02-10,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Decrease in Pressure'],"['No Clinical Signs, Symptoms or Conditions']","IN REGARD TO THIS COMPLAINT, PICTURES WERE PROVIDED FOR REVIEW AND A VFIE MODULE WAS PROVIDED FOR INVESTIGATION. REVIEW OF THE PICTURES AND VISUAL INSPECTION OF THE RETURNED VFIE MODULE REVEALED THAT THE TUBES OF THE VFIE FILTER CAME OFF THE FILTER. FUNCTIONAL INSPECTION FOUND THAT A TUBE IN THE MODULE WAS NOT PROPERLY GLUED TO THE FILTER IN THE VFIE CONNECTOR. DUE TO THE LOOSE FILTER CONNECTION, THE VACUUM COULD NOT BE BUILD UP AND THE EVA SURGICAL SYSTEM WAS TRIGGERED TO DISPLAY THE REPORTED ERROR MESSAGE. THIS IS A KNOWN PHENOMENON AND THAT CORRECTIVE ACTIONS HAVE BEEN IMPLEMENTED TO PREVENT THIS FAILURE FROM OCCURRING IN THE FUTURE. CORRECTIVE ACTION HAVE BEEN IMPLEMENTED: THE GLUE STEP WITH THE FILTER HAS BEEN REPLACED BY PLACING A SLEEVE OVER THE HOSE AFTER IT IS SLID OVER THE FILTER. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (VF-FILTER). SINCE 2020 MORE THAN (B)(4) SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. WE HAVE BEEN INFORMED THAT DURING SURGERY, OIL INJECTION DIDN'T WORK PROPERLY. THE ACTUAL PRESSURE WAS ONLY UP TO 3.3BAR WHILE THE DISPLAYED SETTING WAS 6BAR. OVER 30 MINUTES DELAYED FROM THE SCHEDULE, HOWEVER THE SURGERY WAS FINISHED SUCCESSFULLY. NO REPORT THAT ACTUAL HARM OCCURRED. REPORT OF PROLONGED SURGERY.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
36,1222074-2023-00008,2023-02-15,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Communication or Transmission Problem'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED DURING PROCEDURE THE PEDAL STOPPED WORKING. NO ACTUAL PATIENT HARM OCCURED. SURGERY WAS PROLONGED > 30 MINUTES. IN REGARD TO THIS COMPLAINT, LOGFILES AND PICTURES WERE PROVIDED FOR REVIEW. REVIEW OF THE LOGFILES REVEALED MULTIPLE FOP65541 ERROR MESSAGES, INDICATING AN UNDEFINED HORIZONTAL POSITION OF THE MAIN PEDAL. IT WAS ADVISED TO SET THE TURNING KNOB TO THE MIDDLE TO SEE IF IT SOLVES THE PROBLEM. BASED ON REVIEW OF THE AVAILABLE INFORMATION, IT WAS DETERMINED THAT THE REPORTED COMPLAINT MOST LIKELY IS ATTRIBUTABLE TO A SENSOR ISSUE. HOWEVER, IT CANNOT BE CONFIRMED CONCLUSIVELY AS THE PEDAL WAS NOT RETURNED TO D.O.R.C FOR INVESTIGATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. THEREFORE, NO REMEDIAL OR CORRECTIVE/PREVENTIVE ACTIONS WILL BE UNDERTAKEN AT THIS MOMENT. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (ALL FAILURE MODES INCLUDING ERROR CODE FOP65541). SINCE 2020 MORE THAN 850.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT A FOP65541 ERROR MESSAGE WILL NOT ALWAYS LEAD TO A PROLONGED SURGERY.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
37,1222074-2023-00013,2023-02-16,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Insufficient Flow or Under Infusion'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING PPV PROCEDURE, AFTER OPENING A PPV VITRECTOMY PACK AND CLAMPING THE CASSETTE ON THE PUMP INTERFACE, THE SYSTEM WOULD START PRIMING BUT THEN DISPLAY ON SCREEN THE WARNING ERROR OF PUM83 SELF TEST ERROR: BACKFLUSH BLOCKAGE DETECTED. AFTER OPENING ANOTHER CASSETTE PACK THE SAME ERROR WAS OBSERVED. THE SALES REPRESENTATIVE RESPONDED TO THEIR TECHNICAL QUERIES AND COULD NOT RESOLVE THIS ERROR AFTER CHECKING HP AIR SUPPLY AND REPEATEDLY ATTEMPTING REPRIMING THE SYSTEM WITH DIFFERENT TUBING AND CASSETTE / WASTE BAG OPTIONS. THE SYSTEM IS CURRENTLY NOT CLEARED TO BE USED FOR SURGERIES. THERE WAS NO REPORT THAT ACTUAL PATIENT HARM WAS REPORTED. HOWEVER DUE TO THE REPORTED EVENT IT WAS DECIDED TO ABORT THE PROCEDURE. THE COMPLAINT IS UNDER INVESTIGATION.IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
38,1222074-2023-00018,2023-03-07,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Decrease in Pressure'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING PROCEDURE, ONCE THE SILICONE INJECTION KIT WAS CONNECTED TO PERFORM THE SILICONE EXTRACTION, AN AIR LEAK WAS OBSERVED IN THE CONNECTOR. SURGERY COULD CONTINUE BUT SILICONE REMOVAL IS SLOWER DUE TO AIR LEAK. NO REPORT THAT ACTUAL HARM OCCURRED, HOWEVER DUE TO THE REPORTED EVENT SURGERY WAS PROLONGED > 30 MINUTES. IN REGARD TO THIS COMPLAINT, LOGFILES AND PICTURES WERE PROVIDED FOR REVIEW. BASED ON THE COMPLAINT DESCRIPTION, PREVIOUS INVESTIGATIONS OF SIMILAR COMPLAINTS AND THE PICTURE RECEIVED, IT WAS DETERMINED THAT THE REPORTED COMPLAINT MOST LIKELY IS ATTRIBUTABLE TO A DEFECTIVE O-RING IN THE VFIE CONNECTOR. THE ISSUE WAS SOLVED AFTER REPLACING THE O-RING OF THE EVA SILICONE CONNECTION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. THEREFORE, NO REMEDIAL OR CORRECTIVE/PREVENTIVE ACTIONS WILL BE UNDERTAKEN AT THIS MOMENT. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (VF-ORING). SINCE 2020 MORE THAN 850.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
39,1222074-2023-00019,2023-03-09,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER B.V.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Failure to Deliver Energy'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING PPV PROCEDURE, WHEN IT WAS TIME TO LASER, THE MODULE RESPONDED ONCE AND PRODUCED ERROR CODE LAS1. ALL CONNECTORS WHERE CONNECTED PROPERLY. A NEW LASER PROBE WAS THEN OPENED AND THE MACHINE STILL PRODUCED ERROR LAS1. AFTER RESTARTING THE EVA THE SAME ERROR OCCURRED AFTER PRIMING. AFTER CONSULTING IT WAS CONFIRMED THAT THE MODULE NEEDS TO BE REPLACED. THERE IS NO REPORT THAT ACTUAL PATIENT HARM HAS OCCURRED. HOWEVER DUE TO THE REPORTED EVENT IT WAS DECIDED TO ABORT THE SURGERY. IN REGARD TO THIS COMPLAINT, LOGFILES AND PICTURES WERE PROVIDED FOR REVIEW. REVIEW OF THE PICTURES AND ANALYSIS OF THE LOGFILES CONFIRMED THE OCCURRENCE OF THE REPORTED LAS1 ERROR MESSAGE, INDICATING THAT THE LASER OUTPUT IS INCORRECT. IT IS IMPORTANT TO NOTE THAT NO PHYSICAL EQUIPMENT OR COMPONENTS WERE RETURNED TO D.O.R.C FOR FURTHER INVESTIGATION, MAKING IT DIFFICULT TO DETERMINE THE ROOT CAUSE. SINCE THE INITIAL OCCURRENCE OF THIS COMPLAINT, THE LASER MODULE WAS NOT REPLACED AND THERE HAVE BEEN NO ADDITIONAL REPORTS OF THE SAME ISSUE FOR THE EVA SYSTEM INVOLVED. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. THEREFORE, NO REMEDIAL OR CORRECTIVE/PREVENTIVE ACTIONS WILL BE UNDERTAKEN AT THIS MOMENT. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (LM-LAS1-SURGERY-DELAYED, EVA-LOW-SURGERY-NOT RES AND EVA-LOW-SURGERY-PROLONGED). SINCE 2020 MORE THAN 850.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT THE FAILURE CODE LM-LAS1* WILL NOT ALWAYS LEAD TO A DELAYED SURGERY."" PLEASE NOTE THAT WHILE THE 2023 INCIDENT NUMBERS ARE UP TO DATE, THE 2023 INSTALLED BASE FIGURES ARE FROM APRIL 25TH 2023. AS IN GENERAL THE INSTALLED BASE INCREASES, THE ACTUAL NUMBER OF DEVICES IN THE MARKET MOST LIKELY IS SLIGHTLY HIGHER.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
40,1222074-2023-00026,2023-03-21,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Priming Problem'],"['No Clinical Signs, Symptoms or Conditions']","THE COMPLAINT IS UNDER INVESTIGATION. IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT. AS INVESTIGATIONS ON THE ACTUAL PRODUCT OR REPRESENTATIVE SAMPLE OF A BATCH MAY ALTER THE DEVICE, WE REQUEST TO INFORM US WITHIN 7 DAYS AFTER SUBMISSION OF THIS REPORT, IN CASE THE INVESTIGATIONS THAT ALTER THE DEVICE SHOULD BE HALTED UNTIL APPROVAL OF THE NCA, AS PER ARTICLE 89 OF EU-MDR. WE HAVE BEEN INFORMED THAT DURING PROCEDURE, WHILE THE PATIENT WAS UNDER GENERAL ANESTHESIA, THEY TESTED 3 CARTRIDGE PACKS. THE MACHINE WAS TURNED OFF AND ON AGAIN BUT STILL A PUMP RELATED ERROR MESSAGES OCCURRED. WHEN PLACING THE CARTRIDGE AND CONNECTING THE WHITE TUBING (BSS TO CARTRIDGE), THE BSS FLOWED THROUGH THE BLUE PORT. DUE TO REPORTED EVENT IT WAS DECIDED TO ABORT SURGERY. THERE IS NO REPORT THAT ACTUAL PATIENT HARM OCCURRED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
41,1222074-2023-00025,2023-03-21,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER B.V.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Communication or Transmission Problem'],"['No Clinical Signs, Symptoms or Conditions']","THE DEVICE WILL BE RETURNED BUT IS NOT ACCESSIBLE FOR INVESTIGATION YET. THE INVESTIGATION WILL BE CONTINUED WHEN THE DEVICE IS AVAILABLE FOR EXAMINATION. (SEVERAL PRODUCT REMINDERS ARE SENT TO RECEIVE THE PRODUCT FOR INVESTIGATION.) WE HAVE BEEN INFORMED THAT DURING PHACO PROCEDURE, WHEN THE PRIMING WAS COMPLETED, THE FOOT-PEDAL BATTERY WAS ON 100% CHARGED. BEFORE THE DR COULD BEGIN SCULPTING, THE FOOT-PEDAL WAS NON-RESPONSIVE. NO REPORT THAT ACTUAL PATIENT HARM HAS OCCURRED, HOWEVER DUE TO THE REPORTED EVENT, SURGICAL PROCEDURE WAS PROLONGED 30 MINUTES.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
42,1222074-2023-00023,2023-03-21,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER B.V.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation","['Insufficient Flow or Under Infusion', 'Infusion or Flow Problem']","['No Clinical Signs, Symptoms or Conditions']","IN REGARD TO THIS COMPLAINT, LOGFILES WERE PROVIDED FOR REVIEW. REVIEW OF THE LOG FILES CONFIRMED THE OCCURRENCE OF THE REPORTED CAR162 ERROR MESSAGE AND THAT IT WAS PERSISTENT. THE UNIT HAD BEEN RESTARTED SEVERAL TIMES AND THE REPORTED CAR162 ERROR MESSAGE CAME BACK AFTER EVERY RESTART. THIS ERROR IS OFTEN CAUSED BY CORROSION ON THE BALANCE MASSES AND MAGNETS OF THE ROTORS OF THE PUMP MODULE. IN THAT SITUATION THE ROTORS HAVE A HARD TIME TO LEAVE THE PARKING POSITION. AFTER SALES HAS SUGGESTED TO CHECK THE PUMP SURFACE/PISTON TO SEE IF THEY ARE CLEAN FROM DRIED UP BSS OR RESIDUE. ALSO, THEY SUGGESTED THAT A REFLASH OF THE PUMP MODULE COULD BE PERFORMED, BECAUSE PERHAPS THE ISSUE WAS MAINTAINED IN MEMORY. IF ALL THE ABOVE STATED DID NOT WORK, AFTER SALES HAS RECOMMENDED TO REPLACE THE PUMP MODULE. AS THE PUMP MODULE HAS BEEN REPLACED AND NO NEW COMPLAINT WAS REPORTED ON THIS EVA SINCE THIS COMPLAINT WE ASSUME THE REPLACEMENT OF THE MODULE RESOLVED THE ISSUE. THEREFORE, THE MOST LIKELY CAUSE IS CORROSION ON THE BALANCE MASSES AND MAGNETS OF THE ROTORS OF THE PUMP MODULE. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. THEREFORE, NO REMEDIAL OR CORRECTIVE/PREVENTIVE ACTIONS WILL BE UNDERTAKEN AT THIS MOMENT. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (PU-PARK-STRONG). SINCE 2020 MORE THAN 850.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT WHILE THE 2023 INCIDENT NUMBERS ARE UP TO DATE, THE 2023 INSTALLED BASE FIGURES ARE FROM APRIL 25TH 2023. AS IN GENERAL THE INSTALLED BASE INCREASES, THE ACTUAL NUMBER OF DEVICES IN THE MARKET MOST LIKELY IS SLIGHTLY HIGHER. WE HAVE BEEN INFORMED THAT DURING PROCEDURE, ERROR CAR 162 APPEARED AND THE DOCTOR HAD TO REPLACE THE CARTRIDGE 4 TIMES BUT EACH TIME THE ERROR REOCCURRED. THE DOCTOR WAS ABLE TO COMPLETE THE SURGERY HOWEVER DUE TO THE REPORTED EVENT SURGERY WAS PROLONGED >30. MINUTES. THERE IS NO REPORT THAT ACTUAL PATIENT HARM OCCURRED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
43,1222074-2023-00031,2023-03-29,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Decrease in Pressure'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING VITRECTOMY PROCEDURE (WITH THE CONTINUES INFUSION ACTIVATED) WHEN THE NURSE GOES TO CHANGE THE IOP VALUE FROM 25 TO 20 ON THE SCREEN, THE CONTINUOUS INFUSION STOPS. NEITHER THE NURSE TOUCHED THE STOP BUTTON OF THE CONTINUES INFUSION ON THE SCREEN NOR DID THE DOCTOR STEP ON THE PEDAL TO STOP THE CONTINUOUS INFUSION. SURGERY COULD PROCEED BY TURNING ON THE CONTINUOUS INFUSION ON THE SCREEN. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED OR THAT SURGERY WAS PROLONGED > 30 MINUTES. BASED ON REVIEW OF THE AVAILABLE INFORMATION, IT WAS NOT POSSIBLE TO DETERMINE THE ROOT CAUSE OF THE REPORTED COMPLAINT. REVIEW OF THE LOGFILES DID NOT SHOW ANY ISSUES WITH THE UNIT, AND NOTHING WAS RETURNED TO D.O.R.C FOR INVESTIGATION. THE COMPLAINT IS THEREFORE CLOSED WITH AN INCONCLUSIVE FINDING. THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. NO CORRECTIVE OR PREVENTIVE ACTIONS WILL BE IMPLEMENTED AS A RESULT OF THIS INCIDENT.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
44,1222074-2023-00032,2023-03-30,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER,EVA VITRECTOMY PACK GRAVITY INPUT 25G,Vitrectomy Kit,['Fluid/Blood Leak'],"['No Clinical Signs, Symptoms or Conditions']","CAUSE INVESTIGATION: UNFORTUNATELY, NONE OF THE DISPOSABLE PRODUCTS FORM THE PACK WERE RETURNED TO DORC FOR INVESTIGATION. UNFORTUNATELY, WITHOUT ANY PHYSICAL EXAMINATION AND/OR TESTING, THE REPORTED FAILURE COULD NOT BE CONFIRMED AND ITS CAUSE COULD NOT BE DETERMINED. DEVICE HISTORY RECORD REVIEW REVEALED NO DEVIATIONS AND A DATABASE SEARCH SHOWED THAT NO SIMILAR COMPLAINTS HAVE BEEN REPORTED ON THIS SPECIFIC LOT PRIOR TO THIS CASE OR SINCE. RESULTS OF ASSESSMENT: THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. WE HAVE BEEN INFORMED THAT DURING VITRECTOMY PROCEDURE, WATER LEAKED OUT OF THE INSTRUMENT CAUSING THE FORMATION OF AIR BUBBLES THAT ENTERED THE EYE OF THE PATIENT. IRRIGATION WAS INSUFFICIENT. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED OR SURGERY WAS PROLONGED > 30 MIN.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
45,1222074-2023-00033,2023-04-03,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,EVA TDC VITRECTOMY PACK VGPC INPUT 25G,"Unit, Phacofragmentation",['Material Fragmentation'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING VITRECTOMY PROCEDURE, TWO SMALL PIECES OF METAL WERE SPOTTED ON THE MACULA. THE PARTICLES WERE SUCCESSFULLY REMOVED WITH ANOTHER FORCEPS. THE SURGEON INDICATES THAT THE SMALL PARTICLES COULD COME FROM ONE OF THE INSTRUMENTS USED. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED OR SURGERY WAS PROLONGED > 30 MIN. THOUGH VARIOUS PRODUCTS MIGHT HAVE ATTRIBUTED TO THE COMPLAINT (CUTTER, FORCEPS AND LIGHT PROBE), NONE OF THEM WERE RETURNED FOR INVESTIGATION. ALSO, THE PIECES OF METAL THAT WERE REPORTEDLY FOUND ON THE RETINA WERE NOT SHIPPED TO DORC FOR EXAMINATION. UNFORTUNATELY, WITHOUT ANY OF THE INVOLVED INSTRUMENTS OR THE PARTICLES ITSELF, FURTHER INVESTIGATION AS TO THE ORIGIN OF THE PARTICLES AND IS NOT POSSIBLE. DEVICE HISTORY RECORD REVIEW REVEALED NO DEVIATIONS AND A DATABASE SEARCH SHOWED THAT NO SIMILAR COMPLAINTS HAVE BEEN REPORTED ON THE INVOLVED LOTS PRIOR TO THIS CASE OR SINCE. THE PARTICLES MAY HAVE ORIGINATED FROM ANY METAL INSTRUMENT THAT WAS USED DURING THE OPERATION, BUT THE POSSIBILITY THAT THEY DID IN FACT ORIGINATE FROM ONE OF THE INSTRUMENTS LISTED ABOVE CANNOT BE EXCLUDED. HENCE, THE INVESTIGATION FINDINGS DID NOT LEAD TO A CLEAR CONCLUSION CONCERNING THE CAUSE OF THE REPORTED ADVERSE EVENT.THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES.  COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS.SINCE THE ACTUAL ROOT CAUSE OF THE REPORTED ADVERSE EVENT COULD NOT IDENTIFIED, NO REMEDIAL ACTION/CORRECTIVE ACTION/PREVENTIVE ACTION/FIELD SAFETY CORRECTIVE ACTION (FSCA) WILL BE INITIATED AT THIS POINT. THE ANALYSIS ABOVE IS LIMITED TO VITRECTOMES AND INCLUDES ALL COMPLAINTS WITH FAILURE MODE VI-METALPART AND VI-METALPART-REMOVED. VITRECTOME DISTRIBUTION FIGURES UP TO APRIL 25 2023 ARE REFLECTED. PLEASE NOTE THAT SIMILAR COMPLAINTS HAVE NOT BEEN REPORTED ON EITHER FORCEPS OR LIGHT PROBE.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
46,1222074-2023-00037,2023-04-13,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Communication or Transmission Problem'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING SURGERY, THE BATTERY OF THE FOOT SWITCH JUMPED FROM 83% TO 0%. THE USER TRIED TO CONNECT THE FOOT SWITCH WITH CABLES TO THE MACHINE BUT THIS DID NOT HELP. A BACKUP MACHINE WAS USED IN EXCHANGE IN ORDER TO COMPLETE THE PROCEDURE. NO REPORT THAT ACTUAL HARM OCCURRED, HOWEVER DUE TO THE REPORTED EVENT SURGERY WAS PROLONGED > 30 MINUTES. IN REGARD TO THIS COMPLAINT, A MAIN PEDAL WAS PROVIDED FOR INVESTIGATION. THE COMPLAINT COULD NOT BE REPRODUCED DURING INVESTIGATION, THE PEDAL WORKED ACCORDING TO D.O.R.C SPECIFICATIONS. SINCE NO ISSUES WERE DETECTED DURING TESTING, IT WAS CONCLUDED THAT THE REPORTED COMPLAINT CANNOT BE ATTRIBUTED TO THE MAIN PEDAL THAT WAS PROVIDED FOR INVESTIGATION.THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS.ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (FP-DEFECT-*). SINCE 2020 MORE THAN 850.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT THE FAILURE CODE FP-DEFECT-* WILL NOT ALWAYS LEAD TO A PROLONGED SURGERY.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
47,1222074-2023-00024,2023-04-17,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER B.V.,EVA TDC VITRECTOMY PACK VGPC INPUT 25G,"Unit, Phacofragmentation",['Unsealed Device Packaging'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT THE PACKAGING IS NOT PROPERLY SEALED. THE PRODUCT HAS NOT BEEN USED. NO PATIENT HARM OCCURRED. THE INVOLVED PRODUCT WAS RECEIVED AT DORC ON MARCH 23, 2023. VISUAL EXAMINATION CONFIRMED THE COMPROMISED SEAL. FURTHER INVESTIGATION AS TO THE CAUSE OF THE COMPROMISED SEAL IS CURRENTLY ONGOING.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
48,1222074-2023-00039,2023-04-18,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Output below Specifications'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING PHACO PROCEDURE, WHILE ANESTHESIA WAS ADMINISTERED AND INCISIONS WERE MADE, IT WAS NOTICED THAT THE SUCTION OF THE PHACO HANDPIECE DID NOT WORK. UNABLE TO SOLVE THE ISSUE, IT WAS DECIDED TO ABORT SURGERY AND RESCHEDULE IT TO THE NEXT DAY. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED. IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT. AS INVESTIGATIONS ON THE ACTUAL PRODUCT OR REPRESENTATIVE SAMPLE OF A BATCH MAY ALTER THE DEVICE, WE REQUEST TO INFORM US WITHIN 7 DAYS AFTER SUBMISSION OF THIS REPORT, IN CASE THE INVESTIGATIONS THAT ALTER THE DEVICE SHOULD BE HALTED UNTIL APPROVAL OF THE NCA, AS PER ARTICLE 89 OF EU-MDR.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
49,1222074-2023-00051,2023-06-22,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER B.V.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Output Problem'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING PHACO PROCEDURE, THE MACHINE WAS GIVING RANDOM ERRORS ON DIATHERMY AND VFI PRESSURE. THE SURGEON COULD NOT IDENTIFY THE ISSUES. DUE TO THIS, THE SURGERY WAS ABORTED. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED. REVIEW OF THE LOGFILES REVEALED THE OCCURRENCE OF MULTIPLE PUM90V ERROR MESSAGES. THIS ERROR MESSAGE OCCURS IF THE VGPC IS NOT CONNECTED OR NOT PROPERLY CONNECTED TO THE UNIT. THIS ISSUE COULD NOT BE SOLVABLE IF THE CONNECTOR IS DAMAGED/DEFECTIVE. OTHER ERROR MESSAGES WERE OBSERVED AS WELL BUT GOT RESOLVED. IT WAS RECOMMENDED TO TEST THE UNIT PROPERLY TO SEE IF THERE ARE PROBLEMS WITH THE UNIT OR IF THESE ERRORS MIGHT HAVE BEEN USER ERRORS. UNFORTUNATELY, THE COMPLAINT CANNOT BE FURTHER INVESTIGATED NOR CONFIRMED AS NOTHING WAS RETURNED TO D.O.R.C FOR INVESTIGATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. THEREFORE, NO REMEDIAL OR CORRECTIVE/PREVENTIVE ACTIONS WILL BE UNDERTAKEN AT THIS MOMENT. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (EVA-DEFECT-). SINCE 2020 MORE THAN (B)(4) SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT THE FAILURE CODE EVA-DEFECT- WILL NOT ALWAYS LEAD TO A DELAYED SURGERY. PLEASE NOTE THAT WHILE THE 2023 INCIDENT NUMBERS ARE UP TO DATE, THE 2023 INSTALLED BASE FIGURES ARE FROM (B)(6) 2023. AS IN GENERAL THE INSTALLED BASE INCREASES, THE ACTUAL NUMBER OF DEVICES IN THE MARKET MOST LIKELY IS SLIGHTLY HIGHER.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
50,1222074-2023-00053,2023-07-06,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER B.V.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Decrease in Pressure'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING SURGERY, THE MACHINE WAS UNABLE TO BUILD UP PRESSURE FOR THE OIL IN THE SYRINGE. A BACKUP UNIT WAS USED. SURGERY WAS PROLONGED > 30 MINUTES. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED. THE DEVICE WILL BE RETURNED BUT IS NOT ACCESSIBLE FOR INVESTIGATION YET. THE INVESTIGATION WILL BE CONTINUED WHEN THE DEVICE IS AVAILABLE FOR EXAMINATION. NO CORRECTIVE OR PREVENTIVE ACTIONS CAN BE IMPLEMENTED UNTIL THE INVESTIGATION HAS BEEN COMPLETED. FOLLOWING UP ON THIS EVENT, THE CUSTOMER WAS REQUESTED TO RETURN THE ITEM SUBJECT TO THIS EVENT FOR INVESTIGATION. HOWEVER, WE ARE STILL AWAITING THE SYSTEM TO ARRIVE AT OUR FACILITY. AFTER RETURN OF THE ITEM, (ROOT) CAUSE INVESTIGATION WILL BE PERFORMED. IF NO PRODUCT WILL BE RETURNED, THE INCIDENT WILL BE INVESTIGATED FROM THE LOG FILES.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
51,1222074-2023-00054,2023-07-11,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER B.V.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Failure to Cut'],"['No Clinical Signs, Symptoms or Conditions']","IN REGARD TO THIS COMPLAINT, LOGFILES AND PICTURES WERE PROVIDED FOR REVIEW AND ONE 25 GAUGE DISPOSABLE HIGH SPEED TDC CUTTER AND A VITRECTOMY MODULE WERE RECEIVED FOR INVESTIGATION PROVIDED FOR INVESTIGATION. INVESTIGATION OF THE RETURNED PACK REVEALED THAT THE OUTER KNIFE IS BENT, HOWEVER NO OTHER ANOMALIES WERE OBSERVED. THE VITRECTOME IS PERFORMING ACCORDING TO D.O.R.C SPECIFICATIONS. INVESTIGATION OF THE RETURNED VITRECTOMY MODULE CONFIRMED THE OCCURRENCE OF THE REPORTED VITDEAD ERROR MESSAGE. FURTHER INSPECTION REVEALED THAT THE REPORTED COMPLAINT IS ATTRIBUTABLE TO A DEFECTIVE MAIN PCB. THE MODULE COULD NOT BE RECOGNIZED BY THE MAINBOARD, WHICH LED TO THE OCCURRENCE OF THE REPORTED ERROR MESSAGE. BASED ON THE INVESTIGATION FINDINGS, IT WAS DETERMINED THAT THIS COMPLAINT OCCURRED DUE TO A RANDOM COMPONENT FAILURE OF THE MAIN PCB INSIDE THE VITRECTOMY MODULE. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. THEREFORE, NO REMEDIAL OR CORRECTIVE/PREVENTIVE ACTIONS WILL BE UNDERTAKEN AT THIS MOMENT. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. NO CORRECTIVE OR PREVENTIVE ACTIONS WILL BE IMPLEMENTED AS A RESULT OF THIS INCIDENT. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (VI-MAINPCB). SINCE 2020 MORE THAN (B)(4) HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT THE FAILURE CODES WILL NOT ALWAYS LEAD TO A DELAYED SURGERY. PLEASE NOTE THAT WHILE THE 2023 INCIDENT NUMBERS ARE UP TO DATE, THE 2023 INSTALLED BASE FIGURES ARE FROM (B)(6) 2023. AS IN GENERAL THE INSTALLED BASE INCREASES, THE ACTUAL NUMBER OF DEVICES IN THE MARKET MOST LIKELY IS SLIGHTLY HIGHER. WE HAVE BEEN INFORMED THAT DURING A 25G COMBINED PROCEDURE, PRIMING WAS NORMAL. AFTER THE PHACO OPERATION WAS DONE, THE VITRECTOMY STEPS COULD NOT BE USED DUE TO A DEVICE ERROR. AFTER RESTARTING THE MACHINE AND PRIMING COMPLETELY HOWEVER, THE VITRECTOMY ERROR WAS STILL DETECTED AGAIN. THEREFORE THE SURGEON DECIDED TO ABORT THE SURGERY BECAUSE THEY HAVE NO OTHER MACHINE. SURGERY WAS ABORTED. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
52,1222074-2023-00056,2023-07-28,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER B.V.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Decrease in Pressure'],"['No Clinical Signs, Symptoms or Conditions']","THE COMPLAINT IS UNDER INVESTIGATION. NO CORRECTIVE OR PREVENTIVE ACTIONS CAN BE IMPLEMENTED UNTIL THE INVESTIGATION HAS BEEN COMPLETED. FINAL CONCLUSION IS PENDING THE ANALYSIS OF THE LOGFILES. WE HAVE BEEN INFORMED THAT DURING SURGERY, THE INFUSION IN THE 25G PROGRAM TURNED OFF WITHOUT AUDIBLE ACOUSTIC FEEDBACK OR OPERATING THE FOOTSWITCH. THE EYE THEN WENT SOFT UNTIL INFUSION WAS TURNED BACK ON AGAIN. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED OR SURGERY WAS PROLONGED > 30 MIN.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
53,1222074-2023-00057,2023-07-31,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER B.V.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Decrease in Pressure'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING SURGERY, THE SURGEON CLAIMED THAT THEY WERE LOSING COMPENSATION OF THE INTRAOCULAR PRESSURE. AFTER THE PROCEDURE, THE VALUES OF PRESSURE OF THE MODULE WERE CHECKED WITH A FLUKE DIGITAL PRESSURE GAUGE DPM2 PLUS. THE VALUES OF 20 MMHG, 50 MMHG, AND 150 MMHG WERE WITHIN THE VALUES ESTABLISHED BY DORC (20, 50, AND 149 MMHG). NO REPORT THAT ACTUAL PATIENT HARM OCCURRED OR SURGERY WAS PROLONGED > 30 MIN. IN REGARD TO THIS COMPLAINT, NO LOGFILES NOR PICTURES OR VIDEOS WERE PROVIDED FOR REVIEW. BASED ON REVIEW OF THE AVAILABLE INFORMATION, IT WAS NOT POSSIBLE TO DETERMINE THE ROOT CAUSE OF THE REPORTED COMPLAINT. THIS COULD BE USER-RELATED, HOWEVER LOGFILES WERE NOT RECEIVED FOR REVIEW. AS THE PRESSURE TESTS IN THE FIELD DID NOT REVEAL ANY DEVIATIONS, IT WAS RECOMMENDED TO MONITOR THE ISSUE. IF THE MODULE WILL BE RETURNED, WE WILL INVESTIGATE THE DEVICE AND UPDATE THE REPORT IF NEEDED. THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. NO CORRECTIVE OR PREVENTIVE ACTIONS WILL BE IMPLEMENTED AS A RESULT OF THIS INCIDENT. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (VF-PHACO-SURGERY-HYPOTONY). SINCE 2020 MORE THAN 850.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT WHILE THE 2023 INCIDENT NUMBERS ARE UP TO DATE, THE 2023 INSTALLED BASE FIGURES ARE FROM APRIL 25TH 2023. AS IN GENERAL THE INSTALLED BASE INCREASES, THE ACTUAL NUMBER OF DEVICES IN THE MARKET MOST LIKELY IS SLIGHTLY HIGHER.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
54,1222074-2023-00059,2023-08-15,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER B.V.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Output below Specifications'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING SURGERY, THE PHACO POWER WAS VERY LOW. THEY HAVE TRIED TO INCREASE THE POWER, CHANGE THE CASSETTE, AND CHANGE THE HANDPIECE BUT THE PROBLEM STILL PERSISTED. ANOTHER MACHINE WAS USED TO CONTINUE THE SURGERY. SURGERY WAS PROLONGED > 30 MINS. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED. THE ISSUE ENCOUNTERED COULD NOT BE SEEN UPON REVIEW OF THE LOGFILES. IT WAS RECOMMENDED TO MONITOR THE SITUATION AND REPLACE THE PHACODIATHERMY MODULE IF IT HAPPENS AGAIN. SOMETIMES, A REBOOT OF THE UNIT MAY SOLVE THE ISSUE. THE COMPLAINT COULD BE ATTRIBUTABLE TO THE HANDPIECE, HOWEVER THIS CANNOT BE CONFIRMED. UNFORTUNATELY, THE COMPLAINT CANNOT BE FURTHER INVESTIGATED NOR CONFIRMED CONCLUSIVELY AS NO PRODUCT WAS RETURNED TO D.O.R.C FOR INVESTIGATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. THEREFORE, NO REMEDIAL OR CORRECTIVE/PREVENTIVE ACTIONS WILL BE UNDERTAKEN AT THIS MOMENT. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. NO CORRECTIVE OR PREVENTIVE ACTIONS WILL BE IMPLEMENTED AS A RESULT OF THIS INCIDENT. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (PD-DEFECT-). SINCE 2020 MORE THAN 850.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT THE FAILURE CODES WILL NOT ALWAYS LEAD TO A PROLONGED/DELAYED SURGERY. PLEASE NOTE THAT WHILE THE 2023 INCIDENT NUMBERS ARE UP TO DATE, THE 2023 INSTALLED BASE FIGURES ARE FROM APRIL 25TH 2023. AS IN GENERAL THE INSTALLED BASE INCREASES, THE ACTUAL NUMBER OF DEVICES IN THE MARKET MOST LIKELY IS SLIGHTLY HIGHER.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
55,1222074-2023-00063,2023-08-25,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER B.V.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Failure to Prime'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING SURGERY, THE EVA MACHINE EXPERIENCED A PUM61 ERROR DURING PRIMING, WHICH INDICATES THAT NO IRRIGATION IS AVAILABLE. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED. SURGERY WAS ABORTED. THE COMPAINT IS CURRENTLY UNDER INVESTIGATION AND AWAITING PRODUCT RETURN. NO CORRECTIVE OR PREVENTIVE ACTIONS CAN BE IMPLEMENTED UNTIL THE INVESTIGATION HAS BEEN COMPLETED. THE DEVICE WILL BE INVESTIGATED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
56,1222074-2023-00062,2023-08-25,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER B.V.,"EVA NEXUS, PHACO VITRECTOMY SYSTEM INCLUDING LASER WITH DORC CONNECTOR","Unit, Phacofragmentation",['Visual Prompts will not Clear'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING SURGERY, THE EVA TRIGGERS A MESSAGE DURING PRIMING INDICATING THAT THE CLAMPING FAILED AND THAT THE CARTRIDGE SHOULD BE REMOVED. IN THE END, THE ISSUE COULD NOT BE RESOLVED AND A BACK-UP UNIT WAS USED. 3 NEW CARTRIDGES WERE USED TO TEST WHETHER IT WAS A CARTRIDGE ISSUE, BUT LATER INSPECTION SHOWED THAT IT WAS A PUMP ISSUE INSTEAD. SURGERY WAS PROLONGED MORE THAN 30 MINS. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED. THE COMPLAINT IS CURRENTLY AWAITING INVESTIGATION BY SUPPLIER. NO CORRECTIVE OR PREVENTIVE ACTIONS CAN BE IMPLEMENTED UNTIL THE INVESTIGATION HAS BEEN COMPLETED. THE DEVICE WILL BE INVESTIGATED BY THE SUPPLIER.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA NEXUS PHACO VITRECTOMY SYSTEM INCLUDING LASER WITH DORC CONNECTOR
57,1222074-2023-00067,2023-09-27,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER B.V.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Insufficient Flow or Under Infusion'],"['No Clinical Signs, Symptoms or Conditions']","IN REGARD TO THIS COMPLAINT, A PUMP MODULE WAS PROVIDED FOR INVESTIGATION. INVESTIGATION OF THE RETURNED MODULE REVEALED A DEFECTIVE PNEUMATIC VALVE INSIDE THE MODULE. DUE TO THE DEFECTIVE VALVE, THE MODULE COULD NOT PASS PRIMING AND THE EVA SURGICAL SYSTEM WAS TRIGGERED TO DISPLAY THE PUM71 ERROR MESSAGE ON THE SCREEN. BASED ON INVESTIGATION RESULTS, IT WAS DETERMINED THAT THE REPORTED COMPLAINT IS ATTRIBUTABLE TO A COMPONENT FAILURE OF A PNEUMATIC VALVE INSIDE THE PUMP MODULE. THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. A ROOT CAUSE ANALYSIS AT THE SUPPLIER HAS BEEN REQUESTED (SCAR 2023-007). ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (PU-PNEU-VALVE). SINCE 2020 MORE THAN 850.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT THE FAILURE CODES WILL NOT ALWAYS LEAD TO A DELAYED SURGERY. PLEASE NOTE THAT WHILE THE 2023 INCIDENT NUMBERS ARE UP TO DATE, THE 2023 INSTALLED BASE FIGURES ARE FROM APRIL 25TH 2023. AS IN GENERAL THE INSTALLED BASE INCREASES, THE ACTUAL NUMBER OF DEVICES IN THE MARKET MOST LIKELY IS SLIGHTLY HIGHER. WE HAVE BEEN INFORMED THAT DURING PRIMING, WHILE THE PATIENT WAS UNDER GENERAL SEDATION, THE SURGEON EXPERIENCED MULTIPLE PUMP ERRORS AND WAS NOT ABLE TO START THE PROCEDURE. SURGERY WAS ABORTED. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
58,1222074-2023-00068,2023-10-11,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Failure to Deliver Energy'],"['No Clinical Signs, Symptoms or Conditions']","IN REGARD TO THIS COMPLAINT, LOGFILES AND PICTURES WERE PROVIDED FOR REVIEW. REVIEW OF THE LOGFILES AND PICTURES CONFIRMED THE OCCURRENCE OF THE REPORTED LAS4 ERROR MESSAGE, IT IS RELATED TO THE LASER STOP EMERGENCY BUTTON. HOWEVER LOGFILES INDICATED THAT THIS BUTTON WAS NOT ACTIVATED ON THE DAY OF THE REPORTED EVENT, THEREFORE IT IS ADVISED TO REPLACE THE LASER MODULE. UNFORTUNATELY, THE COMPLAINT CANNOT BE FURTHER INVESTIGATED NOR CONFIRMED CONCLUSIVELY AS NO PRODUCT WAS RETURNED TO D.O.R.C FOR INVESTIGATION. THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. NO CORRECTIVE OR PREVENTIVE ACTIONS WILL BE IMPLEMENTED AS A RESULT OF THIS INCIDENT. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (LM-LAS4 -*). SINCE 2020 MORE THAN (B)(4) SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT THE FAILURE CODE LM-LAS4 WILL NOT ALWAYS LEAD TO A DELAYED SURGERY. PLEASE NOTE THAT WHILE THE 2023 INCIDENT NUMBERS ARE UP TO DATE, THE 2023 INSTALLED BASE FIGURES ARE FROM (B)(6) 2023. AS IN GENERAL THE INSTALLED BASE INCREASES, THE ACTUAL NUMBER OF DEVICES IN THE MARKET MOST LIKELY IS SLIGHTLY HIGHER. WE HAVE BEEN INFORMED THAT DURING VITRECTOMY PROCEDURE, WHEN USING THE LASER AND LASER MODULE AN ERROR MESSAGE OCCURRED. UNABLE TO SOLVE THE ERROR MESSAGE, IT WAS DECIDED TO NOT PERFORM THE LASER TREATMENT BUT TO RESCHEDULE IT. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
59,1222074-2023-00071,2023-10-12,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER B.V.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Insufficient Flow or Under Infusion'],"['No Clinical Signs, Symptoms or Conditions']","IN REGARD TO THIS COMPLAINT, LOGFILES WERE PROVIDED FOR REVIEW. THE VFE13 ERROR MESSAGE IS A CONTROL ERROR INDICATING AN UNEXPECTED BEHAVIOUR, MAYBE BECAUSE THE INPUT PRESSURE IS BELOW THE SETPOINT. THE REQUIRED VACUUM FOR THE VFE COULD NOT BE CREATED. IT WAS ADVISED TO CHECK THE CORRECT CONNECTION OF THE INSTRUMENTS AND THE SUPPLIED PRESSURE, AS WELL AS TO CHECK HOW HIGH THE INPUT PRESSURE IS BECAUSE IT SEEMS TOO LOW. AS THE EVENT COULD ALSO BE RELATED TO THE PEDAL SETTINGS, IT WAS ADVISED TO CHECK IN THE FOOTSWITCH PROGRAMMING PAGE IF THE MAIN PEDAL HORIZONTAL AND VERTICAL INDICATORS ARE AT 0 WHEN THE FOOTSWITCH IS NOT BEING TOUCHED. IF THE FOOTSWITCH IS NOT BEING TOUCHED AND THE VALUES ARE NOT 0, A REPLACEMENT OF THE MAIN PEDAL MIGHT BE REQUIRED. A DATABASE SEARCH SHOWED THAT NO SIMILAR COMPLAINTS WERE REPORTED ON THIS EVA PRIOR TO THIS CASE OR SINCE. UNFORTUNATELY, THE COMPLAINT CANNOT BE FURTHER INVESTIGATED NOR CONFIRMED CONCLUSIVELY AS NO PRODUCT WAS RETURNED TO D.O.R.C FOR INVESTIGATION. THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. NO CORRECTIVE OR PREVENTIVE ACTIONS WILL BE IMPLEMENTED AS A RESULT OF THIS INCIDENT. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (VF-PRESSURE-LOW-*). SINCE 2020 MORE THAN 850.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT THE FAILURE CODES WILL NOT ALWAYS LEAD TO A PROLONGED SURGERY. PLEASE NOTE THAT WHILE THE 2023 INCIDENT NUMBERS ARE UP TO DATE, THE 2023 INSTALLED BASE FIGURES ARE FROM (B)(6) 2023. AS IN GENERAL THE INSTALLED BASE INCREASES, THE ACTUAL NUMBER OF DEVICES IN THE MARKET MOST LIKELY IS HIGHER. WE HAVE BEEN INFORMED THAT DURING SURGERY, DURING PHACO (SCUPLTING/QUADRANT REMOVAL), THE ANTERIOR CHAMBER WAS COLLAPSING, BRINGING THE POSTERIOR CAPSULE FORWARD. THE SURGEON WAS UNSURE IF THE IRRIGATION WAS ON, BUT IT WAS ON. DID ALL THE NORMAL TROUBLESHOOTING BUT THERE WAS NO CHANGE. THE SURGEON CONTINUED WITH THE PROCEDURE WITH CAUTION, ENSURING THAT IRRIGATION WAS KEPT ON AT ALL TIMES AND THIS CAUSED THE SURGERY TO TAKE LONGER. SURGERY WAS PROLONGED > 30 MIN. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
60,1222074-2023-00072,2023-10-18,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,EVA TDC VITRECTOMY PACK VGPC INPUT 25G,"Unit, Phacofragmentation",['Insufficient Flow or Under Infusion'],"['No Clinical Signs, Symptoms or Conditions']","THE COMPLAINT IS UNDER INVESTIGATION. EXAMINE THE PRODUCT THAT WAS RETURNED BY THE CUSTOMER. WE HAVE BEEN INFORMED THAT DURING SURGERY, DURING THE PHACO PROCEDURE, THE SURGEON EXPERIENCED PROBLEMS WITH THE IRRIGATION WHICH CAUSED A SHALLOW ANTERIOR CHAMBER. ANOTHER MACHINE WAS USED TO CONTINUE THE SURGERY. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED OR SURGERY WAS PROLONGED > 30 MIN.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
61,1222074-2023-00076,2023-10-25,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Output Problem'],['Loss of Vision'],"WE HAVE BEEN INFORMED THAT DURING VITRECTOMY SURGERY, AN ERROR MESSAGE OCCURRED. THE PATIENT HAS LOST VISION IN THE OPERATED EYE. FROM THE LOGFILES IT CAN BE CONCLUDED THAT THE INVOLVED EVA COMES FREQUENTLY WITH WARNING MESSAGE ""AIR41"". THIS WARNING TELLS THE USER THAT THE BACKUP AIR PRESSURE FOR THE AIR-MODULE IS NOT WORKING. THE BACKUP AIR PRESSURE (ALSO CALLED SAFETY AIR PRESSURE) IS THERE TO ALLOW THE SYSTEM TO WORK IN A ""SAFE STATE'' FOR A WHILE WHEN THE POWER TO THE SYSTEM WOULD BE LOST WARNING AIR41 CAN BE IGNORED BY THE USER, AND THE SYSTEM WILL WORK AS NORMAL. HOWEVER, IN CASE OF A TOTAL POWER LOSS, THE BACKUP AIR PRESSURE WILL NOT WORK FROM THE LOGFILE INVESTIGATION, THERE IS NO OTHER MALFUNCTIONING OF THE DEVICE FOUND. THE REPORTED VISION LOSS IN THE PATIENT'S EYE CANNOT BE RELATED TO THE ""AIR41"" WARNING MESSAGE; THE EVA SYSTEM. THEREFORE, THE INCIDENT IS ASSESSED AS NOT REPORTABLE. THE REPORTED VISION LOSS IN THE PATIENT'S EYE CANNOT BE RELATED TO THE ""AIR41"" WARNING MESSAGE; THE EVA SYSTEM. THEREFORE A REVIEW OF THE RISK ASSESSMENT IS NOT APPLICABLE.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
62,1222074-2023-00070,2023-10-27,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Improper Flow or Infusion'],"['No Clinical Signs, Symptoms or Conditions']","THE DEVICE WILL BE RETURNED BUT IS NOT ACCESSIBLE FOR INVESTIGATION YET. THE INVESTIGATION WILL BE CONTINUED WHEN THE DEVICE IS AVAILABLE FOR EXAMINATION. (SEVERAL PRODUCT REMINDERS ARE SENT TO RECEIVE THE PRODUCT FOR INVESTIGATION.) NO CORRECTIVE OR PREVENTIVE ACTIONS CAN BE IMPLEMENTED UNTIL THE INVESTIGATION HAS BEEN COMPLETED. INVESTIGATION TO DETERMINE THE ROOT CAUSE OF THE REPORTED EVENT IS ONGOING. WE HAVE BEEN INFORMED THAT DURING SURGERY, MULTIPLE ERRORS APPEARED WHICH COULD NOT BE RESOLVED BY RESTARTING THE DEVICE. ANOTHER UNIT WAS USED TO COMPLETE THE SURGERY. SURGERY WAS PROLONGED > 30 MIN. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
63,1222074-2023-00077,2023-10-31,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER B.V.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Failure to Prime'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING THE PRIMING SEQUENCE AN ERROR NPUM 61 WAS DISPLAYED. THE PRIMING STOPPED AND COULD NOT BE FINISHED. REPRIMING DID NOT RESOLVE THE ISSUE. ANOTHER PACK WAS OPENED AND THAT PRIMING ALSO FAILED. THE MACHINE WAS RESTARTED AND ANOTHER PACK WAS USED, THE PRIMING AGAIN FAILED. THE PATIENT WAS UNDER ANESTHESIA, AFTER 2 HOURS THE PATIENT WAS TAKEN OUT OF ANESTHESIA BECAUSE THE PROBLEM COULD NOT BE FIXED. UNABLE TO SOLVE THE ISSUE, IT WAS DECIDED TO ABORT THE SURGERY. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED. THE COMPLAINT IS UNDER INVESTIGATION. IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT. AS INVESTIGATIONS ON THE ACTUAL PRODUCT OR REPRESENTATIVE SAMPLE OF A BATCH MAY ALTER THE DEVICE, WE REQUEST TO INFORM US WITHIN 7 DAYS AFTER SUBMISSION OF THIS REPORT, IN CASE THE INVESTIGATIONS THAT ALTER THE DEVICE SHOULD BE HALTED UNTIL APPROVAL OF THE NCA, AS PER ARTICLE 89 OF EU-MDR.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
64,1222074-2023-00081,2023-11-08,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER B.V.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Output Problem'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING SURGERY, THE EVA MACHINE EXPERIENCED A PUM71 ERROR DURING PRIMING, WHICH INDICATES THAT NO ASPIRATION PRESSURE POSSIBLE. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED. HOWEVER, SURGERY WAS PROLONGED > 30 MINUTES. THE COMPLAINT IS UNDER INVESTIGATION. IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
65,1222074-2023-00089,2023-12-29,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation","['Insufficient Flow or Under Infusion', 'Infusion or Flow Problem']","['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING SURGERY, BEFORE BEGINNING THE PHACO PROCEDURE, IT WAS NOTICED THAT WATER WAS COMING OUT OF THE HANDPIECE BUT CONSTANT IRRIGATION IS OFF. AFTER RESTARTING, THE MACHINE REFUSED TO PRIME AND THE SCREEN SHOWED AN ERROR MESSAGE. A NEW CARTRIDGE WAS OPENED BUT IT HAD THE SAME PROBLEM. THE PHACO WAS COMPLETED USING ANOTHER MACHINE. SURGERY WAS PROLONGED MORE THAN 30 MINUTES. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED. THE COMPLAINT IS UNDER INVESTIGATION. NO CORRECTIVE OR PREVENTIVE ACTIONS CAN BE IMPLEMENTED UNTIL THE INVESTIGATION HAS BEEN COMPLETED. IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
66,1222074-2024-00002,2024-01-05,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Decrease in Pressure'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING A COMBINED SURGERY, THE EYE WAS COLLAPSING AND THE EVA DID NOT ASPIRATE. THIS HAPPENED DURING THE PHACO AND ALSO DURING VITRECTOMY, THEY CHANGED THE VITRECTOMY PACK AND THE PROBLEM WAS SOLVED. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED OR SURGERY WAS PROLONGED MORE THAN 30 MINUTES. THE COMPLAINT IS UNDER INVESTIGATION. NO CORRECTIVE OR PREVENTIVE ACTIONS CAN BE IMPLEMENTED UNTIL THE INVESTIGATION HAS BEEN COMPLETED. IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT. AS INVESTIGATIONS ON THE ACTUAL PRODUCT OR REPRESENTATIVE SAMPLE OF A BATCH MAY ALTER THE DEVICE, WE REQUEST TO INFORM US WITHIN 7 DAYS AFTER SUBMISSION OF THIS REPORT, IN CASE THE INVESTIGATIONS THAT ALTER THE DEVICE SHOULD BE HALTED UNTIL APPROVAL OF THE NCA, AS PER ARTICLE 89 OF EU-MDR.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
67,1222074-2024-00003,2024-01-11,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Insufficient Flow or Under Infusion'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING SURGERY, THE EVA WAS NOT WORKING AS USUAL. THE SURGEON EXPERIENCED LOW IRRIGATION AND ASPIRATION PRESSURE. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED OR SURGERY WAS PROLONGED MORE THAN 30 MINUTES. UPDATE10JAN2024: IN ADDITION IT WAS REPORTED THAT THE FOOT PEDAL WAS MARKED RED IN THE FIRMWARE. IN REGARD TO THIS COMPLAINT, LOGFILES WERE PROVIDED FOR REVIEW. REVIEW OF THE LOGFILES REVEALED THAT THE RED BOXES AT THE FIRMWARE SCREEN INDICATED THAT THE VERSION OF THE PEDALS COULD NOT BE RETRIEVED BECAUSE THE WIRELESS MODE WAS USED. TO RETRIEVE THE VERSIONS OF THE PEDALS THE USER HAS TO CONNECT THE CABLES BEFORE SWITCHING THE MACHINE ON. THE TECHNICAL APPLICATION SPECIALIST ON-SITE CONFIRMED THIS; THE PEDAL FUNCTIONED AS INTENDED. AS FOR THE PUMP RELATED ISSUE, ON-SITE TESTING OF THE PUMP MODULE BY A TECHNICIAN DID NOT REVEAL ANY ABNORMALITY. THE PROBLEM COULD HAVE BEEN CAUSED BY THE DISPOSABLES, ALTHOUGH FURTHER TESTING DID NOT POINT OUT ANY ABNORMALITIES. UNFORTUNATELY, THE COMPLAINT CANNOT BE FURTHER INVESTIGATED NOR CONFIRMED CONCLUSIVELY AS NO PRODUCT WAS RETURNED TO D.O.R.C FOR INVESTIGATION. THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (EVA-IRRIGATION_ RELATED TO LOW OR NO IRRIGATION). SINCE 2021 MORE THAN (B)(4) SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT WHILE THE 2023 AND 2024 INCIDENT NUMBERS ARE UP TO DATE, THE INSTALLED BASE FIGURES ARE FROM (B)(6) 2023. AS IN GENERAL THE INSTALLED BASE INCREASES, THE ACTUAL NUMBER OF DEVICES IN THE MARKET MOST LIKELY IS SLIGHTLY HIGHER.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
68,1222074-2024-00004,2024-02-29,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER B.V.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation","['Visual Prompts will not Clear', 'Output Problem']","['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT AFTER COMPLETING PRIMING AND DURING PROCEDURE, A MESSAGE CAR160 WAS TRIGGERED. DESPITE MANY ATTEMPTS TO PRIME DURING THE SURGERY (WHILE THE INSTRUMENTS INSIDE THE PATIENTS EYE) THE SURGEON WAS UNABLE TO SOLVE THE ISSUE. NO REPORT THAT ACTUAL PATIENT OR USER HARM OCCURRED BUT THE SURGERY WAS PROLONGED > 30 MIN. THE COMPLAINT IS UNDER INVESTIGATION.IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
69,1222074-2024-00006,2024-03-04,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Infusion or Flow Problem'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING THE VITRECTOMRY SURGERY, CAR151 ERROR WAS NOTIFIED SUBSEQUENTLY, A CARTRIDGE REPLACEMENT WAS CARRIED OUT. ALSO DURING THE OIL REMOVER OPERATION, AN ERROR OCCURRED, LEADING TO THE OPERATION BEING HALTED BEFORE COMPLETION. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED. SURGERY WAS ABORTED. THE COMPAINT IS CURRENTLY UNDER INVESTIGATION.IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
70,1222074-2024-00013,2024-05-17,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Insufficient Flow or Under Infusion'],"['No Clinical Signs, Symptoms or Conditions']","THE COMPLAINT IS UNDER INVESTIGATION. NO CORRECTIVE OR PREVENTIVE ACTIONS CAN BE IMPLEMENTED UNTIL THE INVESTIGATION HAS BEEN COMPLETED. IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT. AS INVESTIGATIONS ON THE ACTUAL PRODUCT OR REPRESENTATIVE SAMPLE OF A BATCH MAY ALTER THE DEVICE, WE REQUEST TO INFORM US WITHIN 7 DAYS AFTER SUBMISSION OF THIS REPORT, IN CASE THE INVESTIGATIONS THAT ALTER THE DEVICE SHOULD BE HALTED UNTIL APPROVAL OF THE NCA, AS PER ARTICLE 89 OF EU-MDR. WE HAVE BEEN INFORMED THAT DURING THE SECOND SURGERY WITH THE SURGEON, A COMBINED PROCEDURE FOLLOWING THE PHACO PROCEDURE, AND SHORTLY AFTER BEGINNING THE VITRECTOMY, THERE WAS NO INFUSION AS REPORTED BY THE NURSES. ALL CHECKS WERE CONDUCTED, AND THERE WERE NO ERROR MESSAGES, INDICATING THAT THE LINES WERE ALSO GOOD. CONSEQUENTLY, THE VITRECTOMY PROCEDURE HAD TO BE SUSPENDED FOR THE PATIENT. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
71,1222074-2024-00014,2024-05-22,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Insufficient Flow or Under Infusion'],"['No Clinical Signs, Symptoms or Conditions']","THE COMPLAINT IS UNDER INVESTIGATION. IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT. AS INVESTIGATIONS ON THE ACTUAL PRODUCT OR REPRESENTATIVE SAMPLE OF A BATCH MAY ALTER THE DEVICE, WE REQUEST TO INFORM US WITHIN 7 DAYS AFTER SUBMISSION OF THIS REPORT, IN CASE THE INVESTIGATIONS THAT ALTER THE DEVICE SHOULD BE HALTED UNTIL APPROVAL OF THE NCA, AS PER ARTICLE 89 OF EU-MDR. WE HAVE BEEN INFORMED THAT DURING RETINA SURGERY, IN THE PRIMING PHASE, ERROR PUM16 APPEARED. THE TEAM RESTARTED THE MACHINE THREE TIMES, BUT THE SAME ERROR PUM61, ALWAYS APPEARED. TO START AND FINISH THE SURGERY, THE CLINIC THEN USED THE B&L ELITE, AND THEY HAD TO REPLACE THE PUMP. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED, BUT THE SURGERY WAS PROLONGED > 30 MINUTES.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
72,1222074-2024-00020,2024-06-27,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER B.V.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Failure to Cut'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT AT THE END OF PRIMING THE CUTTING SOUND OF THE VITRECTOMY WAS ABNORMAL (AFTER THE EVA WAS TURNED ON AND THE VITRECTOMY PACK WAS MOUNTED). AT THE BEGINNING OF THE SURGERY IT WAS VERIFIED THAT THE VITRECTOMY HAND PIECE ASPIRATED BUT DIDN'T CUT WELL. DIFFERENT VITRECTOMES HAND PIECES WERE TRIED BUT THE PROBLEM WASN'T RESOLVED. FINALLY THE SURGERY WAS SUSPENDED. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED, BUT THE SURGERY WAS DELAYED. THE COMPLAINT IS UNDER INVESTIGATION. NO CORRECTIVE OR PREVENTIVE ACTIONS CAN BE IMPLEMENTED UNTIL THE INVESTIGATION HAS BEEN COMPLETED. IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT. AS INVESTIGATIONS ON THE ACTUAL PRODUCT OR REPRESENTATIVE SAMPLE OF A BATCH MAY ALTER THE DEVICE, WE REQUEST TO INFORM US WITHIN 7 DAYS AFTER SUBMISSION OF THIS REPORT, IN CASE THE INVESTIGATIONS THAT ALTER THE DEVICE SHOULD BE HALTED UNTIL APPROVAL OF THE NCA, AS PER ARTICLE 89 OF EU-MDR.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
73,1222074-2024-00018,2024-07-03,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,PHACOEMULSIFICATION/VITRECTOMY SYSTEM,"Unit, Phacofragmentation",['Decrease in Pressure'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING SURGERY, THERE WAS AN OIL INJECTION PROBLEM IN OUR EVA MACHINE. THE FILTER OF THIS MACHINE IS BROKEN, AS CAN BE SEEN IN THE PICTURE. A NEW FILTER FOR THIS MACHINE IS NEEDED TO FIX THIS PROBLEM. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED, BUT THE SURGERY WAS PROLONGED > 30 MINUTES. IN REGARD TO THIS COMPLAINT, A PICTURE WAS PROVIDED FOR REVIEW. REVIEW OF THE PICTURE CONFIRMED THE REPORTED ISSUE. UNFORTUNATELY, THE COMPLAINT CANNOT BE FURTHER INVESTIGATED AS NO PRODUCT WAS RETURNED TO D.O.R.C FOR INVESTIGATION. THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS.ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (VF-VFI-PRESSURE-LOW*). SINCE 2021 MORE THAN 850.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT THE FAILURE CODES WILL NOT ALWAYS LEAD TO A PROLONGED/DELAYED SURGERY. PLEASE NOTE THAT THE COMPLAINT RELATED TO THIS MANUFACTURER INCIDENT REPORT IS INCLUDED IN THE COMPLAINT NUMBERS IN THE TABLE.",DUTCH OPHTHALMIC RESEARCH CENTER,PHACO EMULSIFICATION HANDPIECE
74,1222074-2024-00024,2024-07-17,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Output below Specifications'],"['No Clinical Signs, Symptoms or Conditions']","THE COMPLAINT IS UNDER INVESTIGATION. IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT. AS INVESTIGATIONS ON THE ACTUAL PRODUCT OR REPRESENTATIVE SAMPLE OF A BATCH MAY ALTER THE DEVICE, WE REQUEST TO INFORM US WITHIN 7 DAYS AFTER SUBMISSION OF THIS REPORT, IN CASE THE INVESTIGATIONS THAT ALTER THE DEVICE SHOULD BE HALTED UNTIL APPROVAL OF THE NCA, AS PER ARTICLE 89 OF EU-MDR. WE HAVE BEEN INFORMED THAT DURING VITRECTOMY AFTER DOING EXTRUSION, WHEN CHANGING TO ENDOLASER PHASE, THE ERROR MESSAGE ""LAS0"" APPEARS AND IT WAS NOT POSSIBLE TO DO ANY LASER. THE MACHINE WAS RESTARTED AND CHECKED THAT THE EMERGENCY LASER BUTTON WAS NOT PRESSED AND ERROR CONTINUES SHOWING UP. SURGERY WAS COMPLETED BY USING ANOTHER MACHINE. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED, HOWEVER, DUE TO THE REPORTED EVENT SURGERY WAS PROLONGED > 30MIN.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
75,1222074-2024-00031,2024-08-13,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Insufficient Flow or Under Infusion'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING POSTERIOR PROCEDURE, THE IOP IS UNSTABLE, INFUSION ON/OFF AUTOMATICALLY TURNED OFF. THE FOOTSWITCH FUNCTION DOES NOT HAVE AN IRRIGATION FUNCTION. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED, HOWEVER, DUE TO THE REPORTED EVENT, SURGERY WAS PROLONGED > 30 MINUTES. IN REGARD TO THIS COMPLAINT, LOGFILES WERE PROVIDED FOR REVIEW. REVIEW OF THE LOGFILES REVEALED THAT THE VFIE MODULE HAD SOME INCOMING PRESSURE ERRORS, AND THE INFUSION POLE WAS REPORTING ERRORS AS WELL. LATER IN THE DAY, THE VITRECTOMY MODULE REPORTED A VIT2, WHICH MEANS THAT THE PRESSURE THE UNIT IS RECEIVING IS BELOW 3 BARS. IT WAS ADVISED TO CHECK IF THE INTERNAL PRESSURE IS CORRECT. IF THE INTERNAL PRESSURE IS LOWER, IT WAS RECOMMENDED TO INCREASE IT WITH THE INTERNAL REDUCER IN THE BASE OF THE EVA UNIT. IF THE PRESSURE IS CORRECT, IT COULD ALSO HAVE BEEN THE SUPPLIED PRESSURE FROM THE WALL OUTLET BEING UNSTABLE AT THE TIME. IN ADDITION, IT WAS ADVISED TO CHECK IF THE INFUSION POLE MOTOR IS DRIVING THE INFUSION POLE CORRECTLY, AS THIS ISSUE COULD BE DUE TO THE MOTOR OR THE POLE ITSELF. UNFORTUNATELY, THE COMPLAINT CANNOT BE FURTHER INVESTIGATED NOR CONFIRMED CONCLUSIVELY AS NO PRODUCT WAS RETURNED TO D.O.R.C FOR INVESTIGATION. THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (NX-LOW INFUSION-POSTERIOR). SINCE 2021 MORE THAN 850.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT THE FAILURE CODES WILL NOT ALWAYS LEAD TO A PROLONGED/DELAYED SURGERY. PLEASE NOTE THAT THE COMPLAINT RELATED TO THIS MANUFACTURER INCIDENT REPORT IS INCLUDED IN THE COMPLAINT NUMBERS IN THE TABLE.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
76,1222074-2024-00032,2024-08-15,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Communication or Transmission Problem'],"['No Clinical Signs, Symptoms or Conditions']","THE DEVICE IS NOT YET ACCESSIBLE FOR INVESTIGATION. THEREFOR PRELIMINARY RESULTS OR CONCLUSIONS ARE NOT YET AVAILABLE. THE INVESTIGATION WILL BE CONTINUED WHEN THE DEVICE IS AVAILABLE FOR EXAMINATION. WE HAVE BEEN INFORMED THAT DURING PROCEDURE, ERROR FOP50001 OCCURRED WHEN STARTING THE MACHINE. THE FUNCTION KEYS ON BOTH SIDES OF THE FOOT PEDAL DID NOT WORK. WHEN USING THE LASER, RELEASING THE FOOT PEDAL IMMEDIATELY RESULTED IN THE LASER LEAVING THE READY STATE. IT WAS NEEDED TO CLICK THE LASER AGAIN TO PREPARE. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED, HOWEVER, DUE TO THE REPORTED EVENT SURGERY WAS PROLONGED > 30 MINUTES.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
77,1222074-2024-00030,2024-08-15,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Output below Specifications'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING COMBINED PROCEDURE, THERE WERE PROBLEMS WITH ENDO LASER. AFTER THE DOCTOR TRIED TO CHANGE THE LASER VALUE MORE THAN ONE TIME AND INCREASES IT, WHEN THE DEVICE CALIBRATES TO THE LASER, IT TAKES MORE THAN REGULAR TIME AND IT SHOW AN ERROR. AFTER THAT, THE DEVICE SHOWS THE ENDO LASER WITH RED LIGHT AND CAN'T BE USED, ONLY AFTER RESTARTING THE DEVICE AND PRIMING AGAIN. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED, HOWEVER, DUE TO THE REPORTED EVENT, SURGERY WAS PROLONGED > 30 MINUTES. THE DEVICE IS NOT YET ACCESSIBLE FOR INVESTIGATION. THEREFOR PRELIMINARY RESULTS OR CONCLUSIONS ARE NOT YET AVAILABLE.THE INVESTIGATION WILL BE CONTINUED WHEN THE DEVICE IS AVAILABLE FOR EXAMINATION.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
78,1222074-2024-00040,2024-10-17,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Decrease in Suction'],['Capsular Bag Tear'],"WE HAVE BEEN INFORMED THAT WHILE TRYING TO PERFORM A QUADRANT REMOVAL ON A HARD CATARACT, THE SURGEON NOTICED THERE WAS NO ASPIRATION. DESPITE EFFORTS TO TROUBLESHOOT BY SWITCHING TO TWO DIFFERENT CASSETTE PACKS, THE PROBLEM PERSISTED. UNFORTUNATELY, THIS LED TO A CAPSULAR RUPTURE, PROMPTING THE SURGEON TO PERFORM A VITRECTOMY. THE SURGEON NOTED THAT THE NUCLEUS DROPPED DURING THE PROCEDURE, AND ATTEMPTS WERE MADE TO REMOVE THE FRAGMENTS. GIVEN THE POSSIBILITY THAT SOME PIECES MAY HAVE REMAINED IN THE EYE, THE DECISION WAS MADE TO LEAVE THE EYE APHAKIC FOR THE TIME BEING. A PARS PLANA VITRECTOMY WILL BE REQUIRED LATER TO EXTRACT THE REMAINING PIECES AND TO IMPLANT AN IOL. DUE TO THE REPORTED EVENT, ADDITIONAL SURGERY IS REQUIRED. THE COMPLAINT IS UNDER INVESTIGATION.IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT. AS INVESTIGATIONS ON THE ACTUAL PRODUCT OR REPRESENTATIVE SAMPLE OF A BATCH MAY ALTER THE DEVICE, WE REQUEST TO INFORM US WITHIN 7 DAYS AFTER SUBMISSION OF THIS REPORT, IN CASE THE INVESTIGATIONS THAT ALTER THE DEVICE SHOULD BE HALTED UNTIL APPROVAL OF THE NCA, AS PER ARTICLE 89 OF EU-MDR.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
79,1222074-2024-00041,2024-11-04,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Communication or Transmission Problem'],"['No Clinical Signs, Symptoms or Conditions']","THE COMPLAINT IS UNDER INVESTIGATION. IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT. WE HAVE BEEN INFORMED THAT WHEN STARTING THE MACHINE, ERROR FOP5001 OCCURRED. THE FUNCTION KEYS ON BOTH SIDES OF THE FOOT PEDAL DO NOT WORK. WHEN USING THE LASER, RELEASING THE FOOT PEDAL WILL IMMEDIATELY EXIT THE LASER READY STATE, AND THE LASER NEEDS TO BE ACTIVATED AGAIN TO PREPARE. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED, HOWEVER DUE TO THE REPORTED EVENT SURGERY WAS PROLONGED > 30 MINUTES.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
80,1222074-2024-00046,2024-11-06,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Energy Output Problem'],"['No Clinical Signs, Symptoms or Conditions']","THE COMPLAINT IS UNDER INVESTIGATION. IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT. WE HAVE BEEN INFORMED THAT DURING POSTERIOR PROCEDURE ERROR MESSAGE LAS11 OCCURRED. SURGICAL PROCEDURE WAS COMPLETED WITH ANOTHER DEVICE. NO REPORT THAT ACTUAL PATIENT/ USER HARM OCCURRED. HOWEVER, DUE TO THE REPORTED EVENT SURGERY WAS PROLONGED >30 MINUTES.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
81,1222074-2024-00042,2024-11-18,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Visual Prompts will not Clear'],"['No Clinical Signs, Symptoms or Conditions']","IN REGARD TO THIS COMPLAINT, LOGFILES AND A PICTURE WERE PROVIDED FOR REVIEW. REVIEW OF THE LOGFILES AND PICTURE CONFIRMED THE OCCURRENCE OF THE REPORTED CAR160 ERROR MESSAGE. THIS ERROR CAN BE CAUSED BY AN OBVIOUS ELECTRICAL/MECHANICAL DEFECT IN THE CARTRIDGE PUMP OR WHEN THE PUMP PISTON HITS THE MECHANICAL END-STOP. THIS IS CAUSED BY A MALFUNCTION IN (A COMPONENT OF) THE PUMP. THE ELECTRICAL/MECHANICAL PROBLEM CAUSES A REPRODUCIBLE CAR160 ERROR. THIS ERROR CAN ALSO BE TRIGGERED WHEN THE PUMP PISTON MOVEMENT IS MECHANICALLY BLOCKED, OR WHEN THE WASTE BAG OUTLET IS BLOCKED. UNFORTUNATELY, THE COMPLAINT CANNOT BE FURTHER INVESTIGATED NOR CONFIRMED CONCLUSIVELY AS NO PRODUCT WAS RETURNED TO D.O.R.C FOR INVESTIGATION. THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS.TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. THEREFORE, NO REMEDIAL OR CORRECTIVE/PREVENTIVE ACTIONS WILL BE UNDERTAKEN AT THIS MOMENT. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (PU-ERROR-). SINCE 2021 MORE THAN 850.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT THE FAILURE CODES WILL NOT ALWAYS LEAD TO A PROLONGED SURGERY. PLEASE NOTE THAT THE COMPLAINT RELATED TO THIS MANUFACTURER INCIDENT REPORT IS INCLUDED IN THE COMPLAINT NUMBERS IN THE TABLE. WE HAVE BEEN INFORMED THAT DURING PROCEDURE ERROR CAR160 OCCURRED. TO COMPLETE THE OPERATION, THE SYSTEM WAS RESTARTED. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED, HOWEVER, DUE TO THE REPORTED EVENT, SURGERY WAS PROLONGED > 30 MINUTES.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
82,1222074-2024-00049,2024-12-11,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Pressure Problem'],"['No Clinical Signs, Symptoms or Conditions']","IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT. WE WERE INFORMED THAT WHILE THE CUTTER PASSED INITIAL TESTING, IT FAILED TO FUNCTION PROPERLY DURING SURGERY. AS A RESULT, THE SURGEON SWITCHED TO AN ALTERNATIVE DEVICE TO CONTINUE WITH THE PROCEDURE. NO REPORT THAT ACTUAL PATIENT/USER HARM OCCURRED. HOWEVER, DUE TO THE REPORTED EVENT SURGERY WAS PROLONGED >30 MINUTES.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
83,1222074-2024-00050,2024-12-17,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Visual Prompts will not Clear'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING PRIMING, THE ORANGE AUXILLARY ASPIRATION LINE WAS DRIPPING. AT THE 60% COMPLETE STAGE THE ERROR MESSAGE PUM97 CAME UP , THE CARTRIDGE WAS CHANGED 3 TIMES TO SEE IF IT COULD BE A FAULTY CARTRIDGE. UNABLE TO SOLVE THE ISSUE IT WAS DECIDED TO ABORT THE SURGERY. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED, HOWEVER DUE TO THE REPORTED EVENT SURGERY WAS ABORTED. IN REGARD TO THIS COMPLAINT, LOGFILES WERE PROVIDED FOR REVIEW AND A PUMP MODULE WAS PROVIDED FOR INVESTIGATION. REVIEW OF THE LOGFILES CONFIRMED THE OCCURRENCE OF THE REPORTED PUM97 ERROR MESSAGE, THIS MEANS AN ERROR WAS DETECTED WITH THE SECOND ASPIRATION VALVE. VISUAL INSPECTION OF THE RETURNED MODULE REVEALED OLD TYPE/WORN BUFFERS, AND A BROKEN WASTE VALVE BUFFER. FUNCTIONAL INSPECTION REVEALED A DEFECTIVE PNEUMATIC VALVE INSIDE THE MODULE. DUE TO THE DEFECTIVE VALVE, THE MODULE COULD NOT PASS PRIMING AND THE EVA SURGICAL SYSTEM WAS TRIGGERED TO DISPLAY THE REPORTED ERROR MESSAGE ON THE SCREEN. BASED ON INVESTIGATION RESULTS, IT WAS DETERMINED THAT THE REPORTED COMPLAINT IS ATTRIBUTABLE TO A COMPONENT FAILURE OF A PNEUMATIC VALVE INSIDE THE PUMP MODULE.THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. INVESTIGATION OF THE RETURNED PUMPS REVEALED THAT THE VALVES NEXT TO THE DEFECTIVE VALVE SHOWED THE SAME WEAR AND TEAR BUT IN DIFFERENT PHASES. AS CORRECTIVE ACTION ALL 5 VALVES WILL BE REPLACED DURING A REPAIR RELATED TO A DEFECTIVE VALVE. THIS PREVENTS THE FAILURE OF ANOTHER VALVE WITHIN A SHORT PERIOD AFTER REPAIR.ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (PU-PNEU-VALVE). SINCE 2021 MORE THAN 850.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT THE FAILURE CODES WILL NOT ALWAYS LEAD TO A PROLONGED/DELAYED SURGERY. PLEASE NOTE THAT THE COMPLAINT RELATED TO THIS MANUFACTURER INCIDENT REPORT IS INCLUDED IN THE COMPLAINT NUMBERS IN THE TABLE.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
84,1222074-2025-00002,2025-02-26,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Communication or Transmission Problem'],"['No Clinical Signs, Symptoms or Conditions']","IN REGARD TO THIS COMPLAINT LOGFILES AND A PICTURE WERE PROVIDED FOR REVIEW. REVIEW OF THE LOGFILES AND THE PICTURE CONFIRMED THE OCCURRENCE OF THE REPORTED FOP65541 ERROR MESSAGE ON MULTIPLE DAYS. BASED ON THIS REPEATED ERROR, FOOT PEDAL REPLACEMENT IS RECOMMENDED. THE COMPLAINT CANNOT BE FURTHER INVESTIGATED NOR CONFIRMED CONCLUSIVELY AS NO PRODUCT WAS RETURNED TO D.O.R.C FOR INVESTIGATION. THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (FP-DEFECT-* AND MP-DEFECT). SINCE 2022 MORE THAN 100.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT THE FAILURE CODES WILL NOT ALWAYS LEAD TO A PROLONGED/DELAYED SURGERY. PLEASE NOTE THAT THE COMPLAINT RELATED TO THIS MANUFACTURER INCIDENT REPORT IS INCLUDED IN THE COMPLAINT NUMBERS IN THE TABLE. WE HAVE BEEN INFORMED THAT DURING AN ANTERIOR PROCEDURE, AT THE START OF THE SCULPT PHASE, THE FOOT PEDAL DID NOT RESPOND AT ALL. AN ATTEMPT WAS MADE TO RESTART THE PEDAL BY DISCONNECTING AND RECONNECTING IT, BUT WITHOUT SUCCESS. IT WAS THEN DECIDED TO CANCEL THE SURGERY AND PROCEED WITH IT AT ANOTHER CLINIC. NO REPORT THAT ACTUAL PATIENT / USER HARM OCCURRED. HOWEVER, DUE TO THE REPORTED EVENT SURGERY WAS DELAYED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
85,1222074-2025-00008,2025-03-10,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Decrease in Suction'],['Retinal Hemorrhage'],"IN REGARDS TO THIS COMPLAINT, LOGFILES AND TWO PICTURES WERE PROVIDED FOR REVIEW AND A PUMP MODULE WAS PROVIDED FOR INVESTIGATION. ANALYSIS OF THE DETAILED LOG FILES SHOWED THAT EACH TIME THE PEDAL WAS PRESSED DURING SURGERY, THE ACTUAL ASPIRATION PRESSURE IN THE PUMP MODULE INCREASED AS EXPECTED, WITH NO ABNORMAL BEHAVIOR DETECTED. THE LOG FILES CONFIRMED THAT AN ACTUAL VACUUM WAS BEING MEASURED IN THE PUMP AT THE RELEVANT TIME. POSSIBLE CONTRIBUTING FACTORS WERE CONSIDERED, INCLUDING THE CARTRIDGE AND TUBING, WHICH WERE REPLACED, RULING THEM OUT AS THE CAUSE. A POTENTIAL ISSUE WITH THE PUMP WAS ALSO CONSIDERED. HOWEVER, THE COMPLAINT COULD NOT BE REPRODUCED DURING INVESTIGATION, THE MODULE WORKED ACCORDING TO D.O.R.C SPECIFICATIONS. SINCE NO ISSUES WERE DETECTED DURING TESTING, IT WAS DETERMINED THAT THE REPORTED COMPLAINT CANNOT BE ATTRIBUTED TO THE PUMP MODULE THAT WAS PROVIDED FOR INVESTIGATION. THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. ALL SIMILAR INCIDENTS RELATED TO THE EVA NEXUS SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (EVA-NO ASP-ANTERIOR) SINCE 2022 MORE THAN (B)(4) SURGERIES HAVE BEEN PERFORMED WITH THE EVA NEXUS SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT THE FAILURE CODES WILL NOT ALWAYS LEAD TO A PROLONGED/DELAYED SURGERY. PLEASE NOTE THAT THE COMPLAINT RELATED TO THIS MANUFACTURER INCIDENT REPORT IS INCLUDED IN THE COMPLAINT NUMBERS IN THE TABLE. WE HAVE BEEN INFORMED THAT DURING A CATARACT SURGERY, NO ASPIRATION WAS OBTAINED, RESULTING IN A CAPSULAR RUPTURE AND THE NUCLEUS DROPPING INTO THE POSTERIOR CHAMBER. A POSTERIOR INTERVENTION WAS REQUIRED AND AGAIN THE SURGEON FACED ASPIRATION ISSUES, MAKING IT DIFFICULT TO SECURE THE NUCLEUS. ADDITIONALLY, A SMALL SUB-RETINAL BLEEDING WAS OBSERVED, LOCATED NEAR THE CENTRAL RETINAL VEIN. IT WAS DECIDED TO MONITOR THE BLEEDING. ON DAY ONE, POST-OPERATIVE, THE SUB-RETINAL BLEEDING HAS STOPPED, HOWEVER THE POST-OPERATIVE RESULT REMAINS SUBOPTIMAL, AS EXPECTED FOR AN APHAKIC EYE ONE DAY AFTER SURGERY. DUE TO THE COMPLICATION, THE PATIENT WILL REQUIRE AN ALTERNATIVE IMPLANT (CARNIVALE) IN A FOLLOW-UP PROCEDURE.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
86,1222074-2025-00012,2025-04-03,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Visual Prompts will not Clear'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING SURGERY THAT PUM71 ERROR OCCURRED DESPITE REPLACING THE CARTRIDGE TWICE AND RESTARTING THE EVA SYSTEM. THE WALL AIR CONNECTION WAS CORRECTLY SET. NO REPORT THAT ACTUAL PATIENT/USER HARM OCCURRED. HOWEVER, DUE TO THE REPORTED EVENT SURGERY WAS DELAYED. IN REGARD TO THIS COMPLAINT, LOGFILES AND A PICTURE WERE PROVIDED FOR REVIEW AND A PUMP MODULE WAS PROVIDED FOR INVESTIGATION. REVIEW OF THE LOGFILES AND PICTURE CONFIRMED THE OCCURRENCE OF THE REPORTED PUM71 ERROR MESSAGE. THE COMPLAINT COULD NOT BE REPRODUCED DURING INVESTIGATION OF THE RETURNED MODULE, HOWEVER PUM63 AND POS112 ERRORS WERE FOUND IN THE LOGFILES ALONG WITH PUM71. IT LED TO A SUPPLY PRESSURE ERROR ON TWO DIFFERENT MODULES. AFTER THE PUM63 IS TRIGGERED, THE CARTRIDGE CLAMPS AND AWAITS PRIMING. BASED ON INVESTIGATION RESULTS, IT WAS DETERMINED THAT THE REPORTED COMPLAINT IS ATTRIBUTABLE TO AN EXTERNAL SUPPLY PRESSURE FLUCTUATION. THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. NO CORRECTIVE OR PREVENTIVE ACTIONS WILL BE IMPLEMENTED AS A RESULT OF THIS INCIDENT. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (PU-ERROR-*). SINCE 2022 MORE THAN 100.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT THE FAILURE CODES WILL NOT ALWAYS LEAD TO A PROLONGED/DELAYED SURGERY. PLEASE NOTE THAT THE COMPLAINT RELATED TO THIS MANUFACTURER INCIDENT REPORT IS INCLUDED IN THE COMPLAINT NUMBERS IN THE TABLE.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
87,1222074-2025-00013,2025-04-08,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Insufficient Flow or Under Infusion'],['Intraocular Pressure Decreased'],"WE HAVE BEEN INFORMED THAT DURING A COMBINED SURGICAL CASE, THE CATARACT PROCEDURE WAS COMPLETED SUCCESSFULLY. A LESS EXPERIENCED SURGEON TOOK OVER, AND THE EYE WAS NOTED TO BE VERY SOFT. THE INFUSION CANNULA WAS CLOSE TO SLIPPING OUT SO THE INFUSION WAS MOVED TO ANOTHER PORT, BASED ON ADVICE FROM THE EXPERIENCED SURGEON. UPON RESTARTING THE INFUSION, THE EYE COLLAPSED, POSSIBLY DUE TO BACK-SUCTION. AIR BUBBLES WERE SEEN IN THE CASSETTE, BUT NO ERROR MESSAGES APPEARED. INFUSION PLACEMENT WAS VERIFIED, ALTERNATIVE PRESSURE WAS ACTIVATED, AND THE EYE STABILIZED. THE SURGERY CONTINUED USING THE SAME PACK AND MACHINE WITHOUT FURTHER ISSUES. NO PATIENT OR USER HARM OCCURRED, AND THERE WAS NO DELAY IN SURGERY. THE COMPLAINT IS UNDER INVESTIGATION. IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT. AS INVESTIGATIONS ON THE ACTUAL PRODUCT OR REPRESENTATIVE SAMPLE OF A BATCH MAY ALTER THE DEVICE, WE REQUEST TO INFORM US WITHIN 7 DAYS AFTER SUBMISSION OF THIS REPORT, IN CASE THE INVESTIGATIONS THAT ALTER THE DEVICE SHOULD BE HALTED UNTIL APPROVAL OF THE NCA, AS PER ARTICLE 89 OF EU-MDR.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
88,1222074-2025-00017,2025-04-24,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Failure to Deliver Energy'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING CENTRAL VITREOUS REMOVAL, THE SURGEON PAUSED MOMENTARILY TO USE ENDO-DIATHERMY. AT THAT POINT, AN ADVISORY MESSAGE ""DIA103"" APPEARED, AND CAUTERIZATION WAS NO LONGER POSSIBLE. MORE CRITICALLY, FOLLOWING THE APPEARANCE OF THE ADVISORY, THE SYSTEM DID NOT ALLOW TRANSITION TO ANY OTHER SURGICAL STEP. THE SURGEON CONTINUED BY REMOVING WHAT WAS POSSIBLE WHILE REMAINING IN CENTRAL VITRECTOMY MODE, BUT ULTIMATELY HAD TO REQUEST AN ALTERNATIVE SYSTEM TO COMPLETE THE REQUIRED PROCEDURES. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED, BUT THE SURGERY WAS PROLONGED > 30 MINUTES. IN REGARD TO THIS COMPLAINT LOGFILES, A VIDEO AND A PICTURE WERE PROVIDED FOR REVIEW. REVIEW OF THE LOGFILES AND THE PICTURE CONFIRMED THE OCCURRENCE OF THE REPORTED DIA103 ERROR MESSAGE. A DIA103 ERROR DOES NOT PREVENT A SURGICAL STEP CHANGE; HOWEVER, STEP CHANGES ARE BLOCKED IF THE FOOTSWITCH IS PRESSED DOWN OR MOVED SIDEWAYS. ACCORDING TO THE LOG DATA, NO STEP CHANGE WAS INITIATED VIA THE FOOTSWITCH, AND WHILE IT IS NOT VISIBLE IN THE LOGS WHETHER A STEP WAS ATTEMPTED VIA THE MONITOR, SUCH AN ATTEMPT WOULD HAVE BEEN BLOCKED IF THE PEDAL WAS ACTIVATED. LOG DATA ANALYSIS SHOWED THAT THE DIA103 OCCURRED AT 16:00:51 AND THAT SINCE THEN, THE PEDAL WAS PRESSED HORIZONTALLY AND VERTICALLY FOR ONE MINUTE. DURING THAT TIME, A STEP CHANGE WAS NOT POSSIBLE. THEREFORE, IT IS CONCLUDED THAT THE STEP CHANGE WAS NOT BLOCKED BY THE DIA103 ERROR ITSELF, BUT RATHER DUE TO FOOTSWITCH ACTIVATION AT THAT TIME. THE COMPLAINT CANNOT BE FURTHER INVESTIGATED NOR CONFIRMED CONCLUSIVELY AS NO PRODUCT WAS RETURNED TO D.O.R.C FOR INVESTIGATION. BASED ON THE AVAILABLE DATA AND INVESTIGATION RESULTS, IT WAS CONCLUDED THAT THE MOST LIKELY CAUSE OF THE REPORTED COMPLAINT IS HUMAN ERROR. NO CORRECTIVE OR PREVENTIVE ACTIONS WILL BE IMPLEMENTED AS A RESULT OF THIS INCIDENT. THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (PD-DEFECT-*). SINCE 2022 MORE THAN 100.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT THE FAILURE CODES WILL NOT ALWAYS LEAD TO A PROLONGED/DELAYED SURGERY. PLEASE NOTE THAT THE COMPLAINT RELATED TO THIS MANUFACTURER INCIDENT REPORT IS INCLUDED IN THE COMPLAINT NUMBERS IN THE TABLE.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
89,1222074-2025-00019,2025-05-08,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Visual Prompts will not Clear'],"['No Clinical Signs, Symptoms or Conditions']","IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT. AS INVESTIGATIONS ON THE ACTUAL PRODUCT OR REPRESENTATIVE SAMPLE OF A BATCH MAY ALTER THE DEVICE, WE REQUEST TO INFORM US WITHIN 7 DAYS AFTER SUBMISSION OF THIS REPORT, IN CASE THE INVESTIGATIONS THAT ALTER THE DEVICE SHOULD BE HALTED UNTIL APPROVAL OF THE NCA, AS PER ARTICLE 89 OF EU-MDR. WE HAVE BEEN INFORMED THAT DURING SURGERY, THE MACHINE DISPLAYED ERROR CAP999, WHICH AFFECTED THE PUMP, VFIE, LASER, AND PHACO FUNCTIONS. THEY HAD TO ABORT THE PROCEDURE ON THE AFFECTED MACHINE AND COMPLETE THE SURGERY USING A DIFFERENT ONE. NO REPORT OF PATIENT/USER HARM. HOWEVER, THE PROCEDURE WAS PROLONGED DUE TO THIS EVENT.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
90,1222074-2025-00025,2025-06-04,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Insufficient Flow or Under Infusion'],"['No Clinical Signs, Symptoms or Conditions']","IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT. AS INVESTIGATIONS ON THE ACTUAL PRODUCT OR REPRESENTATIVE SAMPLE OF A BATCH MAY ALTER THE DEVICE, WE REQUEST TO INFORM US WITHIN 7 DAYS AFTER SUBMISSION OF THIS REPORT, IN CASE THE INVESTIGATIONS THAT ALTER THE DEVICE SHOULD BE HALTED UNTIL APPROVAL OF THE NCA, AS PER ARTICLE 89 OF EU-MDR. WE HAVE BEEN INFORMED THAT DURING PROCEDURE AN INFUSION ERROR OCCURRED. TO COMPLETE THE SURGERY, ANOTHER MACHINE WAS UTILIZED. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED. HOWEVER DUE TO THE REPORTED EVENT SURGERY WAS PROLONGED > 30 MINUTES.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
91,1222074-2025-00024,2025-06-05,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE NCBF INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Mechanical Problem'],"['No Clinical Signs, Symptoms or Conditions']","WE HAVE BEEN INFORMED THAT DURING A POSTERIOR PROCEDURE, THE LASER FOOT SWITCH MALFUNCTIONED, REQUIRING THE REPLACEMENT OF BOTH THE FOOT SWITCH AND ITS CABLE IN ORDER TO PROCEED WITH THE PROCEDURE. NO REPORT THAT ACTUAL PATIENT/ USER HARM OCCURRED. HOWEVER, DUE TO THE REPORTED EVENT, SURGERY WAS PROLONGED > 30 MINUTES. IN REGARD TO THIS COMPLAINT, LOGFILES WERE PROVIDED FOR REVIEW AND A LASER PEDAL WAS PROVIDED FOR INVESTIGATION. VISUAL INSPECTION OF THE RETURNED PEDAL REVEALED A LOT OF DAMAGE ON THE OUTSIDE OF THE PEDAL, AND FUNCTIONAL INSPECTION REVEALED A FULLY DEPLETED BATTERY. AFTER CHARGING THE BATTERY, THE CHARGE DID NOT EXCEED 0%. BASED ON INVESTIGATION RESULTS, IT WAS DETERMINED THAT THE REPORTED COMPLAINT IS ATTRIBUTABLE TO A LOSS OF CAPACITY OF THE BATTERY CELL OF THE PEDAL.THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS.ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (LP-BATCELL). SINCE 2022 MORE THAN 1.000.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT THE FAILURE CODES WILL NOT ALWAYS LEAD TO A PROLONGED/DELAYED SURGERY. PLEASE NOTE THAT THE COMPLAINT RELATED TO THIS MANUFACTURER INCIDENT REPORT IS INCLUDED IN THE COMPLAINT NUMBERS IN THE TABLE.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
92,1222074-2025-00028,2025-07-29,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation","['Output below Specifications', 'Output Problem']","['No Clinical Signs, Symptoms or Conditions']","WE RECEIVED INFORMATION THAT DURING AN ENDO LASER PROCEDURE, THE FIRST LASER SPOT SUCCESSFULLY IMPACTED THE RETINA, BUT SUBSEQUENT SPOTS DID NOT. CONSEQUENTLY, THE SURGERY WAS INTERRUPTED. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED, HOWEVER DUE TO THE REPORTED EVENT, SURGERY WAS DELAYED. IN REGARD TO THIS COMPLAINT, LOGFILES AND A PICTURE WERE PROVIDED FOR REVIEW. THE LOGFILES INDICATED THAT THE LASER FIBER WAS BEING REMOVED, AND NO ADDITIONAL ISSUES WERE FOUND IN THE LOGGING RELATED TO THE LASER PROBLEM. IT WAS ADVISED THAT IF NO OTHER FIBER HAD BEEN TESTED, THIS SHOULD BE DONE TO DETERMINE IF IT RESOLVES THE ISSUE. ADDITIONALLY, IT WAS EMPHASIZED THAT THE LASER FIBER MUST BE PROPERLY AND COMPLETELY CONNECTED TO THE LASER INTERFACE FIBER CONNECTOR. IF THE ISSUES PERSIST AND ARE REPRODUCIBLE WITH OTHER FIBERS, PREFERABLY FROM A DIFFERENT LOT NUMBER, A REPLACEMENT OF THE LASER MODULE WOULD BE RECOMMENDED. THE COMPLAINT CANNOT BE FURTHER INVESTIGATED NOR CONFIRMED CONCLUSIVELY AS NO PRODUCT WAS RETURNED TO D.O.R.C FOR INVESTIGATION.THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. ALL SIMILAR INCIDENTS RELATED TO THE EVA SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (LM-LOW-*). SINCE 2022 MORE THAN 100.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT THE FAILURE CODES WILL NOT ALWAYS LEAD TO A PROLONGED/DELAYED SURGERY. PLEASE NOTE THAT THE COMPLAINT RELATED TO THIS MANUFACTURER INCIDENT REPORT IS INCLUDED IN THE COMPLAINT NUMBERS IN THE TABLE.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
93,1222074-2025-00029,2025-07-31,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Communication or Transmission Problem'],"['No Clinical Signs, Symptoms or Conditions']","IN REGARD TO THIS COMPLAINT, LOGFILES WERE PROVIDED FOR REVIEW. REVIEW OF THE LOGFILES CONFIRMED THE OCCURRENCE OF THE REPORTED ERROR MESSAGES. ON SITE SUPPORT ALSO CONFIRMED THE FOOT SWITCH ERROR. FIRMWARE CPU1,2 AND THE FOOT SWITCH WERE FLASHED, AFTER WHICH THE FOOT SWITCH OPERATED IN WIRED MODE BUT NOT WIRELESSLY. TESTING WITH ANOTHER FOOT PEDAL WAS SUGGESTED TO DETERMINE WHETHER THE ISSUE WAS RELATED TO THE FOOT PEDAL OR CAN RECEIVER. THE COMPLAINT CANNOT BE FURTHER INVESTIGATED NOR CONFIRMED CONCLUSIVELY AS NO PRODUCT WAS RETURNED TO D.O.R.C FOR INVESTIGATION. THE RISK IDENTIFIED IS INCLUDED IN THE RISK MANAGEMENT DOCUMENTATION. TREND ANALYSIS INDICATES THAT THE PRODUCT IS PERFORMING WITHIN ANTICIPATED RATES. COMPLAINTS WILL BE CLOSELY MONITORED TO IDENTIFY ANY SIGNIFICANT ADVERSE TRENDS. ALL SIMILAR INCIDENTS RELATED TO THE EVA NEXUS SURGICAL SYSTEM ARE INCLUDED IN THE ANALYSIS (FP-DEFECT-DELAYED). SINCE 2022 MORE THAN 1000.000 SURGERIES HAVE BEEN PERFORMED WITH THE EVA SURGICAL SYSTEMS INSTALLED. PLEASE NOTE THAT THE COMPLAINT RELATED TO THIS MANUFACTURER INCIDENT REPORT IS INCLUDED IN THE COMPLAINT NUMBERS IN THE TABLE. WE HAVE BEEN INFORMED THAT DURING PROCEDURE, THE DOCTOR ENCOUNTERED AN ISSUE WHILE ATTEMPTING TO SCULPT THE NUCLEUS. THE FOOT SWITCH WAS NOT FUNCTIONING, AND AN ERROR MESSAGE APPEARED ON THE SCREEN INDICATING NO CONNECTION TO THE FOOT SWITCH. DESPITE BEING CONNECTED VIA CABLE, RECONNECTING THE CABLE DID NOT RESOLVE THE ISSUE. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED, HOWEVER, DUE TO THE REPORTED EVENT SURGERY WAS DELAYED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
94,1222074-2025-00033,2025-09-16,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER (INTERNA,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Failure to Deliver Energy'],"['No Clinical Signs, Symptoms or Conditions']","IN CASE OF A PRODUCT RETURN, THE DEVICE WILL BE INVESTIGATED, OTHERWISE WE WILL REVIEW THE DEVICE HISTORY RECORD, AND/OR ANY LOG FILES IF AVAILABLE, OR TRY TO REPLICATE THE PROBLEM ON SIMILAR PRODUCT. AS INVESTIGATIONS ON THE ACTUAL PRODUCT OR REPRESENTATIVE SAMPLE OF A BATCH MAY ALTER THE DEVICE, WE REQUEST TO INFORM US WITHIN 7 DAYS AFTER SUBMISSION OF THIS REPORT, IN CASE THE INVESTIGATIONS THAT ALTER THE DEVICE SHOULD BE HALTED UNTIL APPROVAL OF THE NCA, AS PER ARTICLE 89 OF EU-MDR. WE HAVE BEEN INFORMED THAT DURING LASER STEP AN ERROR OCCURRED. THE LASER WAS NOT READY AND THE SCREEN RED. NO REPORT THAT ACTUAL PATIENT HARM OCCURRED. HOWEVER, DUE TO THE REPORTED EVENT, SURGERY WAS PROLONGED > 30 MINUTES.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
95,1222074-2017-00007,2017-08-18,D.O.R.C INTERNATIONAL,EVA OPHTHALMIC SURGICAL SYSTEM,"Instrument, Vitreous Aspiration And Cutting, Ac-Powered","['Obstruction of Flow', 'Insufficient Information']","['Intraocular Pressure, Delayed, Uncontrolled']","THE EQUIPMENT WAS SET UP, PRIMING OK AND DURING THE PHACO THE PRESSURE IN THE ANTERIOR CHAMBER WAS VERY LOW. AS THE SURGEON STARTED THE VITRECTOMY, THE EYE GOT VERY SOFT. ALL THE TUBING WAS CHANGED WITH NO POSITIVE EFFECT. THEN THE SURGEON CHANGED TO GRAVITY FLOW AS THE EYE WAS TOO SOFT DURING THE SURGERY. AFTER THE MACHINE WAS SHUT DOWN AND RESTARTED, THE SURGERY WAS COMPLETE. THE BOTTLE HEIGHT WENT UP TO 100 CM . IT WAS REPORTED THAT THE ONCE THE PRESSURE WAS CHANGED TO 90 MMHG THE CATARACT SURGERY WAS COMPLETED. NOTE: AT THIS TIME INVESTIGATION IS ONGOING. ANY NEW OR CLARIFIED INFORMATION WILL BE SUBMITTED IN A SUPPLEMENTAL REPORT.",D O R C INTERNATIONAL,EVA OPHTHALMIC SURGICAL SYSTEM
96,1222074-2017-00008,2017-08-18,D.O.R.C INTERNATIONAL,EVA TDC VITRECTOMY PACK VGPC INPUT 25G,"Instrument, Vitreous Aspiration And Cutting, Ac-Powered","['Obstruction of Flow', 'Insufficient Information']","['Intraocular Pressure, Delayed, Uncontrolled']","NOTE: AT THIS TIME INVESTIGATION IS ONGOING. ANY NEW OR CLARIFIED INFORMATION WILL BE SUBMITTED IN A SUPPLEMENTAL REPORT. IN ORDER TO INVESTIGATE THE CIRCUMSTANCES OF THE EVENT, DORC HAS COMMUNICATED WITH THE INVOLVED SURGEON AND NURSES. THE USERS INDICATED THAT THE INFUSION PRESSURE WAS VERY LOW DURING BOTH THE PHACO AND VITRECTOMY MODES, WHICH WERE ALSO CONFIRMED AT THE LOG FILE REVIEW OF THE EVA. ON THE OTHER HAND, THE LOG FILE REVIEW REVEALED WITH NO SETTING ERRORS HAD BEEN PERFORMED BY THE USER NOR OBVIOUS SOFTWARE FAILURES. HOWEVER, FURTHER INVESTIGATION WILL CONSIDER IF A MECHANICAL OBSTRUCTION OF THE PHACO AND VITRECOME TIPS AS A POTENTIAL ROOT CAUSE OF LOW IRRIGATION FLOW. THE SUSPECTED PUMP AND THE EVA TDC PACK HAVE BEEN RETURNED TO DORC FOR INVESTIGATION. PLEASE NOTE ASSOCIATED MDR 1222074-2017-00007 THAT HAS BEEN SUBMITTED ON THE EVA SYSTEM. ROOT CAUSE INVESTIGATION AND ANALYSIS: ASSESSMENT REGARDING THE DEVICE INVOLVED IN THE FIELD. DORC HAD REPLACED THE PUMP, THE EVA AT FIELD WORKS WELL WITH NO MORE SIMILAR COMPLAINTS AFTER THEN. FROM THE EVA MEMORY LOGFILE REVIEW, WE CONCLUDE THAT THE EVA WAS WORKING AS DESIGNED. THE INCORRECT INFUSION ASPIRATION PRESSURE WERE RECORDED. HOWEVER, NO SOFTWARE NOR SETTING ERRORS WERE DETECTED BY THE EVA MAIN DEVICE. FROM THE RETURNED PUMP (EVA COMPONENT) INSPECTION, WE CONCLUDE THAT THE PUMP IS IN A GOOD CONDITION AND COULD NOT HAVE CAUSED THE PROBLEM AS FAR AS ALL TESTS WERE PASSED AND WITH NO DEVIATIONS WERE FOUND. INVESTIGATION ON POTENTIAL MECHANICAL OBSTRUCTION, FROM THE INSPECTION ON THE RETURNED VGPC PACK (8310.25G02), WITH A CARTRIDGE, TUBINGS AND A VITRECTOME CUTTER INCLUDED, TO CHECK WHETHER EXISTENCE OF MECHANICAL OBSTRUCTION; WE CONCLUDE THAT ALL RETURNED SUBJECT ACCESSORIES WHICH WERE USED ARE WORKING WITH NO ABNORMALITIES. OTHERS-TO IDENTIFY THE POTENTIAL OTHER ROOT CAUSES, WE HAVE ALSO CONSIDERED POSSIBLE DEFECTS OF THAT, INFUSION CLAMP AND INFUSION TUBING WAS PROPERLY NOT WELL CONNECTED, SUCH AS BLOCKAGE, FOLDED OR TWISTED OF VGPC AND IRRIGATION INFUSION LINES OR THE CLAMP WAS NOT OPEN, FORGOT TO TURN THE STOPCOCK HANDLE TO 90 DEGREES ANTI-CLOCKWISE AS DESCRIBED IN THE MANUAL. (ONLY APPLICABLE TO VGPC VITRECTOMY PROCEDURE, PHACO MODE IS NOT NEEDED.) THE CAP OF AIR FILTER OF THE DRIP CHAMBER (GRAVITY INFUSION) WAS ACCIDENTALLY CLOSED. THE VGPC AIR FILTER IS NOT WELL CONNECTED. THE CANNULA COULD BE BLOCKED (ONLY IN VITRECTOMY STEP), HOWEVER, THE SAMPLE WAS NOT SENT BACK FOR INVESTIGATION. COMMENT-SINCE BOTH PHACO AND VITRECTOMY PROCEDURES, AS WELL AS BOTH VGPC AND GRAVITY INFUSIONS EXPERIENCED LOW IRRIGATION PRESSURES, SO THESE CANNOT HAD HAPPENED AT ALL THESE SITUATIONS IF THERE WAS ONLY ONE ROOT CAUSE CONTRIBUTED TO THE DEFECT. HOWEVER, SINCE THERE WAS NO VIDEO NOR PHOTOGRAPHS HAD BEEN TAKEN FOR REVIEW THE PROCESS OF THE EVENT, NEITHER FROM THE USERS, ABOVE ASSUMPTIONS CANNOT BE CONFIRMED. SINCE THERE IS NO EVIDENCE INDICATES SOFTWARE OR PUMP PROBLEMS, IT IS MOST LIKELY THE DEFECT OF LOW AIR PRESSURE WAS CAUSED BY A MECHANICAL OBSTRUCTION. HOWEVER, WE CANNOT GET CONVINCING EVIDENCE EITHER ABOUT MECHANICAL OBSTRUCTION. BESIDES WE DID NOT RECEIVE FURTHER REQUESTED DATA FROM THE HOSPITAL, WE CANNOT CONTINUE WITH THE INVESTIGATION THUS THE OUTCOME OF THE INVESTIGATION WILL STAY INCONCLUSIVE.",D O R C INTERNATIONAL,EVA
97,1222074-2017-00009,2017-09-12,D.O.R.C INTERNATIONAL,EVA OPHTHALMIC SURGICAL SYSTEM,"Instrument, Vitreous Aspiration And Cutting, Ac-Powered",['Device Operates Differently Than Expected'],"['Optical Tissue, Breakdown Of']","ADDITIONAL INFORMATION HAS BEEN RECEIVED. IT WAS ALSO LEARNED THAT AFTER USE OF VITRECTOMY MODE, THE PUMP MODULE WENT OFF-LINE MODE. THIS PATIENT WAS RE-SCHEDULED WITH ANOTHER OPERATION THE NEXT WEEK WHERE A SULCUS IOL WAS IMPLANTED WITH NO FURTHER ISSUES. THE EVA UNIT IS AT THE HOSPITAL. THE USED INTERFACE PLATE WAS RETURNED TO DORC FOR INVESTIGATION. DORC CONSIDERS THAT CAPSULAR RUPTURE IS AN UNINTENTIONAL PERFORATION OF THE CAPSULAR BAG. AND CAPSULAR TEAR IS CONSIDERED AS MINOR INJURY IN THE DORC GLOBAL HARM LIST. ROOT CAUSE ANALYSIS HAS BEEN PERFORMED BY DORC ON: THE PHACO PERFORMANCE WHICH CAUSED THE CAPSULAR RUPTURE. THE INTERFACE PLATE WHICH CAUSED THE PUMP MODULE TO GO IN OFFLINE MODUS. DORC CONSIDERED THE UNDERLYING CAUSE OF THE REPORTED INCIDENT WAS BECAUSE OF THE COMBINATION OF BOTH FAILURES RESULTED IN NOT COMPLETING THE OPERATION. PHACO PERFORMANCE-THE ANALYSIS OF THE PHACO PERFORMANCE SHOWS THAT THE SURGEON SETTINGS IN COMBINATION WITH A 2.8MM PHACO TIP CREATES A SURGE WHICH CONTRIBUTED TO THE CAPSULAR RUPTURE. DURING THE DEMO PHASE OF EVA 903 SURGEON SETTINGS (300 MMHG VACUUM WITH A NORMAL INCREASE) WERE PROGRAMMED BY DORC, WHICH THE SURGEON AGREED WITH. FOR UNCLEAR REASON THE SURGEON CHANGED HIS MIND AND WANTED A SLOWER VACUUM INCREASE PAIRED WITH A HIGH TOP END VACUUM. AT THAT TIME DORC HAD CLEARLY COMMUNICATED THAT THE REQUESTED SETTINGS COULD LEAD TO PROBLEMS. NEVERTHELESS THE SURGEON INSISTED AND THEREFORE DORC PROGRAMMED THE SETTINGS AS AGREED. THESE SETTINGS IN COMBINATION WITH A 2.8MM PHACO TIP HAD LED TO SURGES AND CONSEQUENTLY TO THE CAPSULAR RUPTURE. INTERFACE PLATE-THE ANALYSIS OF THE RETURNED INTERFACE PLATE SHOWS THAT THE LED PCB, HAD LIGHTED UP THE LED-MODULE, AND HAD BEEN IN CONTACT WITH FLUID. THE FLUID ENTERED THE INTERFACE PLATE AFTER CLEANING WITH A TOO WET CLOTH. THIS HAD CAUSED A SHORT CIRCUIT WHICH HAD LED TO THE PUMP MODULE TO GO IN OFF-LINE MODE. HACO PERFORMANCE. THE SURGEON IS NOW USING 2.5MM PHACO TIP IN COMBINATION WITH HIGH VACUUM 550 MMHG. THIS COMBINATION HAS A NEGLIGIBLE SURGE RISK. INTERFACE PLATE-A GASKET TO PREVENT THE LIQUID FROM ENTERING, AND A CONFORMAL COATING TO PREVENT DAMAGE IN CASE THE LIQUID DOES IN CONTACT WITH THE PCB, HAVE BEEN IMPLEMENTED INTO THE MANUFACTURE PROCEDURE. THE COMBINATION OF BOTH FAILURES RESULTED IN UNCOMPLETED OPERATION. THE PATIENT WAS RE-SCHEDULED TO THE NEXT WEEK AND GOT A SULCUS IOL IMPLANTED. THE GASKET AND CONFORMAL COATING HAVE BEEN IMPLEMENTED INTO THE MANUFACTURE PROCEDURE SINCE 13 NOVEMBER 2017, FOR ALL THE NEW EVAS WILL HAVE THE NEWEST VERSION OF INTERFACE PLATE. FURTHERMORE, ALL INSTALLED BASE EVAS WHERE THE INTERFACE PLATE NEEDS TO BE REPLACED SINCE 13 NOVEMBER 2017 WILL HAVE THE NEWEST VERSION OF INTERFACE PLATE. WE ARE NOT AWARE OF ANY SAME OR SIMILAR EVENTS.",D O R C INTERNATIONAL,EVA OPHTHALMIC SURGICAL SYSTEM
98,1222074-2017-00010,2017-09-14,DUTCH OPHTHALMIC RESEARCH CENTER,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Vitrectomy, Instrument Cutter",['Device Operates Differently Than Expected'],['Eye Injury'],"PREVIOUSLY, DORC HAS INVESTIGATED ON THE RETURNED MONITOR WITH A S.N. OF (B)(4). THE SUBJECT FAILURE (SCREEN FROZEN) WAS REPRODUCED DURING THE EXPERIMENT. HOWEVER, THIS WOULD NOT HAVE HAPPENED IF THERE WAS NO HARDWARE FAILURE. THUS, WE HAVE ALSO REVIEWED THE LOG FILES FROM THE EVA (SN: (B)(4)), IN WHICH IT CAN BE DETERMINED THAT THE REBOOT OF THE EVA WAS EXECUTED TOO QUICKLY, THAT THE TIME WAS TOO SHORT FOR THE MONITOR TO REACT; THEREFORE COULD HAVE LED TO A NOT WORKING STATE OF THE MONITOR. TO FURTHER INVESTIGATE ON THE ROOT CAUSE, THE MONITOR HAS BEEN SENT TO THE SUPPLIER (B)() FOR A FURTHER INSPECTION. 23-03-2018: (B)(4) HAS CONFIRMED THAT THE MONITOR HAS BEEN SENT TO THEIR SUPPLIER NEXCOM. DORC ENGINEER SPECIALIST PROPOSED TO LOOK AT THE FOLLOWS: POWER CONSUMPTION OF THE BIOS BATTERY IF THE PANEL PC IS NOT CONNECTED TO A POWER SOURCE. THE RESULT TO COMPARE WITH NEW PANELS. CONTACT SURFACE OF THE BATTERY HOLDER. CAN THE CONTACT WITH THE BATTERY BREAK OR BECOME WORSE DUE TO VIBRATION OR SHOCK? C) STABILITY OF THE EEPROM. CAN ONLY BE TESTED BY NEXCOM (AT WHAT VOLTAGE DOES THE EEPROM LOSE ITS SETTINGS?). THE SUPPLIER INVESTIGATION RESULTS WILL BE REPORTED IN A NEXT REPORT. DORC HAS INVESTIGATED ON THE RETURNED MONITOR WITH A S.N. OF (B)(4). THE SUBJECT FAILURE (SCREEN FROZEN) WAS REPRODUCED DURING THE EXPERIMENT. HOWEVER, THIS WOULD NOT HAVE HAPPENED IF THERE WAS NO HARDWARE FAILURE. THUS, WE HAVE ALSO REVIEWED THE LOG FILES FROM THE EVA (SN: (B)(4)), IN WHICH IT CAN BE DETERMINED THAT THE REBOOT OF THE EVA WAS EXECUTED TOO QUICKLY, THAT THE TIME WAS TOO SHORT FOR THE MONITOR TO REACT; THEREFORE COULD HAVE LED TO A NOT WORKING STATE OF THE MONITOR. TO FURTHER INVESTIGATE ON THE ROOT CAUSE, THE MONITOR HAS BEEN SENT TO THE SUPPLIER (B)(4) FOR A FURTHER INSPECTION. A SUPPLEMENTAL WILL BE SUBMITTED WHEN THIS IS COMPLETE.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
99,1222074-2017-00025,2017-10-24,DUTCH OPTHALMIC RESEARCH CENTER INTERNATIONAL BV,PHACO EMULSIFICATION HANDPIECE,"Unit, Phacofragmentation",['Insufficient Information'],['Eye Burn'],"A REPORT HAS BEEN RECEIVED OF AN INCIDENT OCCURRING IN (B)(6). CORNEA BURNT RIGHT AFTER THE START OF SCULPTURE MODE. IT WAS REPORTED THE SURGEON IMMEDIATELY AND EMERGENTLY STOPPED THE PHACO SURGERY. AT THIS TIME, THERE IS NO FURTHER INFORMATION. THE INVESTIGATION IS IN PROCESS. ONCE ADDITIONAL INFORMATION IS RECEIVED, A SUPPLEMENTAL WILL BE FILED. THERE IS NO FURTHER INFORMATION ON THE PATIENT OUTCOME AT THIS TIME.",DUTCH OPHTHALMIC RESEARCH CENTER,PHACO EMULSIFICATION HANDPIECE
100,1222074-2017-00028,2017-12-15,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation","['Device Inoperable', 'Device Operational Issue']",['No Code Available'],"INVESTIGATION OF THE SUSPECTED MAIN PEDAL AT DORC INTERNATIONAL COULD NOT REPRODUCE THE CUSTOMER COMPLAINT. THE MAIN PEDAL HAS BEEN SENT TO THE SUPPLIER (B)(4). THE TEST RESULTS OF (B)(4) ARE: THE MAIN PEDAL IS FULL FUNCTIONING WITH THE BACKUP CABLE; THE MAIN PEDAL IS FULL FUNCTIONING IN WIRELESS MODE; THE BATTERY EJECTION BELT OF THE MAIN PEDAL HAS KINKS AT THE LEVEL OF THE BATTERY CONTACTS. THE EJECTION TAPE MAY HAVE BEEN BETWEEN THE CONTACTS OF THE BATTERY AND THE BATTERY COMPARTMENT AT THE CUSTOMER. IT IS ALSO POSSIBLE THAT AT THE CUSTOMER THE BATTERY WAS NOT CORRECTLY PLACED IN THE BATTERY COMPARTMENT AND THEREFORE HAD NO OPTIMAL CONTACT WITH THE BATTERY CONTACTS. THE MAIN PEDAL WILL BE RETURNED FROM (B)(4) TO DORC FOR A DEEPER INVESTIGATION. DORC HAS REPLACED THE SUSPECTED MAIN PEDAL AT THE HOSPITAL. NO FURTHER CORRECTIVE/PREVENTIVE ACTIONS. THE INVESTIGATION RESULTS HAVE BEEN RECEIVED FROM OUR FOOT PEDAL SUPPLIER: (B)(4). THE PEDAL WAS MECHANICALLY DAMAGED: (B)(4) STATED THAT THIS COULD NOT BE THE CAUSE OF ANY WIRELESS CONNECTION PROBLEM. THE PEDAL WAS TESTED ON FUNCTIONALITY IN SEVERAL OCCASIONS AND THE PEDAL COULD BE CONNECTED TO EVA IN ALL CASES. THUS, IT WAS NOT POSSIBLE FOR THE FUNCTIONALITY STOP WORKING DURING USE IN ANY CASES. THE ONLY ISSUE THAT COULD BE FOUND WAS THE FACT THAT THE PEDAL HAD DIFFICULTY GETTING THE WIRELESS CONNECTION TO WORK WHEN IT PAIRED FOR THE FIRST TIME WITH THE EVA MACHINE. HOWEVER, THE WIRELESS FUNCTION COULD BE RESTORED BY CONNECTING AND DISCONNECTING THE CABLE AT A SECOND TIME IN ALL CASES. IN SUMMARY, SINCE ALL THE TESTING ON FUNCTIONALITY OF THE FOOT PEDAL COULD BE RESTORED AND DID NOT FAIL IN ANY CASES DURING USE, WE MUST STATE THAT THE ROOT CAUSE OF THE PROBLEM CANNOT BE FOUND. THE FINAL RESULT IS INCONCLUSIVE. THIS COMPLAINT HAS NOW BEEN CLOSED. INVESTIGATION OF THE SUSPECTED MAIN PEDAL AT DORC INTERNATIONAL COULD NOT REPRODUCE THE CUSTOMER COMPLAINT. THE MAIN PEDAL HAS BEEN SENT TO THE SUPPLIER (B)(4). THE TEST RESULTS OF (B)(4) ARE : THE MAIN PEDAL IS FULL FUNCTIONING WITH THE BACK UP CABLE; THE MAIN PEDAL IS FULL FUNCTIONING IN WIRELESS MODE; THE BATTERY EJECTION BELT OF THE MAIN PEDAL HAS KINKS AT THE LEVEL OF THE BATTERY CONTACTS. THE EJECTION TAPE MAY HAVE BEEN BETWEEN THE CONTACTS OF THE BATTERY AND THE BATTERY COMPARTMENT AT THE CUSTOMER. IT IS ALSO POSSIBLE THAT AT THE CUSTOMER THE BETWEEN CONTACTS OF THE BATTERY AND THE BATTERY COMPARTMENT AT THE CUSTOMER. IT IS ALSO POSSIBLE THAT AT THE CUSTOMER THE BATTERY WAS NOT CORRECTLY PLACED IN THE BATTERY COMPARTMENT AND THEREFORE HAD NO OPTIMAL CONTACT WITH THE BATTERY CONTACTS. THE MAIN PEDAL WILL BE RETURNED FROM (B)(4) TO DORC FOR A DEEPER INVESTIGATION. DORC HAS REPLACED THE SUSPECTED MAIN PEDAL AT THE HOSPITAL. NO FURTHER CORRECTIVE/PREVENTATIVE ACTIONS.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
104,1222074-2018-00007,2018-01-24,D.O.R.C INTERNATIONAL BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Laser, Ophthalmic",['Device Inoperable'],['No Consequences Or Impact To Patient'],"A REPORT HAS BEEN RECEIVED OF AN EVENT THAT OCCURRED IN IRELAND. THE FOOTPEDAL OF EVA IS NOT WORKING AT ALL. THERE IS NO REPORT OF PATIENT INJURY. IT IS UNKNOWN WHEN THE INCIDENT OCCURRED. THE RCA CAN NOT BE FOUND ON THIS FOOT PEDAL. IN (B)(6) 2015, 14 PEDALS WERE EXAMINED, BUT WHETHER THIS PEDAL WAS ONE OF THESE PEDALS IS UNCLEAR. THE RCA OF THESE STUDIES HAVE BEEN STORED. THIS HAS ALREADY BEEN INVESTIGATED AND AFTER AN UPGRADE (FLASH). A NEW FOOT PEDAL HAS BEEN PROVIDED TO THIS FACILITY. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER (DUTCH OPHTHALMIC RESEARCH CENTRE B.V.). DETAILS OF THIS ACTIVITY WERE DISCUSSED WITH CDRH OFFICE OF COMPLIANCE (B)(6)) DURING A TELE-CONFERENCE ON (B)(6) 2017. ALL AVAILABLE INFORMATION HAS BEEN PROVIDED. THIS COMPLAINT HAS NOW BEEN CLOSED",D O R C INTERNATIONAL,EVA COMBINED MACHINE NCBF
105,1222074-2018-00032,2018-02-19,D.O.R.C DUTCH OPHTHALMIC INTERNATIONAL BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Device Operational Issue'],['No Consequences Or Impact To Patient'],"A REPORT HAS BEEN RECEIVED OF AN EVENT THAT OCCURRED IN (B)(6). THE FOLLOWING WAS REPORTED : ""FAILURE WITH FOOT PEDAL DURING DEMO. NEW MAIN PEDAL AND CAN RECEIVER WILL BE SENT"" NO REPORT OF AN INJURY. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. INVESTIGATION SHOWED THAT THE FOOTPEDAL NEEDED A SOFTWARE UPDATE. REPLACEMENT HAS ALREADY BEEN SEND. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER ((B)(4)). DETAILS OF THIS ACTIVITY WERE DISCUSSED WITH CDRH OFFICE OF COMPLIANCE ((B)(6)) DURING A TELE-CONFERENCE ON (B)(6) 2017. THIS COMPLAINT DEEMED REPORTABLE CONSIDERING WORST CASE DURING DEMO/SURGERY, THIS MAY LEAD TO LONG DELAY. HENCE IT IS REPORTABLE. NO INJURY OR ILL EFFECT HAS BEEN REPORTED. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THIS COMPLAINT HAS NOW BEEN CLOSED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
113,1222074-2018-00097,2018-05-04,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Device Operational Issue'],['No Code Available'],"A REPORT FROM (B)(6) WAS RECEIVED AND REPORTED THE FOLLOWING: THE PROBLEM COULD COME FROM A BAD USE OF THE UNIT. SURGERY ON LENS NUCLEUS AT FUNDUS AND THE PROGRAM SELECTION WAS ON THE PHACO FRAGMENTATION (VITRECTOMY AND PHACO WITH LONG NEEDLE). PROGRAM INITIALIZATION AND SELECTION SUCCEEDED. INITIALLY THERE WAS NO PROBLEM WITH VITRECTOMY BUT THEN, WHEN SELECTING THE PHACO FRAGMENTATION STEP AN ERROR MESSAGE OCCURRED WHEN USING THE FOOT PEDAL. AN ATTEMPT WAS MADE TO SELECT A NEW INITIALIZATION AND SELECT THE PHAKO FRAGMENTATION STEP AGAIN AND ONCE AGAIN THE SAME ERROR MESSAGE CONCERNING INACTIVE US OCCURRED. THEY TRIED WITHOUT ANY SUCCESS AN OTHER PHACO HAND PIECE. IT WAS NOT POSSIBLE TO DO THE FRAGMENTATION OF DISLOCATED HARD LENS DEEP IN THE VITREOUS CAVITY. THE SURGERY WAS COMPLETED WITH FRAGMENTATION OF THE LENS LONG AND HARD WITH A VITRECTOMY EXTENDING THE LENGTH OF SURGERY TIME TO AN EXTRA 45MIN. ALL INFORMATION HAS BEEN DISCLOSED. SINCE PHACO FRAGMENTATION DOES NOT WORK PROPERLY DURING SURGERY AND A DELAY IN THE PROCEDURE IS MORE THEN 30 MIN, THIS EVENT IS CONCLUDED AS REPORTABLE. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER (DUTCH OPHTHALMIC RESEARCH CENTRE (B)(4)).DETAILS OF THIS ACTIVITY WERE DISCUSSED WITH CDRH OFFICE OF COMPLIANCE ((B)(6)) DURING A TELE-CONFERENCE ON (B)(6) 2017. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THIS COMPLAINT HAS NOW BEEN CLOSED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
114,1222074-2018-00110,2018-05-10,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Device Operational Issue'],['No Consequences Or Impact To Patient'],"PHACO POWER STARTS CORRECT, BUT IS QUICKLY REDUCED TO TOO LESS POWER WHEN IT PENETRATES THE LENS. DIFFERENT HANDPIECES DID NOT SOLVE THE PROBLEM. NEW PHACO MODULE IS NEEDED. NO FURTHER INFORMATION, ALL HAS BEEN DISCLOSED. SAMPLE IS AVAILABLE. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER (DUTCH OPHTHALMIC RESEARCH CENTRE (B)(4)). DETAILS OF THIS ACTIVITY WERE DISCUSSED WITH CDRH OFFICE OF COMPLIANCE ((B)(6)) DURING A TELE-CONFERENCE ON (B)(6) 2017. THE INVESTIGATION COULD NOT REPRODUCE THE COMPLAINT. THE PHACODIATHERMY MODULE IS WORKING ACCORDING SPECIFICATIONS. ASSUMING WORST CASE DURING SURGERY,PER COMPLAINT DESCRIPTION, THE ALTERNATE HAND PIECE DIDN'T SERVE THE PURPOSE, HENCE THIS CAN BE CONCLUDED AS REPORTABLE. ALL AVAILABLE INFORMATION HAS BEEN PROVIDED. THIS COMPLAINT HAS NOW BEEN CLOSED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
115,1222074-2018-00121,2018-05-11,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Device Operational Issue'],['No Consequences Or Impact To Patient'],"IN (B)(6) THE FOLLOWING WAS DISCOVERED: A PUMP- ERROR 160. THE PUMP PROBLEM OCCURRED ON (B)(6) AT ABOUT 1:00 CLOCK PM DURING A PHACO- SURGERY. THEN TODAY, ON (B)(6), THE ERROR OCCURRED AGAIN AT 9:30 CLOCK AM, DURING A PPV- OPERATION. RESTARTING THE EVA AND REPLACING THE CARTRIDGE WAS NOT HELPFUL. ALL INFORMATION HAS BEEN DISCLOSED. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER (DUTCH OPHTHALMIC RESEARCH CENTRE (B)(4)). DETAILS OF THIS ACTIVITY WERE DISCUSSED WITH CDRH OFFICE OF COMPLIANCE ((B)(6)) DURING A TELE-CONFERENCE ON (B)(6) 2017. THE INCIDENT WILL LEAD TO MAJOR DELAY IN THE SURGERY, THEREFORE THIS COMPLAINT IS CONCLUDED AS REPORTABLE. THIS IS LIKELY DUE TO A PERFORMANCE UNDER SPECIFICATION. THE ASSOCIATED RISK IS A MAJOR DELAY, THEREFORE UPON RETROSPECTIVE REVIEW, THIS COMPLAINT WAS IDENTIFIED AS REPORTABLE. THE COMPLAINT IS CONFIRMED. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THE COMPLAINT HAS NOW BEEN CLOSED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
116,1222074-2018-00123,2018-05-11,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Device Operational Issue'],['Intraocular Infection'],POSSIBLE CONTAMINATION WITH EVA 257 BY A PUMP AND OR A CARTRIDGE MALFUNCTION. A PATIENT WAS DIAGNOSED WITH POST OPERATIVE ENDOPHTHALMITIS. THERE IS NO FURTHER INFORMATION AS TO THE TREATMENT GIVEN TO THIS PATIENT. ALL INFORMATION HAS BEEN DISCLOSED. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER (DUTCH OPHTHALMIC RESEARCH CENTRE (B)(4)). DETAILS OF THIS ACTIVITY WERE DISCUSSED WITH CDRH OFFICE OF COMPLIANCE ((B)(6)) DURING A TELE-CONFERENCE ON (B)(6) 2017. INVESTIGATION REVEALED A CONTAMINATED COMPRESSOR INSTEAD OF THE EVA. THIS HAS BEEN DISCUSSED WITH THE CUSTOMER. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THE COMPLAINT HAS NOW BEEN CLOSED.,DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
117,1222074-2018-00122,2018-05-11,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Device Operational Issue'],['Intraocular Infection'],POSSIBLE CONTAMINATION WITH EVA 257 BY A PUMP AND OR A CARTRIDGE MALFUNCTION. A PATIENT WAS DIAGNOSED WITH POST OPERATIVE ENDOPHTHALMITIS. THERE IS NO FURTHER INFORMATION AS TO THE TREATMENT GIVEN TO THIS PATIENT. ALL INFORMATION HAS BEEN DISCLOSED. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER (DUTCH OPHTHALMIC RESEARCH CENTRE (B)(4)). DETAILS OF THIS ACTIVITY WERE DISCUSSED WITH CDRH OFFICE OF COMPLIANCE ((B)(6)) DURING A TELE-CONFERENCE ON (B)(6) 2017. INVESTIGATION REVEALED A CONTAMINATED COMPRESSOR INSTEAD OF THE EVA. THIS HAS BEEN DISCUSSED WITH THE CUSTOMER. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THE COMPLAINT HAS NOW BEEN CLOSED.,DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
118,1222074-2018-00124,2018-05-11,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Device Operational Issue'],['Intraocular Infection'],POSSIBLE CONTAMINATION WITH EVA 257 BY A PUMP AND OR A CARTRIDGE MALFUNCTION. A PATIENT WAS DIAGNOSED WITH POST OPERATIVE ENDOPHTHALMITIS. THERE IS NO FURTHER INFORMATION AS TO THE TREATMENT GIVEN TO THIS PATIENT. ALL INFORMATION HAS BEEN DISCLOSED. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER (DUTCH OPHTHALMIC RESEARCH CENTRE (B)(4)). DETAILS OF THIS ACTIVITY WERE DISCUSSED WITH CDRH OFFICE OF COMPLIANCE ((B)(6)) DURING A TELE-CONFERENCE ON (B)(6) 2017. INVESTIGATION REVEALED A CONTAMINATED COMPRESSOR INSTEAD OF THE EVA. THIS HAS BEEN DISCUSSED WITH THE CUSTOMER. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THE COMPLAINT HAS NOW BEEN CLOSED.,DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
119,1222074-2018-00125,2018-05-11,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Device Operational Issue'],['Intraocular Infection'],POSSIBLE CONTAMINATION WITH EVA 257 BY A PUMP AND OR A CARTRIDGE MALFUNCTION. A PATIENT WAS DIAGNOSED WITH POST OPERATIVE ENDOPHTHALMITIS. THERE IS NO FURTHER INFORMATION AS TO THE TREATMENT GIVEN TO THIS PATIENT. ALL INFORMATION HAS BEEN DISCLOSED. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER (DUTCH OPHTHALMIC RESEARCH CENTRE (B)(4) ). DETAILS OF THIS ACTIVITY WERE DISCUSSED WITH CDRH OFFICE OF COMPLIANCE ((B)(6)) DURING A TELE-CONFERENCE ON (B)(6) 2017. INVESTIGATION REVEALED A CONTAMINATED COMPRESSOR INSTEAD OF THE EVA. THIS HAS BEEN DISCUSSED WITH THE CUSTOMER. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THE COMPLAINT HAS NOW BEEN CLOSED.,DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
120,1222074-2018-00126,2018-05-14,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Device Operational Issue'],['No Consequences Or Impact To Patient'],"OUR CUSTOMER FACED THE FOLLOWING PROBLEM: DURING SURGERY FOR AN HOUR THERE WAS NO PHACO POWER AT THE CATARACT SURGERY. UNFORTUNATELY RESTARTING FROM THE EVA DID NOT HELP. THE EVA WAS REPLACED BY ANOTHER. PERHAPS THERE IS A PROBLEM WITH THE HAND PIECE. MAYBE THIS IS CAUSED BY HEAT. NO INJURY REPORTED HOWEVER THE EVENT RESULTED IN A PROLONGED DELAY. ALL INFORMATION PERTAINING TO THIS INCIDENT HAS BEEN DISCLOSED. INVESTIGATION COULD NOT REPRODUCE THE COMPLAINT, THE PHACODIATHERMY MODULE IS WORKING ACCORDING SPECIFICATIONS. (B)(4). ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THIS COMPLAINT HAS NOW BEEN CLOSED. IN A RETROSPECTIVE REVIEW OF THIS COMPLAINT, THE ASSOCIATED RISK IS PROLONGED DELAY, THEREFORE DETERMINED TO BE REPORTABLE.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
121,1222074-2018-00133,2018-05-15,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Device Operational Issue'],['No Consequences Or Impact To Patient'],"PUMP ERROR CAR1600 ( SERVO ERROR PUMP ACTUATOR ) OCCURS DURING PHACO. IT FOLLOWS AFTER EACH OTHER. SAMPLE AVAILABLE. ALL INFORMATION AVAILABLE HAS BEEN DISCLOSED. INVESTIGATION DETERMINED SEVERAL DEFECTIVE PARTS INSIDE THE PUMP MODULE. OUR R&D DEPARTMENT IS CURRENTLY TRYING TO RESOLVE THESE ISSUES. THIS OCCURRED DURING PHACO PROCEDURE. THERE WAS AN ERROR IN THE PUMP MODULE, THERE IS NO REPLACEMENT, HENCE CONSIDERED REPORTABLE. ALSO PROLONGED DELAY. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER (DUTCH OPHTHALMIC RESEARCH CENTRE (B)(4).). ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THIS COMPLAINT HAS NOW BEEN CLOSED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
122,1222074-2018-00134,2018-05-16,DUTCH OPTHALMIC RESEARCH CENTER BV,DISPOSABLE HIGH SPEED TDC CUTTER 25 G / 8000 CPM DORC CONTINUUM RANGE,"Instrument, Vitreous Aspiration And Cutting, Ac-Powered",['Device Operational Issue'],['No Consequences Or Impact To Patient'],"DURING OPERATION, AIR BUBBLE HAPPENED. SITUATION IS AS FOLLOWS; EVA SHAVING MODE, 8000CPM, FLOW:SS, VACCUME 600. PLEASE INVESTIGATE IT CAREFULLY AND FIND ROOT CAUSE, AND IMPROVE. SAMPLE IS AVAILABLE. THE INVESTIGATION SHOWED THAT THE PART THAT CONNECTS THE TUBING TO THE VITRECTOME WAS BROKEN AND THE OUTER KNIFE WAS IN A ANGLE. THE INVESTIGATION REGARDING THE AIR BUBBLES COULD NOT BE DONE DUE TO THE BROKEN PART. ASSUMING WORST CASE DURING SURGERY, AIR BUBBLES OBSERVED AT THE PROBE. THIS MAY CAUSE INJURY TO THE PATIENT. HENCE IT IS REPORTABLE. THE RISK IS POSSIBLE INJURY BY MICROBIAL, VIRAL OR PRION INFECTION (PATIENT HARM) THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER (DUTCH OPHTHALMIC RESEARCH CENTRE (B)(4)). DETAILS OF THIS ACTIVITY WERE DISCUSSED WITH CDRH OFFICE OF COMPLIANCE ((B)(6)) DURING A TELE-CONFERENCE ON (B)(4) 2017. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THIS COMPLAINT HAS NOW BEEN CLOSED.",DUTCH OPHTHALMIC RESEARCH CENTER,DISPOSABLE HIGH SPEED TDC CUTTER 25 G 8000 CPM DORC CONTINUUM RANGE
124,1222074-2018-00106,2018-05-23,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Device Operational Issue'],['No Consequences Or Impact To Patient'],"DURING SURGERY, THE SURGEON WAS SWITCHING BETWEEN ANTERIOR (I/A) AND POSTERIOR (VITRECTOME) MODES. WHEN HE SWITCHED OFF THE INFUSION ON HIS FOOT PEDAL DURING I/A MODE, THE MACHINE ASPIRATED AT THE POSTERIOR (CORE VITRECTOMY) MODE, BUT THERE WAS NO INFUSION (THE INFUSION WAS OFF) IN THE MEANWHILE. THE SURGERY WAS COMPLETED WITH THIS DEVICE WITH NO INJURY. THE INVESTIGATION HAS BEEN STARTED. A SUPPLEMENTAL WILL BE REPORTED WHEN NEW INFORMATION IS RECEIVED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
125,1222074-2018-00144,2018-05-23,DUTCH OPTHALMIC RESEARCH CENTER BV,OPHTHALMIC LASER SYSTEM BEAM GUIDE,"Laser, Ophthalmic",['Material Separation'],['No Consequences Or Impact To Patient'],"AN INCIDENT OCCURRED IN (B)(6). THE FOLLOWING HAS BEEN REPORTED: LASER FIBER SEEMED TO BE BROKEN APPROXIMATELY 10CM PRIOR TO THE CONNECTOR. NO LASER BEAM AT THE TIP WHILE THE SURGEON WANTED TO RELEASE THE BEAMS. BUT WE NOTICED BRIGHT RAYS FROM THE BROKEN PART OF THE LASER PROBE, RAYS MIGHT HAVE ESCAPED FROM THE BROKEN PART OF THE FIBER INTO THE ROOM. SAMPLE IS AVAILABLE. THE DEVICE WILL BE SENT TO (B)(6) FOR INVESTIGATION. NO HARM TO A PATIENT. THE LASER PROBE WAS EXCHANGED. THE INVESTIGATION WILL BE STARTED AS SOON AS THE DEVICE IS RECEIVED. A FOLLOW UP WILL BE SUBMITTED FOR ANY NEW INFORMATION.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA OPHTHALMIC SURGICAL SYSTEM
126,1222074-2018-00152,2018-05-24,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Device Operates Differently Than Expected'],['No Consequences Or Impact To Patient'],"MAINBOARD IS GOING TO BOOTLOADER MODUS BY ITSELF DURING SHAVING (NEAR RETINA ) PROCEDURE. ALL WENT RED AND UNIT MUST BE SWITCHED OFF FROM BACKSIDE DURING SURGERY. THE UNIT IS GOING TO BOOTLOADER MODE ITSELF DURING SURGERY, THIS ISSUE CANNOT BE SOLVED RIGHT AWAY HENCE CONSIDERED AS REPORTABLE. (B)(4). ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THE COMPLAINT IS NOT CONFIRMED. THIS COMPLAINT HAS NOW BEEN CLOSED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
127,1222074-2018-00158,2018-05-30,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER (INTERNA,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Infusion or Flow Problem'],"['No Clinical Signs, Symptoms or Conditions']","THE HEAD SURGEON HAS EXPERIENCED TWO OCCASIONS  A VERY SOFT EYE WHEN INJECTING GAS THROUGH THE INFUSION TROCAR. THIS HAS HAPPENED WHEN HE IS GOING FROM AIR TO GAS AND THE OTHER TWO TROCARS HAVE BEEN REMOVED AND HE IS ABOUT TO INJECT GAS.  NO MESSAGE ON SCREEN. FOLLOW-UP (B)(6) 2018: D.O.R.C. RECEIVED MULTIPLE COMPLAINTS ON THE MACHINE CONCERNED. ALTHOUGH DURING A TECHNICAL SERVICE VISIT TO THE LOCATION NO ANOMALIES COULD BE FOUND, IT HAS BEEN DECIDED TO REPLACE THE MACHINE. INVESTIGATION IS BEING CONDUCTED ON THE RETURNED MACHINE.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
128,1222074-2018-00159,2018-05-30,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER (INTERNA,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Infusion or Flow Problem'],"['No Clinical Signs, Symptoms or Conditions']","THE EVA SYSTEM CONTROLS THE PRESSURE OF FLUIDS OR GASES THAT CAN BE PROVIDED USING THE SYSTEM. IT ALSO CONTROLS THE BACK FLUSH. THE EVA SYSTEM PROVIDES FEEDBACK TO THE SURGEON ON THE DEVICE PERFORMANCE. THE EVA SYSTEM IS TESTED AND COMPLIANT WITH IEC 80601 MEDICAL ELECTRICAL EQUIPMENT PART 2-58:2015 PARTICULAR REQUIREMENTS FOR THE BASIC SAFETY AND ESSENTIAL PERFORMANCE OF LENS REMOVAL DEVICES AND VITRECTOMY DEVICES FOR OPHTHALMIC SURGERY. TO FIND OUT THE ROOT CAUSE OF THE REPORTED ISSUE, THE FOLLOWING TESTS WERE PERFORMED: 1) CARTRIDGE PUMP (TESTS ON INFUSION, CONSTANT IRRIGATION, MEASURED ASPIRATION AND INFUSION VGPC); 2) POSTERIOR MODULE (TESTS ON AIR AND VGPC). THESE TESTS EXTENSIVELY CHALLENGE THE FLUIDIC PRESSURE CONTROL SYSTEMS OF EVA, AND INCLUDED MEASUREMENT OF THE PRESSURES DELIVERED BY THE MACHINE. FROM THESE TESTS, NO ANOMALIES RELEVANT TO THE REPORTED ISSUES WERE FOUND. ALL TESTS PASSED THE EXPECTED OUTCOME AND A CAUSE FOR THE REPORTED ISSUE WAS NOT FOUND. THE EVA CONCERNED IS OPERATING AS INTENDED. AT THIS POINT, DESPITE EXTENSIVE TESTING AND GIVEN THE SUBJECTIVE NATURE OF THE COMPLAINT DORC IS UNABLE TO OFFER AN ALTERNATIVE EXPLANATION FOR THE REPORTED ISSUES. D.O.R.C. HAS MADE EXTENSIVE EFFORTS TO REPRODUCE THE REPORTED COMPLAINTS ON THIS MACHINE, BUT THE MACHINE IS OPERATING WITHIN NORMAL PARAMETERS. DORC WILL CONTINUE TO MONITOR THE PERFORMANCE OF BOTH THIS MACHINE AND ALSO OTHER MACHINES THAT MAY BE IN OPERATION AT THIS CUSTOMER, AND WILL RAISE FURTHER REPORTS SHOULD INFORMATION MATERIAL TO THIS CASE EMERGE. THE HEAD SURGEON HAS EXPERIENCED TWO OCCASIONS A VERY SOFT EYE WHEN INJECTING GAS THROUGH THE INFUSION TROCAR. THIS HAS HAPPENED WHEN HE IS GOING FROM AIR TO GAS AND THE OTHER TWO TROCARS HAVE BEEN REMOVED AND HE IS ABOUT TO INJECT GAS. NO MESSAGE ON SCREEN.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
131,1222074-2018-00171,2018-06-05,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Device Operational Issue'],"['Intraocular Pressure, Delayed, Uncontrolled']","A REPORT FROM (B)(6) HAS BEEN RECEIVED AND REPORT A SOFT EYE ISSUE WHEN SWITCHING FROM PHACO TO VITRECTOMY IN 25 COMBINED PROG. AT OUR CUSTOMER THERE ARE INFUSION PROBLEMS ON EVA. THE SURGEON STILL HEARS THE SOUND OF THE DROPS/DROP NOISE, BUT THERE IS NO INFUSION, WHY THE EYES COLLAPSE. THERE IS NO INFORMATION ON INTERVENTION PROVIDED. THIS COMPLAINT WAS REVIEWED DURING THE RETROSPECTIVE REVIEW. INVESTIGATION DETERMINED AN UNSTABLE REDUCER AND DEFECTIVE PCB. AFTER REPLACING THIS PARTS AND READJUSTING THE AIR, THE VFIE MODULE IS WORKING ACCORDING SPECIFICATIONS. THE COMPLAINT IS CONFIRMED. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER ((B)(4). DETAILS OF THIS ACTIVITY WERE DISCUSSED WITH (B)(6) DURING A TELE-CONFERENCE ON (B)(6) 2017. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THIS COMPLAINT HAS NOW BEEN CLOSED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
135,1222074-2018-00187,2018-06-13,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Material Separation'],['No Consequences Or Impact To Patient'],"VIT 3 SEVERAL PRIMING FAILS AND A BREAKDOWN DURING SURGERY. MODULE HAS BEEN REPLACED. MODULE (B)(4) HAS BEEN RETURNED. NO REPORT OF PATIENT INJURY. INVESTIGATION DETERMINED A WRONG AIR ADJUSTMENT, THIS CAN HAPPEN OVERTIME. AFTER RE-ADJUSTING, THE VITRECTOMY MODULE IS WORKING ACCORDING SPECIFICATIONS. VITROCTOME MODULE DEFECT DURING SURGERY, REPLACEMENT RESULTS IN LARGER OR LONG DELAY, HENCE REPORTABLE. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER ((B)(4)). DETAILS OF THIS ACTIVITY WERE DISCUSSED WITH CDRH OFFICE OF COMPLIANCE ((B)(6)) DURING A TELE-CONFERENCE ON (B)(6) 2017. NO INFORMATION REVIEWED REASONABLY SUGGESTS PATIENT INJURY. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THIS COMPLAINT HAS NOW BEEN CLOSED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
136,1222074-2018-00191,2018-06-19,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Device Operational Issue'],['No Code Available'],"THEY STOP THE SURGERY AND TRANSFER THE PATIENT. PCB HOLDER CHARGED 2 TIMES, MAIN PEDAL CHANGED 5 TIMES . FOP ERROR BLOCKAGE DURING SURGERY. IN A REVIEW THE INFORMATION REASONABLY SUGGESTS THAT THIS PATIENT WAS UNDERGOING SURGERY WHEN THE INCIDENT OCCURRED AND THE PATIENT WAS TRANSFERRED TO ANOTHER UNIT FOR COMPLETION OF THE SURGERY. ALL INFORMATION HAS BEEN DISCLOSED. MAIN VOLTAGE OF FOOT PEDAL IS TOO LOW ((B)(4)).PCB HOLDER CHANGED 2 TIMES, MAIN PEDAL CHANGED 5 TIMES & STOPPED SURGERY, HENCE CAN BE CONCLUDED AS REPORTABLE. INFORMATION SUGGESTS THIS OCCURRED DURING SURGERY REQUIRED TRANSFER OF THE PATIENT TO ANOTHER UNIT FOR COMPLETION OF THE SURGERY. THIS IS A DELAY AND PLACED THIS PATIENT AT RISK. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER ((B)(4)). DETAILS OF THIS ACTIVITY WERE DISCUSSED WITH CDRH OFFICE OF COMPLIANCE ((B)(6)) DURING A TELE-CONFERENCE ON (B)(6) 201 THERE IS NO INFORMATION THAT REASONABLY SUGGESTS PATIENT INJURY OCCURRED. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THIS COMPLAINT HAS NOW BEEN CLOSED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
137,1222074-2018-00202,2018-06-22,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Device Operational Issue'],['No Consequences Or Impact To Patient'],"PUMP IN ERROR ""PUMP152"" AND SYSTEM NOT WORKING. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER ((B)(4)). DETAILS OF THIS ACTIVITY WERE DISCUSSED WITH CDRH OFFICE OF COMPLIANCE ((B)(6)) DURING A TELE-CONFERENCE ON (B)(6). THE INVESTIGATION PUMP 152, MOTOR BROKE ERROR, SINCE THIS CANNOT RECTIFIED RIGHT AWAY. HENCE CONSIDERED AS REPORTABLE. AN INCIDENT LIKE THIS COULD LEAD TO A PROLONGED DELAY. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THIS COMPLAINT HAS NOW BEEN CLOSED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
138,1222074-2018-00157,2018-06-25,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation","['Device Displays Incorrect Message', 'Device Operates Differently Than Expected']",['No Consequences Or Impact To Patient'],"DURING SURGERY PHACO WENT LOWER AND LOWER; CHANGED HP NO US POWER. ERROR CODE PHA 103/104. THIS COMPLAINT WAS REVIEWED DURING THE RETROSPECTIVE REVIEW. AN ERROR CODE, PHA 103/104, OCCURRED DURING SURGERY, AND HAD TO BE REPLACED, HENCE REPORTABLE. THIS COULD LEAD TO A PROLONGED DELAY. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER ((B)(4)). DETAILS OF THIS ACTIVITY WERE DISCUSSED WITH CDRH OFFICE OF COMPLIANCE ((B)(6)) DURING A TELE-CONFERENCE ON (B)(6) 2017. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THIS COMPLAINT HAS NOW BEEN CLOSED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
139,1222074-2018-00207,2018-06-26,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Device Operational Issue'],['No Consequences Or Impact To Patient'],"AFTER SALES ASKED US TO ENTER THE FOLLOWING COMPLAINT: THE SURGEON EXPERIENCED A SOFT EYE DURING A VITRECTOMY PROCEDURE (PEELING). THE EYE BECAME SOFT AND HE WAS LOOKING AT THE SCREEN AND NOTICED THAT THE IRRIGATION WAS TURNED OFF BY ITSELF. HE WAS NOT INFORMED BY THE SYSTEM ( VOICE) THAT IT WAS TURNED OFF. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER ((B)(6)). DETAILS OF THIS ACTIVITY WERE DISCUSSED WITH (B)(6) OF COMPLIANCE ((B)(6)) DURING A TELE-CONFERENCE ON (B)(6). AS PER COMPLAINT DESCRIPTION, IRRIGATION TURNED OFF AND IT WAS NOT INFORMED BY THE UNIT. THIS WOULD HAVE HAD SERIOUS IMPACT TO PATIENT IF SURGEON DID NOT NOTICE THE UNIT AND HENCE THIS COMPLAINT IS CONCLUDED AS REPORTABLE. THE HARM WAS A POSSIBLE HYPOTONY. NO INFORMATION REVIEWED SUGGESTS THAT THIS PATIENT WAS HARMED. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THIS COMPLAINT HAS NOW BEEN CLOSED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
140,1222074-2018-00208,2018-06-26,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Device Operational Issue'],['No Consequences Or Impact To Patient'],"COMPLAINT: IRRIGATION SPONTANEOUSLY SWITCHES OFF, NO VERBAL ANNOUNCEMENT FROM EVA. IRRIGATION ICON TURNS STATIS (NO FADING EFFECT), TEXT: ""IRRIGATION OFF"" IS SHOWN. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER (DUTCH OPHTHALMIC RESEARCH CENTRE B.V.). DETAILS OF THIS ACTIVITY WERE DISCUSSED WITH CDRH OFFICE OF COMPLIANCE ((B)(6)) DURING A TELE-CONFERENCE ON (B)(6). AS PER COMPLAINT DESCRIPTION, IRRIGATION TURNED OFF AND IT WAS NOT INFORMED BY THE UNIT. THIS WOULD HAVE HAD SERIOUS IMPACT TO PATIENT IF SURGEON DID NOT NOTICE THE UNIT AND HENCE THIS COMPLAINT IS CONCLUDED AS REPORTABLE. THE HARM WAS A POSSIBLE HYPOTONY. NO INFORMATION REVIEWED SUGGESTS THAT THIS PATIENT WAS HARMED. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THIS COMPLAINT HAS NOW BEEN CLOSED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
143,1222074-2018-00211,2018-06-28,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Device Operational Issue'],"['Intraocular Pressure, Delayed, Uncontrolled']","IRRIGATION SPONTANEOUSLY SWITCHES OFF DURING OIL EXTRACTION, NO ALERT FROM THE EVA THAT THE IRRIGATION WAS SWITCHED OFF. THIS CAUSED A SOFT EYE. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER ((B)(4)). DETAILS OF THIS ACTIVITY WERE DISCUSSED WITH CDRH OFFICE OF COMPLIANCE ((B)(6)) DURING A TELE-CONFERENCE ON (B)(6). AS PER COMPLAINT DESCRIPTION, IRRIGATION TURNED OFF AND IT WAS NOT INFORMED BY THE UNIT. THIS WOULD HAVE HAD SERIOUS IMPACT TO PATIENT IF SURGEON DID NOT NOTICE THE UNIT AND HENCE THIS COMPLAINT IS CONCLUDED AS REPORTABLE. THE HARM WAS A POSSIBLE HYPOTONY. NO INFORMATION REVIEWED REASONABLY SUGGESTS THAT THIS PATIENT WAS HARMED. INFORMATION REPORTED THE PATIENT HAD A SOFT EYE. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THIS COMPLAINT HAS NOW BEEN CLOSED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
144,1222074-2018-00212,2018-06-29,DUTCH OPTHALMIC RESEARCH CENTER BV,DISPOSABLE HIGH SPEED TDC CUTTER 27 G / 8000 CPM DORC CONTINUUM RANGE,"Instrument, Vitreous Aspiration And Cutting, Ac-Powered",['Device Contamination with Chemical or Other Material'],['No Consequences Or Impact To Patient'],THERE WAS SOMETHING ON THE CUTTER. (B)(4). DIRT ON THE CUTTER CAN LEAD TO PATIENT HARM. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THIS COMPLAINT HAS NOW BEEN CLOSED.,DUTCH OPHTHALMIC RESEARCH CENTER,DISPOSABLE HIGH SPEED TDC CUTTER 25 G 8000 CPM DORC CONTINUUM RANGE
145,1222074-2018-00213,2018-06-29,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Device Operational Issue'],"['Eye Injury', 'Intraocular Pressure Increased']",DUE TO A LASER DEFECT THEY HAD TO REPRIME THE MACHINE AT A STAGE OF THE AIR INJECTION SURGICAL STEP. THIS HAS CAUSED AN INCREASE IN THE EYE PRESSURE AS THE TUBING WAS STILL CONNECTED. ADDITIONALLY INFORMATION REPORTED THAT THE INCREASE IN PRESSURE CAUSED RETINAL ISCHEMIA AND LOSS OF EYE. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER (DUTCH OPHTHALMIC RESEARCH CENTRE B.V.). DETAILS OF THIS ACTIVITY WERE DISCUSSED WITH CDRH OFFICE OF COMPLIANCE ((B)(6)) DURING A TELE-CONFERENCE ON (B)(6). ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THIS COMPLAINT HAS NOW BEEN CLOSED.,DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
146,1222074-2018-00224,2018-07-05,DUTCH OPTHALMIC RESEARCH CENTER BV,"EVA, COMBINED MACHINE INCLUDING LASER (DORC CONNECTOR)","Unit, Phacofragmentation",['Device Operational Issue'],['No Consequences Or Impact To Patient'],"DURING VITRECTOMY PRESSURE ROSE TO 111 MMHG AND WOULD NOT REDUCE, HIGHLY DANGEROUS TO OPTIC NERVE. UNFORTUNATELY WE CAN'T SEE WHY THE SYSTEM GOT STUCK. THEY DID A LOT OF PROGRAMMING THIS DAY MAYBE THIS CAUSED THE PROBLEM, WE DON'T KNOW. RECOMMEND TO JOIN THE SURGEONS A COMPLETE DAY AND MONITOR THE UNIT, BETTER SHOULD BE TO CHECK UP THE UNIT BEFORE USE. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A VOLUNTARY RETROSPECTIVE REVIEW OF ALL COMPLAINTS SINCE 2015 BY THE MANUFACTURER (DUTCH OPHTHALMIC RESEARCH CENTRE B.V.). DETAILS OF THIS ACTIVITY WERE DISCUSSED WITH CDRH OFFICE OF COMPLIANCE ((B)(6)) DURING A TELE-CONFERENCE ON (B)(6) 2018. DURING SURGERY THE PRESSURE ROSE TO ITS MAXIMUM THIS COULD CAUSE RETINAL ISCHEMIA. HENCE REPORTABLE. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. THIS COMPLAINT HAS NOW BEEN CLOSED.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA COMBINED MACHINE NCBF
149,1222074-2018-00243,2018-12-26,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER (INTERNA,EVA VITRECTOMY PACK VGPC INPUT 25G,Vitrectomy Kit,['Complete Blockage'],"['Intraocular Pressure, Delayed, Uncontrolled']","INTRAOCULAR INFUSION BLOCKAGE DURING A 25G VITRECTOMY. SUDDEN HYPOTOMY OF THE EYE DURING SURGERY. SINCE THE CONCERNED PRODUCT WAS NOT RETURNED TO DORC, NO PHYSICAL EXAMINATION COULD BE PERFORMED TO CONFIRM THE ALLEGED FAILURE OR TO DETERMINE ITS CAUSE. IT IS POSSIBLE THAT OBSTRUCTION OF THE STANDARD INFUSION LINE OCCURS WHEN THE TIP IS INSERTED INTO THE CANNULA IN AN OBLIQUE ANGLE AND THE CLOSURE VALVE GETS (PARTIALLY) TRAPPED BETWEEN THE CAPILLARY OF THE TIP AND THE CANNULA ITSELF. A PIECE OF CLOSURE VALVE THAT GETS PUNCHED OUT DURING INSERTION OF THE INFUSION LINE OBSTRUCTS THE INFUSION LINE AND CAN RESULT IN COMPROMISED IRRIGATION. IT SHOULD BE NOTED THAT THE PROPER WAY TO INSERT THE INFUSION LINE IS DEPICTED IN THE USER INSTRUCTIONS PROVIDED WITH THIS PRODUCT. OTHER POTENTIAL CAUSES OF BLOCKAGE ARE POSSIBLE, FOR EXAMPLE IF THE INFUSION LINE BECOMES TRAPPED OR KINKED BY MANIPULATION DURING SURGERY. WITHOUT RETURN OF THE PRODUCT IS NOT POSSIBLE TO DETERMINE ROOT CAUSE WITH ANY CERTAINTY. [(B)(4)].",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
150,1222074-2019-00002,2019-01-04,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER (INTERNA,EVA TDC VITRECTOMY PACK VGPC INPUT 25G,Vitrectomy Kit,['Packaging Problem'],['No Known Impact Or Consequence To Patient'],"POSSIBLE PACKAGING INTEGRITY ISSUE WHICH WAS DETECTED BEFORE USE. THE PRODUCT IS RETURNED, INITIAL ANALYSIS TO DETERMINE THE NATURE AND ROOT CAUSE OF THE PACKAGING ISSUE IS IN PROGRESS. ON 28-12-2018: DORC HAS RECEIVED THREE COMPLAINTS RELATED TO THE INTEGRITY OF THA PACKAGING: (B)(4). THE INVESTIGATION OF THE COMPLAINTS WAS COMBINED. THE ANALYSES OF THE RESULTS OF THE INVESTIGATION WAS AS FOLLOWS: THIS PACKAGING IS INDUSTRY-STANDARD TYVEK AND PET-G TRAY, AND THE DESIGN WAS SUCCESSFULLY VALIDATED AND VERIFIED DURING THE DESIGN PROCESS AND SUBSEQUENT PERIODIC RE-VALIDATION. THE IN-PRODUCTION CONTROL IS DOCUMENTED IN THE BATCH RECORDS OF THE LOT OF THIS PRODUCT, NO RELEVANT ANOMALIES IN BATCH RECORDS HAVE BEEN FOUND. RELEVANT RECORDS FOR SEAL TENSILE STRENGTH TESTING (WHICH IS PERFORMED ON EVERY BATCH) SHOWED SEAL STRENGTHS WITHIN THE NORMAL DISTRIBUTION EXPECTED. ALL COMPLAINT SAMPLES OF THE CURRENT THREE COMPLAINTS USE THE SAME BATCHES OF TYVEK AND PET-G TRAYS (THIS IS NOT UNEXPECTED, BATCHES ARE VERY LARGE AND CAN SPAN SEVERAL MONTHS OF PRODUCTION FOR DORC.) ALL BATCHES USED THE SAME SEALING PARAMETERS, WHICH WERE WITHIN THE VALIDATED SEALING WINDOW. IN ALL CASES, THE TYVEK AND ASSOCIATED HOT-MELT ADHESIVE HAS BEEN INVESTIGATED AND SHOWS CLEAR EVIDENCE OF ADHESIVE HAVING BEEN NORMALLY MELTED. COMPLAINTS (B)(4) APPEAR TO SHOW A KNOWN PHENOMENA WITH THIS PACKAGING TYPE, SPECIFICALLY THE SEAL APPEARS TO HAVE EXHIBITED CREEP, LIKELY DURING THE STERILIZATION PROCESS. DURING THIS PROCESS, BOTH HIGH TEMPERATURE AND A PRESSURE DIFFERENTIAL (INTERNAL OF THE TRAY AT HIGHER PRESSURE TRANSIENTLY THAN THE CHAMBER) ARE MAINTAINED. ALTHOUGH THE POROSITY OF THE TYVEK ALLOWS EQUALIZATION, IT IS KNOWN THAT THE SEAL CAN CREEP DURING THIS PROCESS. IT IS PARTLY FOR THIS REASON THAT A SEAL WIDTH OF 6MM IS SPECIFIED IN THE STANDARD. IN THESE TWO COMPLAINT SAMPLES, IT IS NOT POSSIBLE FROM VISUAL INSPECTION TO TELL IF THE CREEP THREATENED THE INTEGRITY OF THE SEAL. ADDITIONAL TEST WERE PERFORMED: 100 PACKS (FROM RETAINED, STERILIZED FINISHED PRODUCT MADE AT A SIMILAR TIME TO THE COMPLAINT SAMPLES, AND USING IDENTICAL SEALING PARAMETERS) WERE PEELED TO OBSERVE FOR ANY SEALING DEFECTS. IN A NUMBER OF CASES, PEELING ARTEFACT'S WERE NOTED. UPON DETAILED REVIEW (AND IN CONJUNCTION WITH THE MANUFACTURER OF THE PACKAGING) IT IS CONCLUDED THAT THESE ARTEFACT'S DO NOT REPRESENT SEAL INTEGRITY ISSUES. SUCH ARTEFACT'S REPRESENT LOCAL AREAS WHERE THE ADHESIVE IS PREFERENTIALLY RETAINED BY THE TYVEK AND NOT THE PET-G. THIS SITUATION CAN BE CREATED BY PEEL ANGLE (THE RELATIVE ANGLE OF THE LID AND TRAY DURING PEELING), PEELING FORCE AND SPEED AND OTHER FACTORS. IT IS CONCLUDED THAT THE ARTEFACT'S SEEN DO NOT REPRESENT INTEGRITY ISSUES. THIS IS SUPPORTED BY REVIEW OF THE TYVEK ON THE SAMPLES DESCRIBED BELOW, WHERE IN ALL CASES THE ADHESIVE IS FULLY MELTED. THIS WOULD NOT BE THE CASE IN THE EVENT OF ""COLD SPOTS"" OR OTHER SEALING PROCESS ISSUES. THIS CONCLUSION IS FURTHER SUPPORTED AS SUBSEQUENT TO THIS PEEL TESTING, DYE PENETRATION TESTING WAS PERFORMED ON AN ADDITIONAL 299 PACKS ACCORDING TO THE STANDARD METHOD. NO SEAL INTEGRITY ISSUES WERE OBSERVED. THIS SUGGESTS THAT NO ISSUES THREATENING THE INTEGRITY OF THE SEAL EXIST IN THESE PACKS. CONCLUSION: IN THE CASES OF (B)(4) IT REMAINS POSSIBLE THAT SEAL INTEGRITY WAS IMPACTED BY CREEP DURING THE STERILIZATION PROCESS. THIS CAN HAPPEN IN ANY STERILIZATION PROCESS. INVESTIGATION ON CONTEMPORARY PRODUCT OF THE SAME TYPE (FROM IDENTICAL BATCHES OF RAW MATERIALS AND SEALING CONDITIONS) DOES NOT HIGHLIGHT ANY SEAL INTEGRITY FAILURES VIA DYE PENETRATION, AND A REVIEW OF ALL BATCH RECORDS DOES NOT SHOW ANY SEAL STRENGTH MEASUREMENTS WHICH GIVE RISE TO CONCERNS OVER SEAL STRENGTH. IN THE CASE OF (B)(4) NO SIGNS OF CREEP ARE IDENTIFIED ON THE RETURNED MATERIAL. THE AVAILABLE EVIDENCE STRONGLY SUGGESTS THAT THE COMPLAINT RELATES TO A PEELING ARTEFACT'S AND IS NOT AN INDICATOR OF POOR SEAL QUALITY.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
151,1222074-2019-00003,2019-01-04,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER (INTERNA,EVA TDC VITRECTOMY PACK VGPC INPUT 25G,Vitrectomy Kit,['Packaging Problem'],['No Known Impact Or Consequence To Patient'],"POSSIBLE PACKAGING INTEGRITY ISSUE WHICH WAS DETECTED BEFORE USE. ON 28-12-2018: DORC HAS RECEIVED THREE COMPLAINTS RELATED TO THE INTEGRITY OF THA PACKAGING: (B)(4). THE INVESTIGATION OF THE COMPLAINTS WAS COMBINED. THE ANALYSES OF THE RESULTS OF THE INVESTIGATION WAS AS FOLLOWS: THIS PACKAGING IS INDUSTRY-STANDARD TYVEK AND PET-G TRAY, AND THE DESIGN WAS SUCCESSFULLY VALIDATED AND VERIFIED DURING THE DESIGN PROCESS AND SUBSEQUENT PERIODIC RE-VALIDATION. THE IN-PRODUCTION CONTROL IS DOCUMENTED IN THE BATCH RECORDS OF THE LOT OF THIS PRODUCT, NO RELEVANT ANOMALIES IN BATCH RECORDS HAVE BEEN FOUND. RELEVANT RECORDS FOR SEAL TENSILE STRENGTH TESTING (WHICH IS PERFORMED ON EVERY BATCH) SHOWED SEAL STRENGTHS WITHIN THE NORMAL DISTRIBUTION EXPECTED. ALL COMPLAINT SAMPLES OF THE CURRENT THREE COMPLAINTS USE THE SAME BATCHES OF TYVEK AND PET-G TRAYS (THIS IS NOT UNEXPECTED, BATCHES ARE VERY LARGE AND CAN SPAN SEVERAL MONTHS OF PRODUCTION FOR DORC.) ALL BATCHES USED THE SAME SEALING PARAMETERS, WHICH WERE WITHIN THE VALIDATED SEALING WINDOW. IN ALL CASES, THE TYVEK AND ASSOCIATED HOT-MELT ADHESIVE HAS BEEN INVESTIGATED AND SHOWS CLEAR EVIDENCE OF ADHESIVE HAVING BEEN NORMALLY MELTED. COMPLAINTS (B)(4) APPEAR TO SHOW A KNOWN PHENOMENA WITH THIS PACKAGING TYPE, SPECIFICALLY THE SEAL APPEARS TO HAVE EXHIBITED CREEP, LIKELY DURING THE STERILIZATION PROCESS. DURING THIS PROCESS, BOTH HIGH TEMPERATURE AND A PRESSURE DIFFERENTIAL (INTERNAL OF THE TRAY AT HIGHER PRESSURE TRANSIENTLY THAN THE CHAMBER) ARE MAINTAINED. ALTHOUGH THE POROSITY OF THE TYVEK ALLOWS EQUALIZATION, IT IS KNOWN THAT THE SEAL CAN CREEP DURING THIS PROCESS. IT IS PARTLY FOR THIS REASON THAT A SEAL WIDTH OF 6MM IS SPECIFIED IN THE STANDARD. IN THESE TWO COMPLAINT SAMPLES, IT IS NOT POSSIBLE FROM VISUAL INSPECTION TO TELL IF THE CREEP THREATENED THE INTEGRITY OF THE SEAL. ADDITIONAL ""TEST WERE"" PERFORMED: 100 PACKS (FROM RETAINED, STERILIZED FINISHED PRODUCT MADE AT A SIMILAR TIME TO THE COMPLAINT SAMPLES, AND USING IDENTICAL SEALING PARAMETERS) WERE PEELED TO OBSERVE FOR ANY SEALING DEFECTS. IN A NUMBER OF CASES, PEELING ""ARTEFACT'S"" WERE NOTED. UPON DETAILED REVIEW (AND IN CONJUNCTION WITH THE MANUFACTURER OF THE PACKAGING) IT IS CONCLUDED THAT THESE ""ARTEFACT'S"" DO NOT REPRESENT SEAL INTEGRITY ISSUES. SUCH ""ARTEFACT'S"" REPRESENT LOCAL AREAS WHERE THE ADHESIVE IS PREFERENTIALLY RETAINED BY THE TYVEK AND NOT THE PET-G. THIS SITUATION CAN BE CREATED BY PEEL ANGLE (THE RELATIVE ANGLE OF THE LID AND TRAY DURING PEELING), PEELING FORCE AND SPEED AND OTHER FACTORS. IT IS CONCLUDED THAT THE ""ARTEFACT'S"" SEEN DO NOT REPRESENT INTEGRITY ISSUES. THIS IS SUPPORTED BY REVIEW OF THE TYVEK ON THE SAMPLES DESCRIBED BELOW, WHERE IN ALL CASES THE ADHESIVE IS FULLY MELTED. THIS WOULD NOT BE THE CASE IN THE EVENT OF ""COLD SPOTS"" OR OTHER SEALING PROCESS ISSUES. THIS CONCLUSION IS FURTHER SUPPORTED AS SUBSEQUENT TO THIS PEEL TESTING, DYE PENETRATION TESTING WAS PERFORMED ON AN ADDITIONAL (B)(4) PACKS ACCORDING TO THE STANDARD METHOD. NO SEAL INTEGRITY ISSUES WERE OBSERVED. THIS SUGGESTS THAT NO ISSUES THREATENING THE INTEGRITY OF THE SEAL EXIST IN THESE PACKS. CONCLUSION: IN THE CASES OF (B)(4) IT REMAINS POSSIBLE THAT SEAL INTEGRITY WAS IMPACTED BY CREEP DURING THE STERILIZATION PROCESS. THIS CAN HAPPEN IN ANY STERILIZATION PROCESS. INVESTIGATION ON CONTEMPORARY PRODUCT OF THE SAME TYPE (FROM IDENTICAL BATCHES OF RAW MATERIALS AND SEALING CONDITIONS) DOES NOT HIGHLIGHT ANY SEAL INTEGRITY FAILURES VIA DYE PENETRATION, AND A REVIEW OF ALL BATCH RECORDS DOES NOT SHOW ANY SEAL STRENGTH MEASUREMENTS WHICH GIVE RISE TO CONCERNS OVER SEAL STRENGTH. IN THE CASE OF (B)(4) NO SIGNS OF CREEP ARE IDENTIFIED ON THE RETURNED MATERIAL. THE AVAILABLE EVIDENCE STRONGLY SUGGESTS THAT THE COMPLAINT RELATES TO A PEELING ""ARTEFACT'S"" AND IS NOT AN INDICATOR OF POOR SEAL QUALITY. (B)(4).",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
181,1222074-2020-00005,2020-01-27,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER (INTERNA,EVA VITRECTOMY TDC KIT 23G,"Unit, Phacofragmentation",['Defective Component'],['No Known Impact Or Consequence To Patient'],"DR. (B)(6) & DR. (B)(6) MENTIONED PROBLEMS WITH THE MACHINE DURING SURGERY, THEY COULD CONTINUE THE SURGERY WITH A NEW CASSETTE & TUBING. THEY USED ALL MATERIAL AS ALWAYS AND WERE NOT ABLE TO SEE WHY THE EYE COLLAPSED, FIRSTLY THEY THOUGHT THE TUBING FROM THE 3-WAY-VALVE INTO THE TROCAR WAS DEFECTIVE BUT THAT WAS NOT THE CAUSE OF THE PROBLEM - THEY THINK THAT THE TUBING ITSELF WAS CAUSING THE PROBLEM. ONLY THE CARTRIDGE AND VITRECTOME WERE RETURNED; NOT THE INFUSION SET AND THE I/A TUBING. THESE WERE PRIMED ON THE EVA 113 USING THE POSTERIOR PROCEDURE. PRIMING WAS SUCCESSFUL AND NO VISUAL DEFECTS WITH THE RETURNED DEVICES WERE FOUND. HENCE, THE PRODUCTS RETURNED TO DORC PERFORMED AS EXPECTED. IN ADDITION, ANALYSIS OF THE DETAILED LOG FILES OF THE EVA CONCERNED INDICATED THAT THE MEASURED IRRIGATION AND ASPIRATION PRESSURES AT THE PUMP LEVEL CORRESPONDED TO THE SETTINGS. FROM THIS, THE CONCLUSION CAN BE DRAWN THAT THE INFUSION TUBING (BSS BOTTLE TO CARTRIDGE) FUNCTIONED WELL. BATCH RECORD REVIEW AND BATCH HISTORY REVIEW DID NOT REVEAL ANY ANOMALIES. HENCE, BASED UPON THE INVESTIGATIONS PERFORMED THE ROOT CAUSE OF THE ISSUE DESCRIBED IN THE COMPLAINT CAN NOT BE DETERMINED BASED UPON THE PRODUCTS RECEIVED AND THE LOG FILES REVIEWED AND IS THEREFORE UNKOWN/INCONCLUSIVE. NO DEFECT COULD BE IDENTIFIED RELATED TO THE PRODUCTS RETURNED TO DORC. IT IS POSSIBLE THAT THE LOW PRESSURE IN THE EYE COULD HAVE BEEN CAUSED BY INCORRECT MACHINE SETTINGS BEING USED DURING THE PROCEDURE OR A KINKED TUBING AT THE TIME OF SURGERY.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA VITRECTOMY TDC KIT 23G
182,1222074-2020-00007,2020-01-27,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER (INTERNA,EVA,"Unit, Phacofragmentation","['Failure to Cut', 'No Pressure']",['No Known Impact Or Consequence To Patient'],"CUTTER STOP WORKING WITHOUT ANY ERROR MSG, CUTTING SOUND (TIK TIK TIK) IS COMING FROM THE VITRECTOMY MODULE BUT AIR PRESSURE (RESPONSIBLE TO DRIVE THE CUTTER) IS NOT COMING OUT FROM THE MODULE SEEM LIKE SOME BLOCKAGE IN THE MODULE. SURGERY HAD TO BE ABORTED DUE TO THIS EVENT. A VISUAL INSPECTION OF THE RETURNED DEVICE FOUND THAT THE GUARANTEE SEALS OF THE MODULE HAD BEEN BROKEN OPEN. TIMING OF THE OPENING OF THE MODULE IS UNCLEAR. WHEN THE RETURNED MODULE WAS TESTED IT COULD IMMEDIATELY BE OBSERVED THAT THE VALVE SET DID NOT WORK PROPERLY AND THE CUTTER DID NOT WORK. FURTHER ANALYSIS DETERMINED THAT THE WHITE VALVE WAS NOT WORKING PROPERLY. THE CAUSE OF THIS WAS THAT THE VALVE WAS STUCK BY DIRT. THE VALVE WAS THEREFORE NOT RESPONDING AND NO AIR WAS COMING OUT OF CONNECTOR. IT SHOULD BE NOTED THAT IN ACCORDANCE WITH THE INSTRUCTION MANUAL THE USER MUST NOT DO ANY MAINTENANCE, OR CALIBRATION OF THE EVA THAT REQUIRE AN OPENING OF THE DEVICE. ALL MAINTENANCE ACTIVITIES THAT REQUIRE OPENING OF THE PROTECTIVE HOUSING HAVE TO BE DONE BY SERVICE PERSONNEL THAT HAS BEEN TRAINED AND AUTHORIZED BY D.O.R.C. INTERNATIONAL. BASED UPON THE FACT THAT TIMING OF THE OPENING OF THE MODULE IS UNCLEAR THE ORIGIN AND TIMING OF THE DIRT ACCUMULATION CAN NOT BE DETERMINED. DORC WILL CONTINUE TO MONITOR THE SAFETY OF ITS DEVICES ON THE MARKET.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
186,1222074-2020-00011,2020-02-11,D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER (INTERNA,EVA TDC VITRECTOMY PACK VGPC INPUT 27G,"Unit, Phacofragmentation",['Adverse Event Without Identified Device or Use Problem'],['Foreign Body In Patient'],"DURING SURGERY THE SURGEON NOTICED THAT THERE WAS A VERY SMALL PARTICLE RESTING ON THE RETINA. THIS PARTICLE WAS REMOVED WITH THE BACK FLUSH INSTRUMENT. SURGEON WOULD LIKE TO KNOW IF THIS PARTICLE COULD POSSIBLY COME FROM THE VITRECTOR OR THE FORCEPS BEING USED DURING THIS SURGERY. THIS COMPLAINT FORM IS FROM THE VITRECTOMY ONLY. PATIENT CHECKED NEXT DAY FOR ANY REACTION TO THE PARTICLE - NONE, ALL IS WELL. REGARDING THIS EVENT BOTH A DISPOSABLE MICROFORCEPS AND A VITRECTOMY CUTTER WERE RECEIVED FOR INVESTIGATION. THE PARTICLE WAS NOT RETURNED AS THIS WAS ASPIRATED DURING SURGERY AND NOT RETAINED FOR INVESTIGATION. THE PRODUCTS (I.E. MICROFORCEPS AND VITRECTOMY CUTTER) WERE VISUALLY INSPECTED TO EVALUATE WHETHER THEY WERE THE SOURCE TO THE PARTICLES OBSERVED DURING SURGERY. REGARDING THE VITRECTOMY CUTTER RETURNED FOR INVESTIGATION IT WAS NOTED THAT THE SHAFT OF THE CUTTER WAS BENT. HOWEVER, THIS IS EXCLUDED AS A POTENTIAL SOURCE OF THE PARTICLE IDENTIFIED IN THE PATIENT'S EYE, BECAUSE IT IS NOT IN A DIRECT CONTACT WITH THE EYE DURING A SURGERY. FURTHERMORE, IT CAN NOT BE RULED OUT THAT THIS DAMAGE OCCURRED AFTER SURGERY AND/OR DURING TRANSPORT OF THE DEVICE BACK TO DORC (I.E. ITEMS WERE RETURNED IN A BOX WITHOUT ANY PROTECTION). THOROUGH VISUAL INSPECTION REVEALED A SMALL BURR ON THE INNER FACET OF THE OUTER KNIFE. DUE TO THE NATURE OF THE MANUFACTURING PROCESS, IT IS FORESEEN THAT OCCASIONAL BURRS WILL FORM DURING USE AND IN RARE CASES THESE BURRS MAY SHED DURING SURGERY (SUCH A FAILURE MODE IS COMMON TO ALL RECIPROCATING VITRECTOMY CUTTERS). HOWEVER, IT IS IMPORTANT TO NOTE THAT ONLY IN CASE OF A VERY LOW OR LACK OF ASPIRATION DURING A VITRECTOMY PROCEDURE IT IS POSSIBLE FOR A BURR TO GET INSIDE AN EYE. NO PROBLEMS WITH FUNCTIONING OF ASPIRATION AT THE TIME OF THE EVENT WERE REPORTED BY THE CUSTOMER. IN ADDITION, DHR REVIEW OF THE VITRECTOMY CUTTER DID NOT SHOW ANY DEVIATIONS. AS THE PARTICLE OBSERVED DURING SURGERY WAS ASPIRED BY THE SURGEON AND NOT RETAINED FOR INVESTIGATION, IT IS NOT POSSIBLE TO CLEARLY DETERMINE IF THE PARTICLE ORIGINATED FROM THE INSTRUMENT INVESTIGATED. IN CONCLUSION, THE INVESTIGATION FINDINGS DO NOT LEAD TO A CLEAR CONCLUSION ABOUT THE CAUSE OF THE REPORTED ADVERSE EVENT.",DUTCH OPHTHALMIC RESEARCH CENTER,EVA
